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Abstract 
 Protein kinase CK2 is a serine/threonine kinase with a multitude of substrates and 
roles in many cellular processes, including mitosis.  CK2 is constitutively active, yet we 
hypothesize that CK2 is indeed regulated in mitosis through subtle means, enabling CK2 
to perform its functions unique to cell division. Our aims were to examine the roles of 
mitotic phosphorylation, subcellular localization, and interplay with mitotic kinases in the 
regulation of CK2 activity. 
 We first examined the role of four highly conserved mitotic phosphorylation sites 
located in the unique C-terminus of CK2α. Phosphospecific antibodies generated against 
the sites show that CK2α phosphorylation is temporally regulated and occurs during 
prophase and metaphase during normal mitotic progression. Proper phosphorylation of 
CK2α is required for proper mitotic progression, as stable cell lines expressing 
phosphorylation site mutants of CK2α display severe mitotic defects. 
 We next examined the impact of these phosphorylation events on the subcellular 
localization of CK2. We show that CK2α, but not CK2α’, localizes to the mitotic spindle. 
Localization of CK2α to the mitotic spindle is phosphodependent, and requires the 
peptidyl-prolyl isomerase Pin1. These results are a rare example of functional divergence 
between the two catalytic isoforms of CK2, and suggest that the role of CK2α 
phosphorylation during mitosis is to promote localization of CK2 to the mitotic spindle.  
 Finally, we examined the possibility that CK2 activity during mitosis is regulated 
through hierarchal phosphorylation events, wherein CK2 would phosphorylate proteins 
only after priming phosphorylation events catalyzed by other mitotic kinases, particularly 
Cdk1. As this phenomenon has never been systematically investigated, we have 
iv 
 
investigated the consensus requirements for CK2 primed phosphorylation, and in 
particular Cdk/CK2 hierarchical phosphorylation. A genome-wide search for potential 
mitotic substrates matching the consensus sequence suggests that Cdk1/CK2 hierarchical 
phosphorylation may indeed contribute to mitotic signaling, particularly on the mitotic 
spindle. 
 Taken together, our results confirm the importance of CK2 in mitotic cell 
division, and highlight several examples of subtle regulation of CK2, through 
phosphorylation, subcellular localization, and interplay with other protein kinases. This 
helps explain how CK2, a constitutively active kinase, can participate in tightly regulated 
cellular processes like mitosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Protein kinase CK2, mitosis, mitotic spindle, phosphorylation, localization, 
Pin1, hierarchical phosphorylation, Cdk1, spindle assembly checkpoint. 
v 
 
Coauthorship 
 
Chapter 2: 
Rich Derksen generated the stable cell lines expressing CK2α phosphorylation mutants 
and CK2β used in these studies, and performed the kinase assays in Figure 2.4D and the 
proliferation experiments shown in Figure 2.5. 
 
Chapter 3: 
Erin Parker generated the stable cell lines expressing Pin1 and Luciferase shRNAs used 
in these studies, and Melanie Bailey generated the Flag-Pin1 plasmids. 
 
Chapter 4: 
Soluble peptides were generated by Huadong Liu in the laboratory of Dr. Shawn Li, and 
the peptide match program used to search the genome was written by Dr. Greg Gloor.   
vi 
 
Acknowledgements 
 First and foremost, thanks to Dr. Dave Litchfield. Thanks for all your advice, 
guidance, support, constructive criticism, funny stories about random people in science, 
smooth phrasings for potentially awkward correspondence, clever analogies, and jokes 
about both my lack of a Mac and the ubiquity of my iPod. Thanks for dealing with all my 
tears, rants, happy dances, and everything in between. The post-it notes were funny, but 
seriously, you really are my hero.  
 I would also like to thank everyone at UWO that took the time to help this project 
progress. My advisory committee, Dr. Eric Ball and Dr. Fred Dick, were a great source of 
guidance and advice. Thanks also to Drs. Shawn Li, Greg Gloor, Lina Dagnino, Marc 
Tini, and David Rodenhiser for their contributions to this project and my development as 
a scientist. A special thanks to Dr. Rob Hegele, who gave me my first real science job 
when I was just a little undergrad, and through his infectious enthusiasm, helped me fall 
in love with science. The flow cytometry performed in Chapter 2 would never have 
happened without the help of Dr. Kristin Chadwick at the London Regional Flow 
Cytometry Facility. Thanks also to Dr. Dale Laird for the use of his confocal, and Jamie 
Simek for his guidance in how to actually go about using the confocal. 
 During my time in the Litchfield lab, I have had the opportunity to work with a 
wide variety of people, all of whom were that special kind of insane that compels people 
to mix stuff they can’t see in tubes all day. Without all of these people, the last five years 
of my life would have been much less entertaining, and I’m grateful to each of them for 
their friendship, support, and unique perspectives on life and science: Melanie Bailey, 
Dave Canton, Victoria Clarke, Rich Derksen, James Duncan, Kelly Duncan, Ashley 
vii 
 
French, Michelle Gabriel, Kathryn Garside, Laszlo Gyenis, Angela Holmes, Kristina 
Jurcic, Mary Ellen Olsten, Dana Onica, Erin Parker, Jennifer Raaf, Jake Turowec, Greg 
Vilk, Kelly Weedmark, and Cunjie Zhang. Special thanks go out to my person, Erin 
Parker; the founding co-president of Club Pure Awesome, Jake Turowec; Angela Holmes 
and Kathryn Garside for being two of my favourite people ever; Ashley French for being 
the world’s greatest lab mom; the neighbour kids, Ryan Mohan and Anita Rao, who were 
always ready for beer and sushi (“Okay, I just have to split my cells”); and everyone that 
made the ‘boy’s office’ such a good time.  
 Thanks also to all of my friends, UWO-related and otherwise, for being 
unfailingly supportive even when I had no time for you, for being ridiculously fun when I 
did, and for being available for beer and distraction when the science was cruel. I am also 
grateful to my family for their support and understanding over the past five years. The 
amount of people who have very little understanding of what I do all day yet still brag 
about me to their friends absolutely staggers me, and I love you for it. 
 Saving the best for last, I would also like to thank Ryan Ruttgaizer for his love 
and support throughout this process. Ryan is always prepared to celebrate successes, 
large or small, but more importantly he’s the greatest cheerleader I have, and his support 
during the tough times was instrumental to the completion of my doctoral work. Now on 
to the next adventure!  
 
  
viii 
 
Table of Contents 
Certificate of Examination        ii 
 
Abstract           iii 
Keywords           iv 
Coauthorship           v 
Acknowledgements          vi 
List of Tables           xi 
List of Figures          xii 
List of Appendices         xv 
List of Abbreviations, Symbols and Nomenclature     xvi 
Chapter 1: Introduction        1 
 1.1 General Introduction       1 
 1.2 The CK2 Family        1 
 1.3 Regulation of CK2 Activity      4 
  1.3.1 Localization       4 
  1.3.2 Protein-Protein Interactions     7 
  1.3.3 Phosphorylation       10 
 1.4 CK2 in the Cell Cycle       11 
  1.4.1 G1/S        12 
  1.4.2 G2/M        16 
 1.5 Objectives         22 
 Bibliography         27 
Chapter 2: Evidence for Regulation of Mitotic Progression through Temporal 
Phosphorylation and Dephosphorylation of CK2α     45 
ix 
 
 2.1 Introduction        45 
 2.2 Materials and Methods       47 
 2.3 Results         53 
 2.4 Discussion         83 
 Bibliography         88 
Chapter 3: Phosphorylation-dependent localization of CK2α to the mitotic spindle 
requires the peptidyl-prolyl isomerase Pin1      94 
 3.1 Introduction        94 
 3.2 Materials and Methods       96 
 3.3 Results         100 
 3.4 Discussion         118 
 Bibliography         121 
Chapter 4: Hierarchical phosphorylation between Cdk1 and CK2 may contribute to the 
regulation of mitosis         127 
 4.1 Introduction        127 
 4.2 Materials and Methods       131 
 4.3 Results         137 
 4.4 Discussion         170 
 Bibliography         183 
Chapter 5: Summary and Perspectives      190 
 5.1 Overview         190 
 5.2 Regulation of CK2 through phosphorylation of CK2α   191 
  5.2.1 CK2α phosphorylation in mitosis    191 
x 
 
  5.2.2 Disruption of CK2α phosphorylation in cells   192 
 5.3 Regulation of CK2 through hierarchical phosphorylation  199 
  5.3.1 Structural comparison of canonical and primed  
   phosphorylation by CK2     200 
  5.3.2 CK2 hierarchical phosphorylation in mitosis   202 
  5.3.3 Hierarchical phosphorylation as a signalling module  204 
 5.4 Mechanisms for regulating CK2 activity in mitosis   207 
 5.5 Future Directions        210 
  5.5.1 CK2 mitotic pathway determination    210 
  5.5.2 CK2β phosphorylation in mitosis    216 
  5.5.3 CK2α/α’ chimeric mice      217 
  5.5.4 CK2 hierarchical phosphorylation in  
   signal transduction      218 
 5.6 Perspectives        219 
 Bibliography         222 
Curriculum Vitae         230 
  
xi 
 
List of Tables 
Table 1.1 Known mitotic substrates of CK2      20 
Table 1.2 Known mitotic interactors of CK2      21 
Table 2.1 Cell cycle distribution of cells expressing phosphorylation  
  site mutant CK2α proteins 12 h after release from a thymidine  
  block         72 
Table 2.2 Cell cycle distribution of nocodazole-arrested cells expressing  
  phosphorylation site mutant CK2α proteins    82 
Table 4.1 Sequences of peptides used in this study     134 
Table 4.2 Potential mitotic substrates for Cdk1/CK2 hierarchical  
  phosphorylation       139 
Table 4.3 Kinetic constants for phosphorylation of CK2 canonical and primed 
  consensus peptides       152 
Table 4.4 Enriched gene function classifications in SXXXXSP peptide  
  match results        164 
Table 4.5 Functional annotation analysis of SXXXXSP peptide match results 165  
Table 4.6 Potential mitotic spindle substrates for Cdk/CK2 hierarchical  
  phosphorylation       167 
  
xii 
 
List of Figures 
Figure 1.1: Schematic representation of CK2 subunits    2 
Figure 1.2: Crystal structure of tetrameric CK2     5 
Figure 1.3: CK2 signaling at the G1/S transition     14 
Figure 1.4: CK2 signaling in mitosis       18 
Figure 1.5: Schematic of potential mechanisms for the regulation of CK2 
  during cell division       25 
Figure 2.1: Generation of CK2α phosphospecific antibodies   54 
Figure 2.2: CK2α phosphospecific antibodies do not display phosphorylation  
  site cross-reactivity       57 
Figure 2.3: CK2α phosphorylation occurs in mitotic cells during prophase and  
  metaphase        58 
Figure 2.4: Inducible expression of CK2α phosphorylation-site mutants  62 
Figure 2.5: Cell proliferation profiles of inducible wild-type and mutant  
  CK2α cell lines show decreased growth with phosphorylation- 
  site mutant expression      65 
Figure 2.6: Expression of CK2α phosphomimetic mutants disrupts 
  cell cycle progression       68 
Figure 2.7: Expression of CK2α phosphomimetic mutants leads to loss of    
  mitotic cells        70 
Figure 2.8: Phosphomimetic CK2α expression causes cell death by  
  mitotic catastrophe       74 
 
xiii 
 
Figure 2.9: Phosphomimetic CK2α expression results in aberrant mitotic  
  spindle formation and missegregation of chromosomes  77 
Figure 2.10: Expression of non-phosphorylatable CK2α abrogates the spindle 
  assembly checkpoint       80 
Figure 3.1: Phosphorylated CK2α localizes to the mitotic spindle   101 
Figure 3.2: CK2α phosphospecific antibody peptide competition assay  104 
Figure 3.3: Mitotic spindle localization is unique to the CK2α catalytic subunit 105 
Figure 3.4: The unique C-terminus of CK2α is responsible for mitotic  
  spindle localization       107 
Figure 3.5: Pin1 recruits phosphorylated CK2α to the mitotic spindle  110 
Figure 3.6: Proper localization of CK2 to the mitotic spindle requires Pin1 catalytic  
  activity and WW domain binding     112 
Figure 3.7: Pin1 protects CK2α from dephosphorylation in vivo   116 
Figure 4.1: Candidate peptides from a PhosphoSite search for S-X-X-S-P are not  
  ideal substrates for primed CK2 phosphorylation   140 
Figure 4.2: Influence of intervening residues on Cdk1/CK2 hierarchical  
  consensus sequence       143 
Figure 4.3: The presence of a proline-directed phosphoserine at position +3 
  dramatically decreases primed CK2 phosphorylation  145 
Figure 4.4: Influence of quantity and spacing of phosphoserine residues on  
  CK2 primed phosphorylation      147 
Figure 4.5 Relative comparison of canonical and primed 
   phosphorylation by CK2      151 
xiv 
 
Figure 4.6 Primed CK2 phosphorylation favours serine as the  
  phosphodeterminant and phosphoacceptor    155 
Figure 4.7 Cdk1 phosphorylation can form a novel site for CK2  
  phosphorylation       158 
Figure 5.1 Model of the effects of spindle assembly checkpoint on the 
   regulation of CK2       196 
Figure 5.2 Potential for CK2 hierarchical phosphorylation with other  
  major mitotic regulatory kinases     205 
Figure 5.3 Mechanisms of regulating CK2 in mitotic cell division   209 
Figure 5.4 A ‘capture and release’ strategy to identify mitotic spindle  
  substrates of CK2       213  
xv 
 
List of Appendices 
 
Appendix A: Supplemental files for Chapter 4   See attached files  
Appendix B: Permission to use copyright materials     232 
  
xvi 
 
List of Abbreviations, Symbols and Nomenclature 
 
°C   degrees Celcius 
µCi   microCurie 
µg   microgram 
µl   microliter 
µM   micromolar 
APC/C   anaphase-promoting complex/cyclosome 
ATP   adenosine triphosphate 
bp   base pair 
BCA   bicinchoninic acid 
BSA   bovine serum albumin 
CAK   Cdk activating kinase 
Cdk   cyclin-dependent kinase 
CENP-E  centromeric protein E 
CK1   Protein Kinase CK1; formerly casein kinase I 
CK2   Protein Kinase CK2; formerly casein kinase II 
CKIP1   CK2 interacting protein 1 (PLECHO1) 
DAG   donkey anti-goat 
DAPI   4’,6-diamidino-2-phenylindole 
DAR   donkey anti-rabbit 
ddH2O   double distilled water 
DMEM  Dulbecco’s modified Eagle Media 
xvii 
 
DMSO   dimethylsulfoxide 
DTT   dithiothreitol 
EGFP   enhanced green fluorescent protein 
ERK   extracellular signal-regulated kinase 
FACS   fluorescence-activated cell sorting 
FACT   facilitating chromatin-mediated transcription 
FBS   fetal bovine serum 
FITC   fluorescein isothiocyanate 
FGF   fibroblast growth factor 
FLAG   DYKDDDDK epitope 
g   relative centrifugal force 
G1   gap 1 
G2   gap 2 
GAM   goat anti-mouse 
GAR   goat anti-rabbit 
GFP   green fluorescent protein 
GSK3   glycogen synthase kinase 3 
GST   glutathione-s transferase 
GTP   guanosine triphosphate 
HA   hemagglutinin (YPYDVPDY) epitope 
HeLa   human cervical carcinoma cells 
HRP   horseradish peroxidase 
IB   immunoblot 
xviii 
 
IP   immunoprecipitation 
IPTG   isopropyl-beta-D-thiogalactoside 
kD   kilodalton 
KD   kinase dead 
M   mitosis 
MAP   microtubule-associated protein 
MAPK   mitogen activated protein kinase 
MCC   mitotic checkpoint complex 
ml   milliliter 
mM   millimolar 
MMTV  mouse mammary tumor virus 
MPM-2  mitotic protein monoclonal-2 
MS   mass spectrometry 
MSCV   murine stem cell virus 
Myc   MASMEQKLISEEDLNN epitope 
Na2VO4  sodium orthovanadate 
NP-40   Nonidet P-40 
OA   Okadaic acid 
ORF   open reading frame 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PBD   polo-box domain 
pS   phosphorylated serine residue 
xix 
 
pT   phosphorylated threonine residue 
pY   phosphorylated tyrosine residue 
 
PCR   polymerase chain reaction 
PI   propidium iodide 
Pin1   protein interacting with NIMA-1 
Plk1   polo-like kinase 1 
PMSF   phenylmethylsulfonylfluoride 
PP2A   protein phosphatase 2A 
PPIase   peptidyl-prolyl isomerase 
PVDF   polyvinylidene difluoride 
RNAi   RNA interference 
rpm   revolutions per minute 
S   synthesis 
SAC   spindle-assembly checkpoint 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
siRNA   short interfering RNA 
shRNA  short hairpin RNA 
TBS   Tris-buffered saline 
TBST   Tris-buffered saline + 0.5% Tween-20 
Tet   Tetracycline 
TopoII   topoisomerase II 
U2OS   Human osteosarcoma cells 
V, A   Volts, Amps 
1 
 
Chapter 1: Introduction1 
1.1 General Introduction 
 Protein phosphorylation has long been recognized as an important post-
translational modification regulating cellular processes (54). In the human genome, 518 
distinct protein kinases have been identified (57), and one third of cellular proteins appear 
to be phosphorylated (1), often at several distinct sites (20). Proper regulation of 
phosphorylation events is crucial to the proper function of cellular signalling pathways, 
and loss of regulation of pathways controlling proliferation and survival can lead to 
cancer (47). Consequently, there is an enormous interest in the development of novel 
therapeutics targeting kinases and phosphatases (52). Among promising therapeutic 
targets is the protein kinase CK2 (95), a serine/threonine kinase that is overexpressed in 
multiple forms of cancer and has oncogenic properties in mice and cultured fibroblasts 
(69). CK2 has various and often interconnected roles in multiple cellular pathways, 
however its long list of substrates and subtle means of regulation have made a thorough 
understanding of CK2 function elusive, even after over 50 years of intensive research. 
1.2 The CK2 Family 
 Originally discovered in 1954 (18), CK2 is a family of enzymes that in humans 
consists of two catalytic subunits, termed CK2α and CK2α’, and one regulatory subunit, 
CK2β (Figure 1.1). The catalytic subunits show high sequence similarity throughout most 
of their coding regions, despite the fact that they are transcribed from different genes,  
                                                            
1 Some of the content in this chapter has been published: St-Denis NA, Litchfield DW. From Birth to 
Death: The Role of Protein Kinase CK2 in the Regulation of Cell Proliferation and Survival (2009). 
Cellular and Molecular Life Sciences 66:1817-1829. 
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Figure 1.1 
 
 
 
 Figure 1.1 Schematic representation of CK2 subunits. Linear representation of the 
sequences of the catalytic isoforms CK2α and CK2α’ and the regulatory subunit CK2β. 
In vivo phosphorylation sites are indicated, including the four mitotic phosphorylation 
sites on the extended C-terminus of CK2α, and the S209 mitotic phosphorylation site and 
autophosphorylation sites on CK2β.  
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CK2α on chromosome 20 (123) and CK2α’ on chromosome 16 (125). The catalytic 
domains of CK2α and CK2α’ are approximately 90% identical (71), but have 
dramatically different C termini, with an extended C-terminal tail on CK2α not present on 
CK2α’ (77). The catalytic subunits are members of the CMGC family of kinases (79), 
which also includes cyclin-dependent kinases (Cdks), the mitogen-activated protein 
kinases (MAPKs and ERKs), and glycogen synthase kinase-3 (GSK3).  In contrast, CK2β 
has no extensive homology to any other known proteins (55), making its role difficult to 
decipher. CK2 subunits are typically found in mammalian cells as a tetramer, in which 
two CK2β subunits dimerize and two catalytic subunits (α/α, α’/α’, or α/α’) bind to the 
CK2β dimer to form a tetramer (35, 40, 42, 90) (Figure 1.2). CK2 has long been 
distinguished from other serine/threonine kinases by its ability to phosphorylate serine 
and threonine residues proximal to acidic amino acids (98), as well as by its unique 
ability to use either ATP or GTP as a phosphate donor (4). Through systematic study of 
CK2 substrates, Pinna et al. have defined the minimal consensus sequence of CK2 
phosphorylation as S/T-X-X-Acidic, where X is any amino acid and the acidic residue is 
typically aspartic acid or glutamic acid (99). Interestingly, phosphorylated serine can also 
act as the proximal acidic residue, enabling CK2 to participate in sequential 
phosphorylation events by using residues phosphorylated by itself or other kinases as part 
of its consensus requirements (2, 99, 121). Though the majority of CK2 substrates 
conform to the established consensus sequence, there are some exceptions. For example, 
the serine 392 site in the tumour suppressor protein p53 is phosphorylated by CK2, 
despite the fact that the sequence does not conform to the CK2 consensus sequence (83). 
Conversely, the presence of the minimal consensus sequence does not necessarily 
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indicate that CK2 will efficiently phosphorylate the site in vivo, as there may be other 
determinants present in the amino acid sequence (84). Additionally, phosphorylation of a 
specific protein at a specific site can be influenced by the many subtle regulatory forces 
acting on CK2 in mammalian cells.  
1.3 Regulation of CK2 Activity 
CK2 is ubiquitously expressed in a variety of cell types and tissues, and is 
considered to be constitutively active, as it is not subject to the strict on/off regulation of 
other kinases, such as MAPKs and CDKs. However, there exist several subtle 
mechanisms by which CK2 activity can be focused on one or more substrates while 
excluding other substrates, and these forms of regulation have been an area of intense 
study in the field. 
1.3.1 Localization 
Original work investigating the localization of CK2 involved subcellular 
fractionation studies; however this line of investigation yielded little insight into the 
subcellular localization of CK2, as it appeared to be ubiquitously expressed throughout 
the cell. Development of antibodies against the holoenzyme offered some additional 
insight, but many advances in the study of CK2 localization came with the development 
of subunit-specific antibodies, allowing comparison and confirmation of CK2 subunit 
localization. Polyclonal serum against purified CK2 have been used to show localization 
to the nucleolus (23) and the plasma membrane (26). Localization at the plasma 
membrane was later confirmed for CK2α with an antibody targeted against that subunit   
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Figure 1.2 
 
Figure 1.2 Crystal structure of tetrameric CK2. Catalytic subunits are shown in blue and 
yellow and regulatory subunits are shown in green and red.  Also indicated is a non-
hydrolyzable ATP analog, AMPPNP, in the active site of one of the catalytic subunits. 
Note that the C-terminal tail of CK2α is truncated in this structure (missing amino acids 
338-391). The structure of the C-terminus is unknown. This representation of the CK2 
tetramer was generated using Swiss PDB Viewer; PDB File 1JWH. 
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(105). Through the use of subunit-specific antibodies and identification of organelle-
specific substrates, CK2 subunits have been localized in the cytoplasm (31, 127) and 
nucleus (62, 105), and colocalizing with the cytoskeleton (31), centrosomes (62, 82), 
mitotic spindle (62, 127), mitochondria (103), endoplasmic reticulum (94), nuclear matrix 
(114, 115), nucleolus (8, 97), and nucleosomes (43). Surprisingly, there even exists a 
CK2-like ectokinase present on the surface of cells (100, 120). Despite all this work, 
there remains some ambiguity as to the precise localization of CK2, as these studies were 
conducted using a variety of techniques, antibodies, fixation methods, and cell lines. This 
also explains the sometimes conflicting results reported in the literature. 
As mentioned above, the development of subunit specific antibodies has allowed 
study of the localization of individual subunits both in tetrameric form and as individual 
protein entities. This has lead to extended knowledge of CK2 localization patterns, but 
has also introduced a new level of complexity to the study of CK2 regulation. Expression 
of fluorescently-tagged versions of CK2α and CK2β have shown differences in 
localization, and also show differences in how efficiently they can dynamically shuttle 
between the nucleus and the cytoplasm (32). Since the binding affinity between CK2α 
and CK2β is high (10), this indicates the presence of discrete subpopulations of free 
catalytic subunits, with specialized functions from the tetramer.  
Clearly, the localization of CK2 is dynamic, and seems to depend on a cell’s 
requirements for CK2 activity in space and time. Often, specific localization of CK2 
depends on protein-protein interactions with a variety of cellular proteins, and often leads 
to phosphorylation of specific substrates in those locations.   
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1.3.2 Protein-Protein Interactions 
 CK2 localization is an important mechanism in targeting the kinase to its proper 
substrates at any given time, and this localization is largely mediated through protein-
protein interactions. These interactions can be subdivided into two types: interactions 
between CK2 family members, and interactions between CK2 and other cellular proteins. 
While CK2 is normally found in tetrameric form, it is unknown whether tetramers of 
different composition have different roles in the cells, but this may represent another 
level of CK2 regulation. CK2β, termed a ‘regulatory’ subunit due to the resemblance of 
the CK2 tetramer to other tetrameric kinases such as PKA, does not actually confer much 
regulation on the activity of the tetramer, however there are some substrates that are more 
efficiently phosphorylated by individual catalytic subunits in the absence of CK2β (81).  
In fact, CK2β has been demonstrated to have several signalling functions in the cell that 
are completely unrelated to the catalytic activity of CK2 (Reviewed in (10)). In 2002, 
Martel et al. investigated the role of CK2β in the phosphorylation of CK2 substrates, and 
scored CK2 substrates into three classes, based on the impact of CK2β on the efficiency 
of phosphorylation (81). The first substrate class included substrates that show a strict 
requirement for CK2β for phosphorylation, including p53, Topoisomerase IIα, and 
Cdc25B. Class II substrates, such as Nucleolin and Hsp90, are unaffected by the presence 
or absence of CK2β, while class III substrates like Calmodulin and S100B are 
phosphorylated only in the absence of CK2β (81). This research showed that tetrameric 
composition of CK2 can be modulated for different substrates.  An interesting possibility 
concerns the formation of high molecular weight structures consisting of large numbers 
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of CK2 tetramers. CK2 tetramers can self-aggregate in vitro, and reproducibly and 
reversibly form organized higher structures like 4-tetramer rings and larger, filamentous 
structures (117). It is unknown whether these higher order structures are present in vivo, 
but if so, they would further expand the sophistication of CK2 regulation through subunit 
composition. 
Extending past CK2 subunit composition, CK2 can also be regulated through 
interactions with other cellular proteins. Localization of CK2 to various subcellular 
locales, for example, seems to be largely mediated by protein-protein interactions. These 
interacting proteins include β-Tubulin (31) and CKIP-1 (now termed PlecHo1) (15), 
which target CK2 to the microtubules and plasma membrane respectively. There are also 
several proteins that seem to directly alter CK2 catalytic activity or stabilize the enzyme 
purely through binding, such as FGF-1 and -2 (14, 109), Hsp90 (86), and Cdc37 (61). 
Additionally, several interactors seem to reflect enzyme-substrate interactions, such as 
nucleolin (65), Topoisomerase IIα (12) and Nopp140 (66).  There are also interacting 
proteins that, though binding to CK2, can modulate its catalytic activity to specific 
substrates. Interactions between CK2 and Pin1, a peptidyl-prolyl isomerase, lead to 
inhibition of Topoisomerase II phosphorylation (85).  Conversely, interaction between 
CK2 and the FACT complex (composed of hSpt16 and SSRP1), which occurs in 
response to UV light, leads to enhanced phosphorylation of p53 (60). While it seems that 
interactions with other cellular proteins can have varying effects on CK2, it is clear that 
protein-protein interactions do play a role in regulating the localization, activity, and 
substrate specificity of CK2. 
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Several CK2 interacting proteins mediate their interactions through binding with 
CK2β, including some mentioned above (12, 14, 66). Additionally, the CK2β subunit has 
several additional interacting proteins unique from the catalytic subunits, including the 
protein kinases c-Mos (19), A-Raf (13, 46), and Chk1 (41), which suggests that CK2β 
acts as a promiscuous interacting subunit for various kinases (10). While most CK2 
interacting proteins show little specificity between the two CK2 catalytic subunits, there 
are a few substrates and interacting proteins which specifically interact with either CK2α 
or CK2α’. For example, CK2α, but not CK2α’, binds to the serine/threonine phosphatase 
PP2A (49), CKIP-1 (15), and Pin1 (85) in mammalian cells. Several large scale 
endeavours have been undertaken to identify and catalogue CK2 interactors in yeast, 
using two-hybrid assays and large proteomic interaction screens (21, 34, 51, 64). These 
screens have highlighted the many varied functions for CK2 in yeast, displaying a large 
amount of interacting partners. Also, comparison between different CK2 subunits shows 
that at least some of these interacting proteins show functional specialization for one or 
more CK2 subunits.  Large scale interaction studies in mammalian systems are much less 
comprehensive, due to the increased technical challenges of isolating and identifying 
protein complexes from mammalian cells (29, 102). However, these global screens seem 
to confirm that the large numbers of interaction partners and the functional specialization 
between subunits observed in yeast are also present in mammalian systems (45). Clearly, 
much needs to be accomplished before we can achieve a validated “CK2 interactome” 
and can use this catalogue of CK2 interacting proteins to elucidate the roles and 
regulatory patterns of CK2 activity. 
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1.3.3 Phosphorylation 
 Another mechanism governing the subtle regulation of CK2 is phosphorylation of 
its subunits. CK2β is autophosphorylated following tetramer assembly at serines 2, 3 and 
4 (70). Mutation of the sites increases the stability of CK2β, suggesting that 
autophosphorylation may regulate ubiquitination and proteasome-dependent degradation 
of CK2β in cells, essentially regulating the levels of protein (128). In addition to the 
autophosphorylation sites, CK2β is also phosphorylated in a cell cycle dependent manner 
by Cdk1 at serine 209 (70). CK2β can also be phosphorylated in vitro by Chk1 at T213 
(63). The purpose of CK2β  phosphorylation remains unknown. The CK2α catalytic 
subunit is also phosphorylated in a cell cycle dependent manner by Cdk1, at four residues 
in its unique C-terminus (threonines 344 and 360 and serines 362 and 370) (17, 72). The 
presence of these sites indicates independent regulation of the CK2 catalytic subunits in 
the cell cycle, and a specialized role for CK2α (or α2β2 tetrameric forms) in mitosis. 
These phosphorylation sites do not directly affect CK2 activity (16), but it is 
hypothesized that they may contribute to subtle regulation of CK2, by forming binding 
sites for interacting proteins and/or targeting CK2 towards favourable substrates or away 
from unfavourable substrates in the context of mitotic progression. 
 Many protein kinases, including MAPKs, require phosphorylation on the 
activation loops present in their catalytic sites for maximal catalytic activity, either 
through autophosphorylation or phosphorylation by upstream kinases in a signal 
transduction pathway (56). While no in vivo evidence exists to indicate that CK2 activity 
is increased by activation loop phosphorylation, CK2 catalytic subunits have been shown 
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to be tyrosine phosphorylated.  Donella-Deana et al. showed that recombinant catalytic 
subunits of CK2 are autophosphorylated at tyrosine 182 in the CK2 activation loop in an 
intermolecular (trans) fashion (25). This was not the first indication that CK2 may act as 
a dual-specificity kinase, as previous reports had shown CK2 phosphorylation of the 
nucleolar immunophilin Fpr3 at tyrosine 184 both in yeast and in vitro, albeit with less 
favourable enzyme kinetics than with serine phosphorylation (80, 122). Recent work in 
our laboratory has confirmed that tyrosine phosphorylation can indeed be catalyzed by 
CK2 in vivo. Phosphorylation of CK2 at tyrosine 182 is dependent on CK2 activity and 
decreases in the presence of CK2 inhibitors. Furthermore, this work suggests that a 
number of mammalian proteins may be tyrosine phosphorylated by CK2 (119). 
Investigation of the effects of CK2 autophosphorylation could lead to increased 
understanding of CK2 regulation, however the possibility of CK2 acting as a dual 
specificity kinase in mammalian cells adds greatly to the complexity of its signalling. 
1.4 CK2 in the Cell Cycle 
 CK2 has been implicated in every stage of cell cycle progression, and catalyzes 
the phosphorylation of several proteins crucial to the successful production of daughter 
cells. In yeast, genetic studies have shown requirements for CK2 for progression through 
the G1/S and G2/M transitions (36). In mammalian cells, antisense oligonucleotides 
against CK2 subunits, microinjection of CK2 antibodies, and inhibitors of CK2 can all 
inhibit cell cycle progression, suggesting that mammalian cells require CK2 for the 
G0/G1, G1/S, and G2/M transitions (74, 75, 96). Studies outlining the interactions and 
effects of CK2 activity on cell cycle proteins have further confirmed the importance of 
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CK2 throughout the cell cycle. Cell cycle progression is largely mediated by the 
controlled activation and deactivation of Cyclin-dependent kinases (Cdks), including 
Cdk4/Cyclin D and Cdk2/Cyclin E at the G1/S transition, and Cdk1/Cyclin B at the 
G2/M transition (89). These kinases are activated at the appropriate times in part by the 
activity of the Cdk-activating kinase (CAK), an enzyme consisting of Cdk7, Cyclin H, 
and MAT1 (ménage à trois 1) (73). Even at this earliest stage of cell cycle progression 
signalling, CK2 has a role. The CK2α subunit forms a complex with Cyclin H (30), and 
phosphorylates the cyclin at serine 315 (106). This phosphorylation event has no effect 
on CAK complex formation, but is critical for full CAK activity (106).  
1.4.1 G1/S 
The signal to begin DNA replication and prepare for cell division is transduced from 
extracellular growth signals through the G1/S CDKs, leading to hyperphosphorylation of 
pRB and transcription of vital cell cycle genes due to release of E2F transcription factor 
inhibition (108). Once the initial stimulus for growth has been transduced to the G1/S 
Cdks, CK2 has additional roles in regulating the initiation of DNA replication and 
preparation for division (Figure 1.3). The most well-studied role for CK2 in G1/S is its 
regulation of the tumour suppressor protein p53, a transcription factor involved in DNA 
damage signalling that can elicit both cell cycle arrest and induction of apoptosis (108). 
p53 is phosphorylated by CK2 at serine 392 in response to UV radiation-induced DNA 
damage, resulting in increased DNA binding and transcriptional activation (58, 59). In 
response to DNA damage caused by UV light, CK2 forms an interaction with the FACT 
complex (consisting of SSRP1 and hSPT16), resulting in increased CK2 activity towards 
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p53 (59, 60). SSRP1 is also a substrate of CK2, and phosphorylation decreases SSRP1 
binding to DNA, halting transcription in the event of DNA damage (67). In undamaged 
cells, p53 is constantly produced and degraded, and the degradation of p53 is induced by 
MDM-2 (murine double minute clone 2), which targets p53 for processing by the 26S 
proteasome. In the presence of cellular stress, the interaction between MDM-2 and p53 is 
disrupted, leading to stabilization of p53, which can then elicit a cellular response (108). 
MDM-2 is also a substrate of CK2, which phosphorylates it at serines 269 (3, 37), 267 
(50), and 260 (3). CK2 phosphorylation at serine 267 leads to reduced ability to direct 
p53 degradation (50). Phosphorylation at serine 269 has been shown to decrease MDM-2 
binding to pRB, and expression of phosphorylation-site mutants of MDM-2 cause altered 
growth (38). Treatment of cells with the CK2 inhibitor TBB (4,5,6,7-
tetrabromobenzotriazole) leads to induction of p53 and its transcriptional target genes (3), 
providing additional evidence of the importance of CK2 regulation of p53 signalling. 
 Another mechanism by which CK2 regulates G1/S signalling is through 
interaction and phosphorylation of Cdk inhibitory proteins. p21WAF1/CIP1, an potent 
inhibitor of Cdk2 whose expression is induced by p53 activation (108), binds to CK2β 
(39). CK2 can phosphorylate p21WAF1/CIP1 in a CK2β-dependent manner, indicating that 
CK2β acts to target the catalytic subunits to this substrate (101). p27KIP1, another Cdk2 
inhibitor, is also phosphorylated by CK2 in a CK2β-dependent manner (113). The effects 
of CK2 phosphorylation of these substrates has not been determined, but suggests that 
CK2 can regulate progression through G1/S though multiple mechanisms. 
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Figure 1.3 
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Figure 1.3 CK2 signaling at the G1/S transition. Positive growth signals lead to 
activation of the S phase Cdks, Cdk2 and Cdk4, which inhibit pRB binding to E2F 
transcription factors. Once pRB dissociates from E2F proteins, they induce the 
transcription of genes required for DNA replication. However, in the presence of DNA 
damage, the cell will arrest before replication through the action of p53. When DNA 
damage is sensed, CK2 binds to the FACT complex and phosphorylates SSRP1, leading 
to decreased transcription in the presence of DNA damage. Binding to FACT targets CK2 
kinase activity towards p53. Phosphorylation of p53 by CK2 increases DNA binding and 
transcription of DNA-damage induced genes. p53 levels are regulated by degradation 
through binding to MDM-2, which targets p53 to the 26S Proteasome. After DNA 
damage is detected, CK2 phosphorylation of MDM-2 leads to decreased degradation of 
p53. p53 induces expression of the Cdk2 inhibitory proteins, p21 and p27, which then 
bind to and are phosphorylated by CK2. Inhibition of Cdk2 by p21 and p27 decreases 
transcription of S phase genes in the presence of DNA damage. Thick arrows denote CK2 
phosphorylation. Thin arrows denote regulatory effects within the pathway, with pointed 
arrowheads representing activating effects, and flat arrowheads representing inhibitory 
effects. 
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1.4.2 G2/M 
 Upon completion of DNA replication, the cell then progresses through the G2 
stage of the cell cycle and enters mitosis. Entry into mitosis is dependent on the activation 
of Cdk1, which occurs at the G2/M transition by a combination of phosphorylation, 
dephosphorylation, and expression of its regulatory cyclin, Cyclin B (68). Upon 
activation of Cdk1, a massive wave of phosphorylation triggers the onset of mitosis (93). 
However, if DNA damage is present, Cdk1 activation is delayed due to activation of the 
DNA damage checkpoint, and the DNA is repaired (48). Mitosis is composed of several 
stages: in prophase, the DNA condenses to form discrete chromosomes (9), the nuclear 
envelope breaks down (44), and the centrosomes, also replicated during S phase, migrate 
to opposite poles of the cell (22). Formation of the mitotic spindle by the centrosomes 
leads to attachment of spindle fibres to the centromeres of the condensed chromosomes, 
through a multiprotein complex called the kinetochore (87). The kinetochore is the site of 
the mitotic checkpoint complex (MCC), the protein effectors of the spindle assembly 
checkpoint (SAC). The SAC  halts mitotic progression until each pair of sister chromatids 
is properly attached to one kinetochore from each pole (termed amphitelic attachment), 
ensuring that the daughter cells receive equal amounts of DNA (87). Proper attachment to 
the kinetochores causes progression into metaphase, at which point the chromosomes line 
up along the metaphase plate, directly in between the two centrosomes. Once the 
chromosomes line up, the cell progresses into anaphase, in which protein linkers between 
sister chromatids are severed, the DNA is decatenated, and the chromosomes divide and 
are pulled to the centrosomes by the mitotic spindle (111). In telophase, new nuclear 
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envelopes form around the divided sets of DNA (44), the DNA decondenses (9), and the 
remainder of the cell divides in two through a process called cytokinesis (111). Through 
the action of an actin-myosin contractile ring at the midpoint of the cell, the organelles, 
cytoplasm and plasma membrane are divided equally, producing two identical daughter 
cells (7).  
 Several lines of evidence point to specific roles for CK2 in the G2/M transition 
and mitosis (Figure 1.4). CK2 colocalizes with the mitotic spindle and centrosomes (62, 
127), and many proteins involved in mitosis are interacting partners and/or substrates of 
CK2, including β-Tubulin (31), Cdc25B (116),Tau (6), Condensin (112), PP2A (49), and 
Microtubule associated proteins (MAP) 1A and 1B (6). Through sequential 
phosphorylation of Wee1 with Plk1 and Cdk1, CK2 phosphorylation leads to the 
degradation of Wee1 and onset of mitosis (121). Attenuation of CK2 activity or 
knockdown of CK2 subunits has been shown to abrogate the SAC after nocodazole 
treatment, in concert with the p38 MAPK (104). As mentioned above, CK2α and CK2β 
are both phosphorylated in mitosis (17, 70, 72), suggesting that these subunits in 
particular are differentially regulated to perform unique roles in mitosis. 
 Many cell cycle regulatory proteins are phosphorylated by CK2, including 
Topoisomerase II (24, 28), Cdc34 (11),  and Six1 (33) (Table 1.1), however the precise 
details of these phosphorylation events remain largely unknown.  CK2 phosphorylation 
of Topoisomerase II was initially detected in mammalian cells using the mitosis-specific 
MPM-2 (mitosis protein monoclonal-2) and 3F3/2 phosphospecific antibodies, which 
recognize the CK2 sites at serine 1469 and threonine 1342, respectively (24, 28). 
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Figure 1.4 
 
Figure 1.4 CK2 signalling in mitosis. At the onset of mitosis, the master regulatory 
kinase Cdk1 is activated in part by phosphorylation by Wee1A. Once active, Cdk1 
phosphorylates CK2 on both CK2α and CK2β. Phosphorylation of CK2α forms binding 
sites for both the mitotic kinase Plk1 and the peptidyl-prolyl isomerase Pin1. CK2, Cdk1, 
and Plk1 participate in hierarchal phosphorylation of Wee1A, leading to its ubiquitination 
and degradation by the 26S Proteasome. This results in full activation of Cdk1 and the 
onset of mitosis. Phosphorylation-dependent binding to Pin1 results in decreased 
phosphorylation of Topoisomerase IIα by CK2 at mitosis-specific sites. The function of 
this is unknown. Additionally, the role of CK2β phosphorylation has not been 
determined. 
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Intriguingly, CK2 can regenerate a number of other MPM-2 reactive phosphoepitopes 
lost following phosphatase treatment, indicating that there are additional mitotic 
substrates of CK2, and that the MPM-2 antibody may be instrumental in detecting them 
(28).  
 In addition to mitosis-specific substrates, CK2 also forms protein-protein 
interactions in a mitosis-specific manner (Table 1.2). One of the most intriguing CK2 
interactors in mitosis is Pin1, a peptidyl-prolyl isomerase which catalyzes the cis-trans 
isomerization of proline residues adjacent to phosphorylated serine or threonine (124). 
Due to the similarities between its isomerization consensus sequence and the 
phosphorylation consensus sequence of Cdk1, Pin1 binds to several important mitotic 
phosphoproteins, and may have a role in regulation of mitosis (Reviewed in (78)). Studies 
in our laboratory have shown that Pin1 binds specifically to CK2α on its phosphorylated 
C-terminal tail. Furthermore, this interaction forms a complex with Topoisomerase IIα, 
and leads to decreased CK2-catalyzed phosphorylation of Topoisomerase IIα (85). It is 
currently unknown whether Pin1 simply binds to the CK2α mitotic phosphorylation sites 
or actually catalyzes the adjacent prolines, but what is clear is that protein-protein 
interactions between Pin1 and phosphorylated CK2α can regulate CK2 activity. Recently, 
a proteomic screen of Plk1 Polo-Box Domain (PBD) interactors in mitosis identified 
CK2α as a cell cycle-specific, phosphorylation-specific interactor of Plk1 (76). 
Intriguingly, threonine 344, one of the four mitotic phosphorylation sites located on the 
CK2α C terminus, fits the consensus sequence for PBD binding (27). Plk1 is an important 
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TABLE 1.1. Known mitotic substrates of CK2.  
Protein Site Function Reference 
Topoisomerase IIα T1342 G2/M DNA 
Damage 
Checkpoint, DNA 
decatenation 
(24) 
Topoisomerase IIα S1469 G2/M DNA 
Damage 
Checkpoint, DNA 
decatenation 
(28) 
Wee1 S121 Serine/threonine 
kinase 
(121) 
CDC25B S186, S187 Dual-specificity 
phosphatase 
(116) 
CDC25C T236 Dual-specificity 
phosphatase 
(107) 
PTP-S2 ND Tyrosine 
phosphatase 
(88) 
CDC34 S205, S222, S231, 
T233, S236 
Ubiquitin ligase (11) 
Bdp1 S390, S341, T437, 
S446 
Transcription factor (53) 
Six1 ND Transcription factor (33) 
ND: Not determined 
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TABLE 1.2. Known mitotic interactors of CK2.  
 
Protein Function Experimental Evidence Reference 
 
Pin1 
 
Peptidyl-prolyl isomerase 
 
GST Pulldown 
 
(85) 
Plk1 Serine/threonine kinase GST Pulldown (76) 
β-Tubulin Structural spindle protein Coimmunoprecipitation (31) 
Wee1* Serine/threonine kinase Coimmunoprecipitation (92, 126) 
Chk1* Serine/threonine kinase Coimmunoprecipitation (41) 
*Interaction mediated through CK2β 
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kinase regulating multiple facets of mitotic progression (Reviewed in (118)), and 
determining the role of this interaction in mitotic progression could shed new light on the 
role of CK2 in mitosis. 
 The onset of proteomic studies of mitotic phosphorylation and interaction events 
have provided additional information regarding the role of CK2 in mitosis. Proteomic 
investigations have confirmed previous localization studies by identifying CK2 as a 
component of both the centrosomes (5) and spindle midbody (110). Phosphoproteomic 
screens have identified additional potential mitotic substrates of CK2, including Septin-2, 
INCENP, and MAP7 (91). The limitation of proteomics approaches to identify 
phosphorylation-specific targets and interactors of CK2α is that the phosphorylation sites 
are not readily available for mass spectrometric analysis. This is due to a lack of lysine 
residues in the CK2α C-terminus, resulting in a protein fragment too large to ionize 
efficiently after typical trypsin digestion. For this reason, large mitotic proteomic screens 
(which typically use only trypsin) have been of limited value to the study of CK2α 
phosphorylation. 
1.5 Objectives 
 As discussed above, CK2 is instrumental for several cellular processes, including 
multiple stages in the process of cell proliferation. However, how CK2 is regulated to 
ensure proper function at various points in the cell cycle is not well understood. In this 
thesis, we examine the regulation of CK2 during cell division (Figure 1.5). We 
hypothesize that CK2 is regulated during mitosis, enabling the constitutively active 
kinase to perform functions unique to cell division. 
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 First, we generated phosphospecific antibodies against the four mitotic 
phosphorylation sites in the C-terminus of CK2α. As CK2α phosphorylation had 
previously only been shown in cells arrested in mitosis using the microtubule poison 
nocodazole (17, 72), these antibodies were used to investigate CK2α phosphorylation 
during the normal progression of mitosis. We also generated stable cell lines expressing 
CK2α phosphorylation-site mutant proteins, with the objective of studying the effects of 
disruption of CK2α phosphorylation on mitotic progression. The results of these studies 
are discussed in detail in Chapter 2. 
 Secondly, we examined the subcellular localization of CK2 during mitosis. While 
previous studies have demonstrated CK2 localization to the mitotic spindle, the subunit 
specificity of this localization produced mixed results (62, 127). Additionally, the effect 
of the four mitotic phosphorylation sites in CK2α had not been examined. Using the 
aforementioned phosphospecific antibodies, we employed immunostaining and confocal 
microscopy to examine the mitotic localization of unphosphorylated and phosphorylated 
CK2α. The results of this study are discussed in detail in Chapter 3. 
 Finally, we examined the role of hierarchal phosphorylation between CK2 and the 
mitotic master kinase, Cdk1. As mentioned above, as CK2 is an acidophilic kinase, it has 
the ability to participate in hierarchal phosphorylation events by using a phosphoserine 
residue as its acidic determinant for phosphorylation (2, 121). In mitosis, this 
phenomenon results in proper degradation of Wee1A, an important regulator of mitotic 
entry (121). Intriguingly, these hierarchical phosphorylation events essentially put CK2, a 
constitutively active kinase, under the strict regulation of Cdk1, and this may in part 
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explain  how CK2 activity towards mitotic substrates is regulated. We were therefore 
interested in discovering other potential mitotic substrates of CK2 that may be regulated 
in the same way. Since hierarchal phosphorylation has never been systematically 
investigated, it was first necessary to determine an optimal consensus sequence for 
hierarchical phosphorylation involving CK2 and Cdk1, before conducting a genome-wide 
bioinformatics screen to identify potential mitotic substrates. Results from this work are 
discussed in detail in Chapter 4.  
 Overall, these studies have used a variety of approaches to extend our 
understanding of the role and regulation of CK2 during mitosis. Collectively, the results 
in this thesis demonstrate that CK2, although largely regarded as constitutively active, is 
regulated through multiple subtle means, including phosphorylation, localization, and 
concerted action with differentially regulated kinases. Through these regulatory 
mechanisms, CK2 is effectively targeted towards mitotic substrates, leading to proper 
mitotic division and maintenance of genomic stability.  
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Figure 1.5 
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Figure 1.5 Schematic of potential mechanisms for the regulation of CK2 during cell 
division.  While CK2 is intrinsically constitutively active, it may be regulated by multiple 
mechanisms during mitosis. Changes in subcellular localization can lead to association 
with the centrosomes (in purple) and the mitotic spindle (in orange), where CK2 has a 
number of interacting proteins and potential substrates. From the mitotic spindle, CK2 
could also access several DNA-associated substrates. Condensed mitotic chromosomes 
are shown in blue. CK2α and CK2β are phosphorylated by Cdk1/Cyclin B at the onset of 
mitosis. Phosphorylation of CK2α leads to protein-protein interactions with Plk1 and 
Pin1. It is unknown whether interaction with Pin1 leads to isomerization of prolyl 
residues adjacent to the CK2α phosphorylation sites. As well, the interplay between these 
different modes of regulation has not been studied. 
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Chapter 2: Evidence for Regulation of Mitotic Progression through 
Temporal Phosphorylation and Dephosphorylation of CK2α1 
2.1 Introduction - Proper progression through mitosis is mediated by a complex web 
of signalling pathways that ensure faithful division of genetic material, and deregulation 
of these pathways can lead to aneuploidy and genetic instability (15). Protein kinase CK2 
is a pleiotropic serine/threonine kinase that is upregulated in a variety of human cancers 
(Reviewed in (12)) and possesses oncogenic properties in mice and fibroblast cultures 
(18, 29). The kinase is generally found as a tetramer, with two catalytic subunits (CK2α 
and/or CK2α’) and two regulatory subunits (CK2β) (11). CK2 is involved in signalling 
pathways controlling multiple cellular processes, including cell cycle control and cell 
survival (Reviewed in (19)). In these pathways, CK2 has a multitude of different 
interacting proteins and substrates, and subsequently, information on the precise 
regulation of CK2 has been elusive.  
Expression of CK2 is essential for viability in both yeast and slime mold (16, 30), 
and is required for progression through the G1/S and G2/M transitions of the yeast cell 
cycle (13, 30). In mammalian cells, there are requirements for CK2 at the G0/G1, G1/S, 
and G2/M phases of the cell cycle (21, 22, 31). CK2α, one of the catalytic subunits of 
CK2, contains four proline-directed phosphorylation sites (T344, T360, S362, and S370) 
that are phosphorylated in nocodazole-arrested cells (4, 20). The reactions are catalyzed 
in vitro by the mitotic cyclin-dependent kinase Cdk1, which is believed to be the kinase 
responsible in cells (4). These phosphorylation sites are located on the extended C-
terminal tail of CK2α and are therefore not present in CK2α’ (25). This difference 
                                                            
1 A modified version of this chapter has been published: St-Denis NA, Derksen DR, Litchfield DW. 
Evidence for Regulation of Mitotic Progression through Temporal Phosphorylation and 
Dephosphorylation of CK2α (2009). Molecular and Cellular Biology 29(8):2068-2081.  
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between isoforms suggests some functional specialization for the catalytic subunits of 
CK2. Interestingly, while mice lacking CK2α’ are viable (40), CK2α knockout results in 
embryonic lethality (23). The CK2α  C-terminal phosphorylation sites are conserved in 
birds and mammals, further supporting the idea that they play an important role in 
regulating the function of CK2 (25).  
To examine the phosphorylation of CK2α in mitosis, we generated 
phosphospecific antibodies against its phosphorylation sites. We show that CK2α is 
phosphorylated in mitotic cells. This phosphorylation occurs mainly in prophase and 
metaphase, decreases through anaphase, and is absent in telophase and cytokinesis. To 
gain insight on the function of CK2α phosphorylation in mitosis, cell lines with 
tetracycline-regulated expression of phosphorylation-site mutants of CK2α, either with 
phosphomimetic aspartic acid or glutamic acid substitutions (CK2α-4D, CK2α-4E) or 
with non-phosphorylatable alanine substitutions (CK2α-4A) were examined. Expression 
of CK2α phosphomimetic mutant proteins resulted in aberrant centrosome amplification, 
chromosomal segregation defects, and loss of mitotic cells through mitotic catastrophe. 
Non-phosphorylatable CK2α expression did not result in these effects, but cells showed 
decreased ability to arrest following spindle insult by nocodazole treatment. Taken 
together, these results show that proper temporal regulation of CK2α phosphorylation is 
required for proper mitotic progression, and highlight a role for CK2α phosphorylation in 
maintenance of spindle integrity and control of cell division. 
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2.2 Materials and Methods 
 Antibodies - Polyclonal antibodies against phosphorylated CK2α were raised in 
New Zealand White rabbits against phosphorylated peptides (pT344: CANSSVPpTSGG; 
pT360/pS362: CISSVPpTPpSPL; pS370: CRRRLAGpSPVI) coupled to Keyhole Limpet 
Hemocyanin by Covance Research Products, Inc. (Denver, PA). Non-phosphospecific 
antibodies were immunodepleted from the antisera on SulfoLink Resin (Pierce) 
conjugated to non-phosphorylated versions of the above peptides. Phosphospecific 
antibodies were isolated from the resultant flow through by affinity purification with 
phosphorylated peptides. Polyclonal anti-CK2α, anti-CK2β and anti-Cdk1 antiserum 
have been previously described (22). The monoclonal antibody 12CA5 which reacts 
against the HA epitope was purchased from Roche. The culture supernatant from the 
hybridoma producing the 9E10 monoclonal antibodies directed against the Myc epitope, 
developed by J.M. Bishop was obtained from the Developmental Studies Hybridoma 
Bank developed under the auspices of the NICHD and maintained by The University of 
Iowa, Department of Biological Sciences, Iowa City, IA 52242. Goat CK2α, Phospho-
Histone H3 (Serine 10), Cyclin B1 and Cytochrome C antibodies were purchased from 
Santa Cruz Biotechnology.  Pericentrin antibodies were purchased from AbCam. 
Monoclonal antibodies against β-tubulin were a generous gift from Dr. Lina Dagnino 
(Department of Pharmacology, University of Western Ontario). Goat anti-rabbit (GAR) 
or goat anti-mouse (GAM) horseradish peroxidase (HRP) secondary antibodies were 
purchased from BioRad. FITC-GAR was from Sigma, and Texas Red-GAR and 
AlexaFluor® 488-GAM were from Molecular Probes. Fluorescent secondary antibodies 
for immunoblot detection were purchased from LI-COR Biosciences. 
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 Plasmid Constructs - The CK2α-HA/Myc-CK2β bidirectional plasmid in pBI 
(Clontech) and CK2α phosphorylation site mutant proteins in pRc/CMV (Invitrogen) 
have been previously described (31, 42). To introduce the CK2α phosphorylation site 
mutations into the tetracycline-responsive, bidirectional pBI vector, the pRc/CMV 
vectors were cut with BstBI and BlpI restriction endonucleases (New England Biolabs) to 
release a 1040 base pair insert containing the mutations at the C-terminal phosphorylation 
sites. The CK2α-HA/Myc-CK2β bidirectional plasmid was digested in the same manner, 
and the mutated inserts were ligated into the wild type plasmid, thus replacing a wild type 
CK2α C-terminus with a mutant C-terminus.  All plasmids were verified by DNA 
sequencing. 
 Generation and Maintenance of Cell Lines - UTA6 cells were derived from the 
human osteosarcoma U2OS cell line, and express the tetracycline trans-activator (tTA) 
fusion protein (a generous gift from Dr. Christoph Englert, Forschungszentrum 
Karlsruhe, Germany) (9). Cell lines expressing CK2α-HA and CK2α-KD-HA (Kinase 
Dead) have been previously described (42). Cell lines with tetracycline-regulated 
expression of HA-tagged CK2α phosphorylation site mutants were generated by co-
transfection of CK2α-4D-HA, CK2α-4E-HA, or CK2α-4A-HA with the pTK-hyg 
plasmid (Clontech) in the presence of tetracycline. Drug selection with 500 μg/mL 
hygromycin and 460 μg/mL G418 (Life Technologies Inc.) began 48 hours after 
transfection. Once stably transfected colonies had formed, they were picked and 
transferred to 96-well dishes. Colonies were expanded and tested for tight inducible 
expression of CK2α phosphorylation site mutants by western blot analysis. Cells were 
maintained in Dulbecco's Modified Eagle Medium (DMEM) (Sigma) with 10% fetal calf 
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serum (Invitrogen), antibiotic supplements (0.1 mg/mL streptomycin and 100 units/ml 
penicillin) (Life Technologies Inc.), and 1.5 mg/mL tetracycline (Sigma). To achieve cell 
synchronization in S phase, cells were treated by double thymidine block with two 16 
hour treatments with 2mM thymidine (Sigma) separated by a 10 hour incubation without 
thymidine. To achieve cell synchronization in G2/M, cells were released from S phase 
arrest for 8 hours and then treated with 40 ng/mL nocodazole (Sigma) for 18 hours.  
 Cell Lysis and Immunoprecipitation - Cells were lysed on ice in NP-40 lysis 
buffer (50mM Tris pH 7.5, 150mM NaCl, 1% NP-40, 1 µg/mL Pepstatin A, 1 µg/mL 
Leupeptin, 1mM PMSF, 1mM NaF, 4mM Na2VO4). The lysates were sonicated on ice in 
three 10s bursts and then centrifuged in a Beckman TL100.2 rotor at 55000 rpm for 15 
min. For immunoprecipitation, 1 mg of total cell lysate was incubated with 2 µL of 
12CA5 anti-HA antibody or 5 µL of anti-Cdk1 antisera bound to Protein A Sepharose for 
one hour at 4˚C. Beads were washed four times in lysis buffer and proteins were eluted in 
boiling sample buffer.  Where dephosphorylation was required, lysates were incubated 
with 1 μL of Lambda Phosphatase (New England Biolabs) for 30 minutes at 37°C. 
 Immunoblot analysis - The protein concentration of each sample was determined 
using the BCA protein assay (Pierce). Equal amounts of protein lysate were separated by 
SDS-PAGE using the method of Laemmli (19). Proteins were transferred to 
polyvinylidene difluoride (PVDF) membranes (Boehringer Mannheim) for 1 hour at 15 V 
and 0.3 A using the Trans-blot Semi-Dry Electrophoretic transfer apparatus (Bio-Rad).  
Immunoblotting was performed by blocking one hour in 5% BSA in TBST, followed by 
overnight incubation with the primary antibody.  Immune complexes were detected either 
by incubation with HRP-linked secondary antibodies and detection by 
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chemiluminescence, or incubation with fluorophore-linked secondary antibodies and 
detection on a LI-COR Near-Infrared Fluorescent Scanner and Odyssey V3.0 software. 
 Kinase Assays - CK2 activity was measured in whole cell extracts using a 
synthetic peptide substrate (RRRDDDSDDD) (23). Assays were performed for 5 minutes 
or 10 minutes at 30°C in a final reaction volume of 30 μl containing 50 mM Tris-HCl (pH 
7.5), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT and 0.1 mM ATP (specific activity 500-
1000 cpm/pmol, ICN) and 0.1 mM substrate peptide. Reactions were initiated by the 
addition of 2 μg or 4 μg of cell extract.  The reactions were terminated by spotting 10 μL 
of the reaction mixture on P81 phosphocellulose paper. Samples were washed 4 times in 
1% phosphoric acid and once in 95% ethanol. Activity was detected with a Beckman LS 
5801 scintillation counter. Cdk1 activity was measured using Histone H1 (Calbiochem) 
as described in (22). 
 Growth Curve Construction - CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, and 
CK2α-4A-HA expressing cells were seeded in 6-well dishes at a starting density of 20 
000 cells per well.  Protein expression was induced and complete media was added in the 
presence or absence of 1.5 μg/ml tetracycline. The media was changed every 3 days. On 
days 0, 1, 3, 5 and 7, the cells were harvested with 5 mM EDTA in PBS and counted with 
a haemocytometer. Trypan blue (Gibco) was used to distinguish viable from non-viable 
cells.  
 Cell Cycle Analysis - CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, and CK2α-4A-
HA expressing cells were arrested in S phase by double thymidine block. Upon release 
from thymidine block, protein expression was induced and complete media was added to 
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the cells in the presence or absence of 1.5 μg/ml tetracycline.  For 24 hours, floating and 
adherent cells were collected every two hours with 5mM EDTA in PBS and fixed in 70% 
ethanol overnight at 4 º C.  Cells were then washed with PBS and stained with propidium 
iodide (PI) staining solution (0.1% sodium citrate, 0.1% Triton X-100, 50 µg/mL PI 
(Sigma), and 0.1 mg/mL DNAse-free RNAse A (Sigma)) for 20 minutes at 37˚C. 
Nocodazole arrested cells were fixed and stained as above. Cells stained with Phospho-
Histone H3 were harvested 12 hours after thymidine release and induction then fixed as 
above. After washes with PBS, PBS + 0.5% Triton X-100, and PBS + 5% BSA (PBS-
BSA), cells were incubated two hours with 1 µg/mL Phospho-Histone H3 in PBS-BSA. 
Positive cells were detected using goat anti-rabbit FITC (1:200) (Sigma) in PBS-BSA. 
Cells were then counterstained with PI as above. Cells were analyzed on a Becton 
Dickinson fluorescence-activated cell sorter (FACScan) using Cell Quest Pro software 
(Becton Dickinson).  In each sample, 20,000 events in a specific gated region were 
counted. Data analysis was carried out using FlowJo software (Tree Star).    
 Immunostaining and Microscopy - Cells used for immunostaining were grown on 
Poly-L-Lysine coated coverslips (Bio-Rad). For mitochondrial staining, cells were 
incubated for 30 minutes with 200 nM MitoTracker® Deep Red 633 FM prior to fixation. 
Following fixation with 50:50 Methanol:Acetone, coverslips were incubated in 0.1% 
Glycine in PBS and blocked in 5% FBS in PBS. Primary and secondary antibody 
incubations were performed at 37˚C for 1 hour and 30 minutes respectively. After 
washing with PBS, DNA was stained with DAPI and coverslips were mounted onto 
microscope slides with AirVol. Cells were visualized on a Zeiss META 510 LSM 
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Confocal microscope. Z-series images of 0.6 µm thickness were captured and processed 
with Zeiss software and Adobe Photoshop. 
 Trypan Blue Viability Assays - Cells were arrested by thymidine block and protein 
expression was induced as above. Twenty-four hours after induction, floating and 
adherent cells were collected using 5mM EDTA in PBS and stained with 0.4% Trypan 
Blue Stain (Gibco). Total and non-viable cells were counted with a haemocytometer. 
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2.3 Results 
Generation and characterization of CK2α phosphospecific antibodies 
 To investigate mitotic phosphorylation of CK2α, we generated polyclonal 
antibodies targeting the four C-terminal phosphorylation sites. Three antibodies were 
made, targeting the T344, T360/S362, and S370 phosphorylation sites respectively. 
Following affinity purification, the antibodies were tested for phosphospecificity. 
Phosphorylation of CK2α can be detected after gel electrophoresis by its slight mobility 
decrease (Figure 2.1A, CK2α immunoblot). Lysates from cells arrested in S phase by 
thymidine block show no mobility shift due to phosphorylation, and accordingly, show 
no reactivity when immunoblotted with CK2α phosphospecific antibodies (Figure 2.1A, 
Thymidine lanes). Lysates from cells arrested in mitosis by nocodazole treatment show 
robust reactivity towards CK2α phosphospecific antibodies at a position corresponding to 
the phosphorylated portion of the total CK2α (Figure 2.1A, Nocodazole lanes). 
Additionally, all three phosphospecific antibodies show no cross-reactivity to 
unphosphorylated CK2α. To confirm that these antibodies are specifically detecting 
phosphorylation, we next immunoblotted lysates from nocodazole arrested cells after 
dephosphorylation with λ-Phosphatase. As shown in Figure 2.1B, treatment with λ-
Phosphatase resulted in loss of the mobility-shift associated with CK2α phosphorylation 
and loss of reactivity to CK2α phosphospecific antibodies. To test the ability of the 
phosphospecific antibodies to detect phosphorylated CK2α in cells, nocodazole-arrested 
cells were fixed and immunostained using CK2α phosphospecific antibodies. DNA was 
stained with DAPI. All three antibodies exclusively stain mitotic cells, recognized by the 
condensed nature of the chromosomes (Figure 2.1C). The signal is specific to   
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Figure 2.1 
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Figure 2.1 Generation of CK2α phosphospecific antibodies. A. Lysates from cells 
arrested in S phase by double thymidine block or mitosis by nocodazole treatment were 
immunoblotted with CK2α phosphospecific antibodies targeting phosphorylated T344, 
T360/S362, or S370. Total CK2α was detected using a CK2α antibody. B. Lysates from 
nocodazole-arrested cells were left untreated or dephosphorylated using λ-Phosphatase 
before immunoblotting as in A. C. Nocodazole-arrested cells were fixed and 
immunostained using CK2α phosphospecific antibodies. DNA was stained with DAPI. 
Mitotic cells are recognizable by the condensation of chromosomes. Magnification: 40X. 
D. CK2α phosphospecific antibodies were preincubated with phosphorylated peptides 
corresponding to the appropriate phosphorylation site before immunostaining of 
nocodazole-arrested cells as in C. DNA is stained with DAPI. Magnification: 20X. 
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phosphorylated CK2α, as preincubation of the antibodies with the phosphorylated 
peptides used in antibody generation completely blocks detection by immunostaining 
(Figure 2.1D). To test for cross-reactivity between the three antibodies, we also 
preincubated each antibody with peptides targeting the other phosphorylation sites. When 
peptides targeted the same phosphorylation site as the antibody, antibody reactivity was 
blocked, but peptides targeting phosphorylation sites not targeted by a particular antibody 
did not inhibit antibody reactivity (Figure 2.2). Taken together, these results confirm that 
the phosphospecific antibodies are specific to the CK2α C-terminal phosphorylation sites. 
CK2α is phosphorylated in prophase and metaphase and dephosphorylated during 
anaphase 
While CK2α has long been known to be maximally phosphorylated in nocodazole-treated 
cells on the basis of its shift in electrophoretic mobility (4, 20), phosphospecific 
antibodies provide new opportunities to directly evaluate the extent of phosphorylation as 
mitosis progresses in a non-arrested cell. To test whether CK2α phosphorylation occurs 
in all mitotic cells, we compared the proportion of CK2α phosphorylated in cells 
undergoing normal mitotic progression versus those arrested in mitosis by nocodazole 
treatment. U2OS cells were arrested in S phase by double thymidine block and released 
into the cell cycle for 9, 12, or 15 hours. At these time points, mitotic cells were collected 
by mitotic shake-off and analyzed for CK2α phosphorylation using the phospho-S370 
antibody (Figure 2.3A). When equal amounts of cell lysates were subjected to western 
blot analysis, CK2α was found to be phosphorylated in mitotic cells, albeit at lower levels 
than in cells treated with nocodazole. This result is also shown using a total CK2α 
antibody, with mitotic cells exhibiting the characteristic shift seen upon  
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Figure 2.2 
 
 
 
 
Figure 2.2 CK2α phosphospecific antibodies do not display phosphorylation site cross-
reactivity. CK2α phosphospecific antibodies were preincubated with phosphorylated 
peptides corresponding to all three antibodies generated before immunostaining of 
nocodazole-arrested cells. DNA is stained with DAPI. Mitotic cells are recognizable by 
the condensation of chromosomes. Magnification: 40X. 
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Figure 2.3 
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Figure 2.3 CK2α phosphorylation occurs in mitotic cells during prophase and metaphase. 
A. U2OS cells were synchronized in S phase by double thymidine block and released into 
mitosis for 9, 12 or 15 hours before harvest. Lysates were immunoblotted using the P-
S370 CK2α phosphospecific antibody. Total CK2α is also shown. Mitotic cells were 
detected using a Phospho-Histone H3 (Ser 10) antibody. NC, Nocodazole-treated. B. 
U2OS cells were synchronized as in A, fixed 12 hours after thymidine release, and 
immunostained with antibodies against phosphorylated CK2α (Red) and total CK2α 
(Green). DNA was stained with DAPI. Magnification: 63X. C. U2OS cells were arrested 
in mitosis by nocodazole treatment, washed, and harvested at 20 minute intervals after 
removal of nocodazole. Lysates were immunoblotted with antibodies against 
phosphorylated CK2α, total CK2α, Cyclin B1 to detect the onset of anaphase, and 
Phospho-Histone H3 (Serine 10) to detect mitotic cells.  D. Cells were arrested in mitosis 
as in C, and plated on slides following release. After fixation and DAPI staining, cells 
were scored for mitotic stage based on DNA morphology. At least 100 cells were scored 
for each time point in each of three replicate experiments. The error bars indicate one 
standard deviation from the mean. 
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 phosphorylation. Phospho-Histone H3 (Serine 10) was used as a marker of mitosis.  
We next examined whether CK2α phosphorylation was occurring throughout 
mitosis. To achieve this, U2OS cells were arrested in S phase by double thymidine block, 
released from the block for 12 hours and then fixed for immunostaining with 
phosphospecific and total CK2α antibodies. As shown in Figure 2.3B, cells in prophase 
and metaphase show robust phospho-CK2α staining. The signal decreases in anaphase 
and is undetectable in telophase and cytokinesis. To confirm this result, cells were 
arrested in prometaphase by nocodazole treatment to enable tracking of the 
phosphorylation in a synchronized population. After removal of nocodazole, cells were 
harvested at 20 minute intervals to track CK2α phosphorylation through mitosis by 
western blot analysis using CK2α phosphospecific antibodies (Figure 2.3C). 
Phosphorylation was initially strong, and decreased after 80 minutes of progression. This 
result is also shown using a CK2α antibody, with mitotic cells exhibiting the 
characteristic shift seen upon CK2α phosphorylation. This correlated well with the onset 
of anaphase, as Cyclin B expression decreases just prior to the onset of CK2α 
dephosphorylation. Histone H3, which remains phosphorylated at serine 10 until the 
completion of cytokinesis (7), served as a marker for late mitosis. To determine the 
average mitotic stage of cells at each time point, cells were incubated on coverslips after 
release from nocodazole arrest and sorted into mitotic stages based on DNA morphology 
(Figure 2.3D). The majority of cells remained in prophase and metaphase until the 60 
minute time point and progressed into anaphase at 80-100 minutes after release. From 
these results, we conclude that CK2α is phosphorylated in mitotic cells, but at lower 
levels than in nocodazole-arrested cells. This phosphorylation is temporally regulated, 
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with maximal phosphorylation in prophase and metaphase and dephosphorylation at the 
onset of anaphase. 
Characterization of cell lines with inducible expression of CK2α phosphorylation site 
mutants 
The above results indicate that temporal regulation of CK2α phosphorylation may 
be important for mitotic progression. To study the role of the phosphorylation of CK2α in 
cell cycle progression, all four proline-directed phosphorylation sites unique to the CK2α 
C-terminus (T344, T360, S362, and S370) were mutated to either aspartic acid (CK2α-
4D) or glutamic acid (CK2α-4E), in order to mimic the phosphorylated state. 
Additionally, the phosphorylation sites were mutated to alanine (CK2α-4A) in order to 
generate a non-phosphorylatable form of CK2α (Figure 2.4A). UTA6 cells with stable, 
tetracycline-regulated expression of CK2α phosphorylation site mutants were generated 
using a bidirectional plasmid expressing both an HA-tagged CK2α phosphorylation site 
mutant and Myc-tagged CK2β (Figure 2.4B). This bidirectional system has the advantage 
of maintaining the stoichiometry of the CK2 tetramer, and tetracycline regulation ensures 
tight control over expression of the mutant proteins.  Myc-CK2β coimmunoprecipitates 
with CK2α-HA, indicating that the exogenously expressed proteins can interact in the 
cell, and are likely incorporated into mixed CK2 tetramers with endogenous CK2 (Figure 
2.4C). In cell lysates, the presence of CK2α phosphorylation site mutants caused an 
increase in kinase activity comparable to the increase seen with wild type CK2α-HA. 
Thus, these phosphorylation site mutations do not appear to directly affect the enzymatic 
activity of CK2α (Figure 2.4D). 
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Figure 2.4 
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Figure 2.4 Inducible expression of CK2α phosphorylation-site mutants. A. CK2α C-
terminal phosphorylation sites (T344, T360, S362 and S370) were mutated to aspartic 
acid (CK2α-4D-HA), glutamic acid (CK2α-4E-HA), or alanine (CK2α-4A-HA). B. HA-
tagged CK2α mutants were stably expressed from a tetracycline-regulated bidirectional 
vector along with Myc-tagged CK2β. MCSI/II, Multiple Cloning Sites I and II; CMV, 
Cytomegalovirus promoter; TRE, Tetracycline-responsive Element. C. Inducible 
expression of tetrameric complexes containing CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, 
CK2α-4A-HA and Myc-CK2β. Cells were incubated for 24 hours in the presence (+) or 
absence (-) of tetracycline. Equal amounts of lysate were resolved by SDS-PAGE and 
subjected to immunoblot analysis with antibodies targeted against CK2α and CK2β, or 
immunoprecipitated with a 12CA5 (anti-HA) antibody and immunoblotted with an anti-
Myc antibody. D. Lysates were prepared from cells with tetracycline-regulated 
expression of CK2α-HA, CK2α-KD-HA (Kinase dead), CK2α-4D-HA, CK2α-4E-HA, 
and CK2α-4A-HA, cultured in the presence (+ Tet, white bars) or absence (- Tet, black 
bars) of tetracycline for 24 hours. Lysates were incubated with a synthetic peptide 
substrate of CK2 (RRRDDDSDDD) and [γ-32P]-ATP. Kinase activities are the average of 
four determinations.  The error bars indicate one standard deviation from the mean. 
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Expression of CK2α phosphorylation site mutants results in decreased proliferation 
 To determine if mutation of the four conserved CK2α phosphorylation sites had 
any effect on cell proliferation, we analyzed the growth of cells expressing CK2α-HA, 
CK2α-4D-HA, CK2α-4E-HA, or CK2α-4A-HA in combination with Myc-CK2β. Protein 
expression was induced by removal of tetracycline from the culture medium and cells 
were counted over a seven-day period to examine proliferative capacity compared to cells 
grown in the absence of CK2α overexpression. Cells expressing wild type CK2α-HA 
showed a slight decrease in proliferation over the seven day period, consistent with 
previous results (38). In the three phosphorylation site mutant cell lines, the proliferation 
defects were more marked compared to their non-expressing counterparts (Figure 2.5A). 
To ensure that the observed growth defects were not artefacts from random integration 
events in the construction of the stable cell lines, growth curves were also prepared using 
additional cell lines expressing each mutant protein. These cell lines also exhibited 
decreased growth upon expression of CK2α mutant proteins (Figure 2.5B).The decreased 
proliferation observed upon expression of CK2α phosphorylation site mutant proteins 
suggests that CK2α phosphorylation does have a functional effect on cellular 
proliferation. 
As expression of CK2α phosphorylation site mutant proteins caused varied 
decreases in proliferation, we next sought to determine if any specific point in the cell 
cycle was perturbed upon expression. Cells expressing CK2α-HA, CK2α-4D-HA, CK2α-
4E-HA, and CK2α-4A-HA were grown in the presence or absence of tetracycline and 
arrested in S phase by double thymidine block. Upon release from a double thymidine 
block, CK2α mutant protein expression was induced (Figure 2.6A). 
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Figure 2.5 
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Figure 2.5 Cell proliferation profiles of inducible wild-type and mutant CK2α cell lines 
show decreased growth with phosphorylation-site mutant expression. A. Cells expressing 
CK2α-HA, CK2α-4A-HA, CK2α-4D-HA, and CK2α-4E-HA  were seeded in six-well 
dishes at 2 x 104 cells/well and cultured in the presence (+ Tet, straight line) or absence ( 
- Tet, dashed line) of 1.5 µg/µl tetracycline at Day 0.  The growth media was changed 
every three days.  Cell counts were obtained in triplicate for a period of 7 days.  The 
results represent the average of three independent experiments. The error bars indicate 
one standard deviation from the mean. * indicates a significant difference between + 
tetracycline and – tetracycline samples (P < 0.05). B. Alternate cell lines expressing 
CK2α-4A-HA, CK2α-4D-HA, and CK2α-4E-HA were treated as in panel A. 
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Cells were fixed at two hour intervals for 24 hours, stained with PI, and analyzed by flow 
cytometry. Samples from each stable cell line without protein induction showed similar 
cell cycle progression profiles, with a maximum amount of cells containing 4N DNA 
content 8-12 hours after release from the thymidine block (Figure 2.6B). Profiles from 
cells expressing CK2α phosphomimetic mutants showed a maximum amount of 4N cells 
at slightly earlier time points, and all three phosphorylation site mutants showed a marked 
decrease in cells with 4N DNA content. The CK2α-4A-HA expressing cells show a 
modest decrease in mitotic cells at the 10 and 12 hour time points, while the CK2α-4D-
HA and CK2α-4E-HA expressing cells show more marked decreases in mitotic cells from 
the 10-hour time point onwards. This indicates that expression of CK2α phosphorylation 
site mutants may affect the timing of transit to G2/M, and lead to loss of cells in mitosis. 
When cells were treated as in Figure 2.6A, but induced for protein expression six hours 
before release from thymidine block, there were no differences in cell cycle profiles 
compared to cells induced at the time of release (Figure 2.6C), indicating that expression 
of CK2α phosphorylation-site mutants does not affect S phase entry or progression. 
 The loss of mitotic cells observed could have several explanations, including cell 
cycle arrest, or loss of cells due to cell death. To investigate whether the loss of mitotic 
cells is due to G2 arrest, we employed Phospho-Histone H3 (Serine 10) staining and PI 
staining to distinguish between G2 cells and mitotic cells (39). Cells were released from a 
double thymidine block and protein expression was induced as in Figure 2.7A. At the 12 
hour time point, cells were fixed and analyzed for Phospho-Histone H3 positivity and 
DNA content.  Representative histograms are shown in Figure 2.7A. 
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Figure 2.6 
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Figure 2.6 Expression of CK2α phosphomimetic mutants disrupts cell cycle progression. 
A. CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, and CK2α-4A-HA cell lines were 
synchronized using a double thymidine block (TB), then cultured in the presence (+ tet) 
or absence (- tet) of tetracycline for 24 hours.  B. Cell cycle profiles of synchronized 
CK2α cell lines. The 0 hr time point was denoted as the point in time immediately after 
the double thymidine block.  Cells were harvested and fixed at 2 hour intervals, stained 
with PI and analyzed by flow cytometry. The percentage of cells in G2/M was taken from 
the percentage of cells containing 4N DNA content. C. Cells expressing CK2α-HA, 
CK2α-4D-HA, CK2α-4E-HA, and CK2α-4A-HA were treated as in panel A, but were 
induced for protein expression either at the same time as release from S-phase arrest 
(labelled 0; trace in black) or six hours before S phase arrest (labelled -6; trace in grey). 
After 12 hours of cell cycle progression, cells were fixed and stained with Propidium 
Iodide and subjected to cell cycle analysis.  
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Figure 2.7 
 
Figure 2.7 Expression of CK2α phosphomimetic mutants leads to loss of mitotic cells. A. 
Phospho-Histone H3 (Serine 10) staining of cells twelve hours after double thymidine 
block release and induction of CK2α phosphorylation site mutants. Cells were fixed and 
stained with Phospho-Histone H3 (Serine 10) antibody with a FITC-GAR secondary 
antibody and PI. Samples were analyzed by flow cytometry. B. Graphical representation 
of the percentage of G2/M cells in mitosis 12 hours after release from double thymidine 
block. C. Graphical representation of the amount of cells with Sub-G1 levels of DNA 12 
hours after release from double thymidine block. For B and C, significant differences 
between each cell line in the presence or absence of tetracycline are denoted by * (P > 
0.05 by pair wise analysis of variance). 
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The cell cycle distribution for each cell line, averaged from three independent 
experiments, is shown in Table 2.1. Recapitulating the results seen in Figure 2.6B, 
expression of CK2α-HA had no effect on the percentage of cells in mitosis. Compared to 
the total percentage of cells in G2/M, expression of CK2α-4D-HA and CK2α-4E-HA 
resulted in an almost complete loss of mitotic cells (Figure 2.7B). The decrease in mitotic 
cells did not accompany a corresponding increase in G2 cells, as would be expected if the 
loss of mitotic cells were due to a G2/M arrest. In fact, the amount of G2 cells also 
significantly decreases upon expression of CK2α-4D-HA or CK2α-4E-HA (Table 2.1). 
Interestingly, the CK2α-4D-HA and CK2α-4E-HA cell lines showed an accumulation of 
cells with sub-G1 levels of DNA upon expression of phosphomimetic CK2α (Figure 
2.7C). No accumulation of sub-G1 cells was observed with either CK2α-HA or CK2α-
4A-HA expression. Therefore, we conclude that the loss of mitotic cells observed upon 
expression of the CK2α phosphomimetic forms is not due to cell cycle arrest in S phase 
or G2 phase, but instead may be attributed to cell death.  
Phosphomimetic CK2α expression causes cell death by mitotic catastrophe 
Cell cycle analysis of cells expressing CK2α phosphomimetic mutants showed a 
dramatic increase in cells with sub-G1 amounts of DNA, indicating cell death. To 
quantitate the extent of cell death upon phosphomimetic CK2α expression, we arrested 
cells in S phase by double thymidine block and induced protein expression upon release 
into the cell cycle (Figure 2.8A). Cells were allowed to progress through mitosis and 
were stained 24 hours after thymidine release with Trypan Blue. In this assay, viable cells 
remain unstained, while nonviable cells are stained dark blue. While the wild type CK2α-
HA cell line and the nonphosphorylatable CK2α-4A-HA cell line showed 
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TABLE 2.1. Cell cycle distribution of cells expressing CK2α phosphorylation site  
  mutants 12 hours after thymidine release 
 Percent Cellsc 
 
Cell Line Sub-G1 G1 S G2a Mb 
CK2α-HA  
+Tetracycline 
 
0.64 
 
32.04 
 
13.77 
 
48.79 
 
4.01 
-Tetracycline 
 
0.59 29.89 15.16 49.60 4.13 
CK2α-4D-HA         
+Tetracycline 
 
0.36 
 
28.91 
 
17.97 
 
46.79 
 
4.85 
-Tetracycline 
 
7.92 33.21 24.98 32.27 0.97 
CK2α-4E-HA 
+Tetracycline 
 
0.44 
 
31.71 
 
15.47 
 
44.08 
 
7.26 
-Tetracycline 
 
7.85 33.05 22.77 34.40 1.23 
CK2α-4A-HA 
+Tetracycline 
 
0.41 
 
31.22 
 
16.36 
 
44.67 
 
6.80 
-Tetracycline 
 
0.35 31.29 15.45 46.59 5.91 
a Cells with 4N DNA negative for Phospho-Histone H3 staining 
b Cells with 4N DNA positive for Phospho-Histone H3 staining 
c Bold font indicates significant differences between + tet and – tet samples (P < 0.01) 
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 no decrease in the amount of viable cells upon CK2α expression, the CK2α-4D-HA and 
CK2α-4E-HA cell lines showed significant decreases in viability upon protein expression 
(Figure 2.8B). To ensure that the observed cell death was related to cell cycle progression 
and not a direct result of CK2α phosphomimetic expression, cells were induced for 
protein expression for 24 hours in a continuous thymidine-induced S-phase arrest. There 
was little evidence of cell death in CK2α phosphomimetic expressing cells arrested in S 
phase; therefore the cell death observed in the CK2α phosphomimetic cell lines requires 
both protein expression and progression through the cell cycle.  Since the cell death 
observed was cell cycle dependent and seemed to involve the specific loss of mitotic 
cells, we hypothesized that the loss of mitotic cells is due to induction of mitotic 
catastrophe. To confirm that cells expressing CK2α-4D-HA or CK2α-4E-HA are dying 
during the process of cell division, we employed immunostaining to detect cells that are 
simultaneously mitotic and apoptotic. To identify mitotic cells, cells were immunostained 
with a Phospho-Histone H3 (Serine 10) antibody. We used Cytochrome C release from 
the mitochondria as a marker of early apoptosis, combining immunostaining with a 
Cytochrome C antibody with MitoTracker® Deep Red 633 FM staining to visualize the 
mitochondria. A representative cell in the process of both mitosis and apoptosis is shown 
in Figure 2.8C. As shown in Figure 2.8D, expression of CK2α-4D-HA or CK2α-4E-HA 
caused a large increase in mitotic catastrophe over baseline levels. Expression of neither 
CK2α-HA nor CK2α-4A-HA caused any increase in the amount of mitotic catastrophe 
observed. From this we conclude that expression of CK2α phosphomimetic mutant 
proteins results in cell death by mitotic catastrophe.   
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Figure 2.8 
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Figure 2.8 Phosphomimetic CK2α expression causes cell death by mitotic catastrophe. 
A. CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, and CK2α-4A-HA cell lines were 
synchronized in S phase by double thymidine block (TB). Upon release, cells were 
induced for CK2α expression and analyzed 12 hours (Panels C and D) or 24 hours (Panel 
B) after release into the cell cycle. B. Cells were incubated 24 hours after release from 
thymidine treatment and stained with Trypan Blue to assess viability. The percentage of 
cells excluding blue staining (indicating cell viability) was tabulated for at least 200 cells 
in each of three independent experiments. Cells were also maintained in S phase by 
continued thymidine treatment and assayed for viability. The error bars indicate one 
standard deviation from the mean. Significant differences between each cell line in the 
presence or absence of tetracycline are denoted by * (P > 0.05 by pair wise analysis of 
variance). C. Cells expressing wild type or mutant forms of CK2α were fixed after 12 
hours of cell cycle progression and immunostained with antibodies against Phospho-
Histone H3 Serine 10 (P-H3), and Cytochrome C (Cyt C). Mitochondria were stained 
with MitoTracker® Deep Red 633 FM (Mitotracker) to visualize Cytochrome C release. 
D. The percentage of cells exhibiting features of mitotic catastrophe was tabulated for at 
least 100 mitotic cells in each of three independent experiments. The error bars indicate 
one standard deviation from the mean. Significant differences between each cell line in 
the presence or absence of tetracycline are denoted by * (P > 0.05 by pair wise analysis of 
variance). 
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Mitotic defects induced by CK2α phosphomimetic expression include aberrant spindle 
formation and missegregation of chromosomes  
Expression of CK2α phosphomimetic mutants caused a dramatic increase in cell 
death by mitotic catastrophe. To further examine the mitotic defects caused by expression 
of CK2α-4D-HA or CK2α-4E-HA, cells were arrested at S phase, released into mitosis 
and induced for expression of CK2α phosphorylation site mutant proteins (Figure 2.9A). 
Cells were then fixed and immunostained with antibodies against β-Tubulin and 
Pericentrin, to visualize the mitotic spindle and the centrosomes respectively (5). 
Interestingly, cells expressing phosphomimetic forms of CK2α show multiple 
centrosomes, resulting in the formation of pseudobipolar, tripolar, and multipolar cells 
(Figure 2.9B). The aberrant numbers of centrosomes in these cells appears to be due to 
centrosome fragmentation and not over duplication, as cells expressing CK2α-4D-HA or 
CK2α-4E-HA display proper numbers of centrosomes in S phase (Data not shown). Even 
among the proportion of phosphomimetic CK2α-4D-HA and CK2α-4E-HA expressing 
cells that displayed two centrosomes, we noted abnormalities in the chromosomal 
segregation, including chromosomes that did not seem to line up properly at the 
metaphase plate, and lagging chromosomes during separation in anaphase. When these 
varied phenotypes were quantified, approximately half of the cells expressing CK2α-4D-
HA or CK2α-4E-HA showed defects in chromosomal segregation (Figure 2.9C). The 
dramatic phenotypes observed upon expression of phosphomimetic CK2α indicate that 
CK2α phosphorylation may be involved in maintenance of centrosome integrity and 
proper chromosomal segregation. 
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Figure 2.9 
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Figure 2.9  Phosphomimetic CK2α expression results in aberrant mitotic spindle 
formation and missegregation of chromosomes. A. CK2α-HA, CK2α-4D-HA, CK2α-4E-
HA, and CK2α-4A-HA cell lines were synchronized in S phase by double thymidine 
block. Upon release, cells were induced for CK2α expression and fixed 12 hours after 
release into the cell cycle. B. Cells were immunostained with antibodies against 
Pericentrin (to visualize centrosomes) (Red) and β-Tubulin (to visualize microtubules) 
(Green). DNA was stained with DAPI. C. The percentage of cells with missegregation of 
chromosomes was tabulated for at least 100 anaphase cells in each of three independent 
experiments. The error bars indicate one standard deviation from the mean. Significant 
differences between each cell line in the presence or absence of tetracycline are denoted 
by * (P > 0.05 by pair wise analysis of variance). 
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Nonphosphorylatable CK2α expression abrogates the spindle assembly checkpoint 
 Phosphorylation of CK2α was originally identified in cells treated with 
nocodazole, and therefore with an activated Spindle Assembly Checkpoint (SAC) (32). 
Because of this, we examined whether disruption of CK2α phosphorylation would affect 
the ability of cells to arrest in mitosis after microtubule disruption by nocodazole 
treatment. Cells were treated with nocodazole in the presence or absence of CK2α 
phosphorylation site mutant expression. After fixation and PI staining, cell cycle analysis 
was employed. While expression of wild type or phosphomimetic CK2α had no effect on 
the ability of the cells to arrest in mitosis upon SAC activation, we observed a significant 
number of cells expressing CK2α-4A-HA that lost the ability to arrest after spindle 
damage, resulting in a decrease in G2/M cells and increases in both sub-G1 and G1 cells 
(Figure 2.10A). The average percentages of cells in each stage of the cell cycle for each 
cell line are shown in Table 2.2. To confirm the loss of metaphase arrest in cells 
expressing nonphosphorylatable CK2α, Cdk1 activity was investigated (37). Upon 
immunoprecipitation of Cdk1, cells expressing CK2α-4A-HA showed both decreased 
expression of Cyclin B1 and decreased phosphorylation of Histone H1, indicating that 
these cells have an abrogated SAC (Figure 2.10B). The average Cdk1 activity from three 
independent experiments is shown in Figure 2.10C. We conclude that proper 
phosphorylation of CK2α is required to maintain the SAC in response to spindle damage. 
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Figure 2.10 
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Figure 2.10 Expression of non-phosphorylatable CK2α abrogates the spindle assembly 
checkpoint. A. Cell cycle profiles of cells expressing CK2α-HA, CK2α-4D-HA, CK2α-
4E-HA, or CK2α-4A-HA were arrested in mitosis by nocodazole treatment in the 
presence or absence of tetracycline, followed by fixation and PI staining. Samples were 
analyzed by flow cytometry. B. Cdk1 was immunoprecipitated from lysates prepared 
from nocodazole-arrested cells expressing CK2α-HA, CK2α-4D-HA, CK2α-4E-HA, or 
CK2α-4A-HA. Immunoprecipitates were immunoblotted for Cdk1 and Cyclin B1, or 
used in kinase assays with Histone H1 and γ-32P-ATP. Phosphorylation is shown by a 
representative autoradiograph. Total Histone H1 is shown by Coomassie Blue staining. C. 
Graphical representation of Cdk1 kinase activity. Results are the average of three 
independent experiments. Error bars indicate one standard deviation from the mean. 
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TABLE 2.2 Cell cycle distribution of nocodazole-arrested cells expressing CK2α 
phosphorylation-site mutants 
 
Percent Cellsa 
 
Cell Line Sub-G1 G1 S G2/M 
CK2α-HA  
+Tetracycline 
 
7.00 
 
6.33 
 
10.57 
 
88.26 
-Tetracycline 
 
7.01 6.04 11.50 73.50 
CK2α-4D-HA         
+Tetracycline 
 
3.89 
 
3.13 
 
10.88 
 
71.80 
-Tetracycline 
 
4.28 7.33 17.00 63.29 
CK2α-4E-HA 
+Tetracycline 
 
3.40 
 
5.81 
 
11.41 
 
76.86 
-Tetracycline 
 
4.92 8.91 18.84 73.59 
CK2α-4A-HA 
+Tetracycline 
 
5.24 
 
5.57 
 
12.37 
 
82.64 
-Tetracycline 
 
14.87 10.93 24.74 51.41 
a Bold font indicates significant differences between + tet and – tet samples (P < 0.01) 
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2.4 Discussion 
In this study, we have investigated the role of CK2α phosphorylation in mitosis. 
Our data indicate that precise regulation of these phosphorylation events is required for 
proper mitotic progression. Through generation of phosphospecific antibodies against 
four phosphorylation sites known to be phosphorylated in nocodazole arrested cells (4, 
20), we show that these sites are also phosphorylated in cells progressing through normal 
mitosis. Mitotic phosphorylation is strongest during prophase and metaphase and 
decreases during anaphase, becoming undetectable by telophase and cytokinesis. The 
temporal pattern of phosphorylation observed matches the temporal activation of Cdk1, 
the kinase believed responsible for these phosphorylation events (20).  
We next sought to determine the function of CK2α phosphorylation by 
observation of phenotypes associated with expression of either CK2α phosphomimetic 
mutants (CK2α-4D-HA and CK2α-4E-HA) or non-phosphorylatable mutant CK2α 
(CK2α-4A-HA). Proliferation curves showed decreased growth in all three lines 
compared with expression of CK2α-HA, with particular defects shown in the 
phosphomimetic cell lines. Subsequent cell cycle analysis showed sub-G1 cells upon 
CK2α phosphomimetic expression, indicating that mitotic cells were dying in a cell cycle 
dependent manner. Upon CK2α-4D-HA or CK2α-4E-HA expression, mitotic cells 
undergo mitotic catastrophe, a type of cell death occurring in mitosis due to deficiency in 
cell cycle checkpoint control or cellular damage (6).This may serve as a mechanism to 
eliminate cells that, if permitted to progress through mitosis, would result in aneuploid 
daughter cells. The stimulus for induction of mitotic catastrophe may be the centrosomal 
amplification observed in phosphomimetic-expressing cells, leading to aberrant spindle 
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formation and chromosomal missegregation. Similar results have recently been observed 
in Drosophila melanogaster, as RNA interference silencing of the CkIIα gene causes 
mitotic abnormalities, including centrosome abnormalities and lagging chromatids (3). In 
mammalian cells, CK2 has been shown to colocalize with the centrosomes (9, 26) and 
mitotic spindle (17, 42), and many components of the mitotic machinery interact with 
and/or are substrates of CK2, including β-Tubulin, Microtubule-associated Proteins 1A 
and 1B, Tau, Condensin, and Protein Phosphatase 2A  (2, 10, 14, 35). Recent proteomic 
investigations have identified CK2 as a component of both the centrosome and the 
spindle midbody (1, 34). Phosphoproteomic analysis of mitotic spindles recently 
identified a number of possible CK2 substrates, including both known CK2 substrates 
such as Topoisomerase IIα and HSP-90, and novel substrates such as Septin-2, INCENP, 
and MAP7 (28).  While the mechanism by which aberrant CK2α phosphorylation leads to 
centrosomal defects is unknown, it is clear that proper regulation ensures spindle 
organization and maintains genomic integrity. 
As CK2α phosphorylation occurs mainly during prophase and metaphase, we 
theorize that the defects seen upon expression of CK2α phosphorylation-site mutant 
proteins may be due to loss of temporal control of phosphorylation. During a normal cell 
division, CK2α remains unphosphorylated until the onset of prophase, when 
phosphorylation occurs. In the presence of spindle abnormalities, CK2α phosphorylation 
is at a maximum. Once all chromosomes are lined up at the metaphase plate, CK2α is 
dephosphorylated as the cell enters anaphase, and remains dephosphorylated until the 
next cell division. Defects seen upon expression of CK2α phosphorylation-site mutant 
proteins may represent the consequences of loss of temporal regulation of 
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phosphorylation. When CK2α seems phosphorylated before the onset of prophase, 
decreased centrosome integrity leads to abnormal spindle formation and chromosomal 
missegregation. Cells expressing phosphomimetic CK2α also undergo mitotic 
catastrophe, either as a result of these spindle abnormalities, or alternatively, when CK2α 
seems to remain phosphorylated after the metaphase-anaphase transition. Expression of 
non-phosphorylatable CK2α results in loss of cell cycle arrest after spindle damage, 
indicating that CK2α phosphorylation plays a role in maintaining the SAC. This result 
was particularly interesting. Cells expressing CK2α-4A-HA did not display dramatic 
mitotic defects, showing only a slight decrease in proliferation compared to cells 
expressing wild type CK2α. This corresponds well with the finding that not all CK2α 
seems to be phosphorylated in a normally dividing cell, and indicates that only a subset of 
CK2α needs to be modified to fulfill its mitotic purposes. However, upon treatment of 
cells with nocodazole, when CK2α phosphorylation is at maximum levels, expression of 
non-phosphorylatable CK2α neutralizes the activated SAC, allowing cells to progress 
through mitosis even in the presence of endogenous phosphorylated CK2α. The 
involvement of CK2 in SAC signaling has been previously demonstrated, as depletion of 
CK2 activity compromises SAC arrest after nocodazole treatment (33). However, the role 
of CK2α phosphorylation has not been examined.  
Interestingly, expression of CK2α phosphorylation-site mutants elicits mitotic 
phenotypes even in the presence of comparable amounts of endogenous CK2α. Since the 
mutant proteins are capable of forming complexes with Myc-CK2β and presumably 
incorporate into mixed tetramers with endogenous CK2 subunits, this suggests that CK2α 
phosphorylation-site mutants may have a dominant effect over endogenous, and 
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presumably phosphorylated, CK2α. This dominant effect may be mediated through 
blocking or encouraging phosphorylation-dependent interactions between CK2 and 
mitotic proteins. It seems likely that the CK2α phosphorylation sites serve as a regulatory 
mechanism, likely through forming an interaction site for the binding of other proteins. 
This has been shown to be the case for Pin1, a cis/trans peptidyl-prolyl isomerase with a 
number of mitotic substrates. Pin1 selectively isomerizes proline residues adjacent to 
phosphorylated serine or threonine residues (41). While C-terminal phosphorylation of 
CK2α does not affect general kinase activity of CK2, as measured by kinase assays with a 
substrate peptide, it is plausible that phosphorylation at these sites may be important in 
the regulation of CK2 activity against particular substrates, as is the case for 
Topoisomerase IIα.  The modulation of CK2 kinase activity towards Topoisomerase IIα 
is dependent on Pin1 binding, as a complex is formed between CK2, Pin1, and 
Topoisomerase IIα  (27). It remains unknown whether this regulatory mechanism is 
involved in selective binding and modulation of additional CK2 substrates. Recently, a 
proteomic screen of Plk1 Polo-Box Domain (PBD) binding proteins identified CK2α as a 
phosphorylation-dependent mitotic binding partner for Plk1 (24). Plk1 is a mitotic kinase 
with multiple roles in mitotic progression (36). Interestingly, the protein sequence 
surrounding the CK2α T344 phosphorylation site corresponds to the consensus sequence 
for Plk1 PBD binding (8). Further investigation of the interplay between these two 
mitotic kinases may reveal precise roles for CK2α phosphorylation in mitosis. 
Overall, we have shown that CK2α is phosphorylated during mitotic progression, 
and that these phosphorylation events do indeed have a regulatory role in the process of 
cell division. Substitution of these residues leads to mitotic catastrophe, defects in 
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centrosome amplification, and abrogation of the SAC. Collectively, these results offer 
evidence of a role for reversible phosphorylation of CK2α in the control of cell division. 
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Chapter 3: Localization of Phosphorylated CK2α to the Mitotic Spindle 
is Dependent on the Peptidyl-prolyl Isomerase Pin11 
3.1 Introduction -   Reversible phosphorylation by protein kinases is a regulatory 
mechanism crucial for cell signalling, providing a temporary switch in protein function 
leading to the proper cellular response to a stimulus. When the stimulus induces 
proliferation, the cell undergoes a highly regulated series of events ultimately leading to 
mitosis. Protein kinases play crucial roles in regulating mitotic progression, and 
understanding these roles will increase our understanding of the process of mitosis, and 
may lead to the development of targeted therapies against proliferative diseases such as 
cancer. Our focus is on determining the role of protein kinase CK2 in mitotic regulation. 
CK2 is a serine/threonine kinase with a plethora of substrates that is ubiquitously 
expressed and exhibits constitutive activity. CK2 is typically found as a tetramer, 
composed of two regulatory CK2β subunits, and two catalytic subunits, CK2α and 
CK2α’. CK2α and CK2α’ share 90% sequence identity, differing only in their C-termini 
(18). Unlike many protein kinases, CK2 is not subjected to strict on/off regulation, but 
instead seems to be regulated through a variety of mechanisms, including subcellular 
localization, protein-protein interactions, and phosphorylation (27). CK2 is involved in 
many cellular responses, including regulation of transcription and translation, cell 
proliferation, and cell survival (35).  
 CK2 has long been recognized for its importance in mitosis. CK2 is required for 
progression through the G1/S and G2/M transitions in yeast and mammalian cells (9, 14, 
15, 29). RNA interference silencing of the Drosophila melanogaster CkIIα gene leads to 
                                                            
1 A modified version of this chapter is currently in revision: St-Denis NA, Bailey ML, Parker EL, Litchfield 
DW (2010). Localization of CK2α to the mitotic spindle is dependent on the peptidyl-prolyl isomerase 
Pin1. (Journal of Cell Science) 
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mitotic abnormalities (5). Furthermore, CK2 colocalizes with centrosomes and the 
mitotic spindle (10, 43), where it interacts with and/or phosphorylates a variety of spindle 
components, including β-Tubulin (8), Condensin (37), Tau (2), and Microtubule 
Associated Proteins 1A and 1B (2). Proteomic studies have confirmed CK2 as a 
component of both the centrosome and the spindle midbody (1, 33), and 
phosphoproteomic analyses of the mitotic spindle have identified a number of potential 
CK2 substrates (22, 26). Interestingly, the CK2α isoform of CK2 is maximally 
phosphorylated in mitosis (12) at four sites in its unique C-terminus (T344, T360, S362, 
and S370) (7, 13). In our previous work, we used phosphospecific antibodies to show that 
phosphorylation is temporally regulated, occurring during prophase and metaphase. 
Stable expression of phosphorylation site mutants of CK2α results in multiple mitotic 
defects, including centrosome amplification, chromosomal missegregation and mitotic 
catastrophe (34). These results indicate that proper phosphorylation of CK2α is required 
for mitotic progression.  
 Since CK2α phosphorylation does not directly affect its kinase activity (6), we 
investigated whether phosphorylation affects its subcellular localization during mitosis. 
In this report we show that phosphorylated, but not unphosphorylated, CK2α localizes to 
the mitotic spindle. Furthermore, we show that Pin1, a peptidyl-prolyl isomerase 
important for mitotic progression, is required for localization of phospho-CK2α. We 
conclude that CK2α phosphorylation acts as a regulatory mechanism to localize CK2 to 
the mitotic spindle, which may target it towards specific mitotic substrates. 
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3.2 Materials and Methods 
Antibodies- CK2α, CK2α’, and phospho-CK2α antibodies have been previously 
described (12, 34). The CK2α antibody used to detect non-phosphorylated CK2α (C-18) 
was obtained from Santa Cruz Biotechnologies. Monoclonal β-Tubulin antibodies were a 
gift of Dr. Lina Dagnino (Department of Physiology and Pharmacology, University of 
Western Ontario). Other antibodies used were: biotin-conjugated HA (3F10) (Roche), 
Alexa-Fluor 488-conjugated HA (Molecular Probes), DsRed (Clontech), Pericentrin 
(Abcam), Pin1 (R&D Systems), monoclonal Flag M2 (Sigma), polyclonal Flag M2 (Cell 
Signalling Technologies), and β-Actin (Sigma). Secondary antibodies were obtained from 
LiCOR Biosciences and Molecular Probes. 
Plasmid Constructs - HA-CK2α, HA-CK2α’, HA-CK2α/α’, and HA-CK2α’/α constructs 
have been previously described (28). The unique C-terminus of CK2α was introduced 
into the DsRed2-C1 vector (Clontech) by PCR amplification using the forward primer 
5’AATCCGCGGTACTGGACAAACTGC3’ and the reverse primer 
5’AAAGGATCCCATCAGGAGACAG3’. The resultant fragment was subcloned into 
DsRed2-C1 using SacII and BamH1 restriction sites. Alanine and aspartic acid mutations 
were introduced by site-directed mutagenesis using a Quik-Change II Site-Directed 
Mutagenesis kit (Stratagene). Short hairpin RNA (shRNA) constructs targeting 
Luciferase and Pin1 were obtained from M. Golding and G. DiMattia. Two Pin1 shRNAs 
were constructed, Pin1A (5’CACCGTCACACAGTATTTA3’) and Pin1B 
(5’GGCCGAATTGTTTCTAGTT3’), targeting two different sequences in the 3’ 
untranslated region of Pin1. The Luciferase shRNA has been previously described (38). 
For Flag-Pin1 construction, oligonucleotides containing the Flag epitope and Not1 and 
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EcoR1 restriction sites (5’AATTGGCAATGGACTACAAAGACGATGACGACAAG 
GCGGCCGCCTCAGAATTCCT3’;5’CTAGAGGAATTCTGAGGCGGCCGCCTTGTC
GTCATCGTCTTTGTAGTCCATTGCC3’) were annealed and introduced into 
pcDNA3.1. Pin1, Pin1-Y23A, Pin1-R68/69A, and Pin1-C113S were subcloned from 
previously described pY204 plasmids (4) using Not1 and EcoR1 and ligated into 
pcDNA3.1-Flag.  All sequences were confirmed by DNA sequencing. 
Cell Culture- U2OS and HeLa cells were cultured in Dulbecco’s modified eagle medium 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and antibiotic 
supplements (0.1 mg/mL streptomycin and 100 U/mL penicillin; Life Technologies Inc.). 
Cells were synchronized in S phase by two 16 hour treatments with 2 mM thymidine 
(Sigma) separated by 10 hours incubation without thymidine. To synchronize cells in 
G2/M, cells were released from S-phase arrest and treated with 40 ng/mL nocodazole 
(Sigma) for 18 hours. Plasmid constructs were introduced into cells by calcium phosphate 
transfection. Cell lines stably expressing shRNA plasmids targeting Luciferase or Pin1 
were generated by addition of 4 µg/ml puromycin (Sigma) 48 hours post-transfection. 
Discrete colonies formed were then isolated and expanded. Samples from individual 
colonies were screened for Pin1 levels by immunoblot. 
Cell lysis and phosphatase treatment- Cells were lysed on ice in NP-40 lysis buffer (50 
mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 1 μg/mL each Pepstatin A and leupeptin, 1 
mM phenylmethylsulfonyl fluoride (PMSF), 1 mM NaF, and 4 mM Na2VO4). Following 
sonication on ice, lysates were centrifuged at 13000 X g for 15 minutes at 4°C. 
Dephosphorylation of lysates was performed using λ-phosphatase (New England 
Biolabs). Cells were lysed in the absence of phosphatase inhibitors, and incubated 30 min 
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at 37°C in the presence of 1 mM MnCl2, 50 mM HEPES pH 7.5, 100 mM NaCl, 2 mM 
DTT, 0.01% Brij 35, and 200 U of λ-phosphatase. 
Immunoblot Analysis- The protein concentration of each sample was determined with the 
BCA protein assay (Pierce). Equal amounts of cell lysates were separated by sodium-
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) by the method of 
Laemmli (11). Proteins were then transferred to nitrocellulose membrane for 1 hour at 15 
V and 0.3 A using a Trans-Blot semidry electrophoretic transfer apparatus (Bio-Rad). 
Membranes were blocked for one hour with 5% bovine serum albumin in Tris-buffered 
saline before overnight incubation with the primary antibody.  After one hour incubation 
with fluorophore-linked secondary antibodies, immune complexes were detected on a 
LiCOR near-infrared fluorescent scanner using Odyssey V3.0 software.   
Immunostaining and Microscopy-  Cells used for immunostaining experiments were 
grown on poly-L-lysine coated coverslips (BD Falcon). Cells were fixed in 3.7% 
paraformaldehyde for 30 min before incubation with 0.1% Glycine in PBS for 30 min, 
permeabilization with 0.1% Triton X-100 in PBS for 5 min, and blocking with 5% FBS 
for 1 hour. Primary and secondary antibody incubations were done for 1 hour and 30 min 
respectively, followed by staining with 4’,6’-diamidino-2-phenylindole (DAPI). All 
incubations were performed at 37°C. Coverslips were mounted on slides with AirVol. 
Microscopic images were acquired with Zeiss Zen software on a Zeiss META 510 LSM 
confocal microscope. Images were processed using Adobe Photoshop. 
Mitotic Spindle Isolation- Mitotic spindles were isolated from U2OS cells by the method 
of Silljé and Nigg (32). Briefly, cells were arrested in G1/S with 1.6 μg/mL aphidicolin 
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(Sigma) for 16 hours, released into the cell cycle for 8 hours, and then arrested in mitosis 
by incubation with 40 ng/mL nocodazole for 16 hours. Mitotic cells were collected and 
washed to remove nocodazole, then reincubated until the majority of cells entered 
metaphase, at which point the cells were treated with 5 μg/mL Paclitaxel (Taxol; 
Calbiochem). Cells were collected, washed with PBS supplemented with 2 ug/mL 
Latrunculin B, 1 mM PMSF, and 5 μg/mL Taxol, then lysed with spindle lysis buffer 
(100 mM PIPES pH 6.9, 1 mM Mg2SO4, 2 mM EGTA, 0.5% NP-40, 5 μg/mL Taxol, 2 
μg/mL Latrunculin B, 200 μg/mL DNAse1, 10 μg/mL RNAseA, 1 U/mL micrococcal 
nuclease, 20 U/mL Benzonase, 1 mM PMSF, 1 μg/mL of each of pepstatin A, leupeptin, 
and aprotinin, and 20 mM β-glycerophosphate). Following incubation with 1 mM PIPES 
pH 6.9 with 5 μg/mL Taxol, isolated spindles were confirmed by phase microscopy and 
resuspended in Laemmli buffer for SDS-PAGE. 
Dephosphorylation Assay- Phosphorylated CK2α was immunoprecipitated from 
nocodazole arrested Pin1 shRNA expressing cells using Protein A Sepharose and 1 μL of 
anti-CK2α serum for 1 h at 4°C, then incubated for 10 min at 30°C in the presence of 1 
nM, 10 nM, or 100 nM GST, GST-Pin1, or GST-Pin1-R68/69A, purified as previously 
described (3), in 20 mM HEPES pH 7.0 with 1 mM DTT, 1 mM MnCl2, 10 ug/mL BSA, 
and 50 mM Leupeptin. 0.05 U of PP2A (Millipore) was added for 30 min at 30°C. 
Okadiac acid was used at 10 nM. Reactions were stopped by addition of Laemmli buffer. 
The assay was performed in triplicate. 
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3.3 Results 
Phosphorylated CK2α localizes to the mitotic spindle 
 CK2α has been previously reported to localize to the mitotic spindle (10, 43), but 
the phosphorylation-dependence of this localization has not been examined. To 
investigate this, we used phosphospecific antibodies targeted against the T344, 
T360/S362, and S370 phosphorylation sites (34). These antibodies specifically detected 
phosphorylated CK2α in nocodazole-arrested cells, but showed no reactivity against 
unphosphorylated CK2α in thymidine-blocked cells (Figure 3.1A, the S370 antibody is 
shown). Antibody phosphospecificity was confirmed using λ phosphatase treatment of 
mitotic lysates (Figure 3.1B). To detect non-phosphorylated CK2α, we used an antibody 
that was serendipitously found to detect only non-phosphorylated CK2α, presumably due 
to its generation against an overlapping and non-phosphorylated CK2α C-terminal 
epitope (Figure 3.1A,B). Mitotic cells were immunostained for β-Tubulin and either 
phospho-CK2α or non-phospho-CK2α, and confocal microscopy was used to examine 
localization (Figure 3.1C). In all three cases, phospho-CK2α colocalized with β-Tubulin, 
while the non-phospho-CK2α did not. To extend this result to a population of cells, we 
isolated mitotic spindles from cells and immunoblotted the spindles for CK2α (Figure 
3.1D). Whole mitotic lysates are also shown. Cells treated with nocodazole, which 
inhibits mitotic spindle formation by inducing microtubule depolymerisation (44), were 
used as a negative control. Confirming the colocalization results, phospho-CK2α 
copurified with isolated mitotic spindles, while non-phospho-CK2α did not. These results 
indicate that phosphorylated CK2α preferentially localizes to the mitotic spindle. 
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Figure 3.1 
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Figure 3.1 Phosphorylated CK2α localizes to the mitotic spindle. (A) Lysates from cells 
arrested in S phase with Thymidine (Thy) or prometaphase with Nocodazole (Noc) were 
immunoblotted with antibodies targeting phosphorylated CK2α, nonphosphorylated 
CK2α, and total CK2α. (B) Nocodazole-arrested lysates were also dephosphorylated with 
λ Phosphatase before immunoblotting as in A. (C) Mitotic cells were immunostained with 
β-Tubulin and either phospho-CK2α or non-phospho-CK2α antibodies, followed by 
confocal microscopy. Scale bars, 5 μm. (D) Left panel: Purified mitotic spindles 
visualized by phase microscopy. Right panel: Purified mitotic spindles were 
immunoblotted with phospho-CK2α, non-phospho-CK2α, and total-CK2α antibodies. β-
Tubulin immunoblotting shows the presence of mitotic spindles. S, spindles; NC, 
nocodazole control.  
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To confirm the specificity of the phosphospecific antibodies, peptide competition assays 
were performed, in which each antibody was preincubated with either non-
phosphorylated or phosphorylated versions of the peptide epitope used to generate the 
antibody. While incubation with non-phosphorylated peptide did not affect spindle 
localization, incubation with phosphorylated peptide caused an almost complete loss of 
reactivity, confirming that the phosphospecific antibodies are detecting phospho-CK2α 
on the mitotic spindle (Figure 3.2).  
Spindle localization requires phosphorylation of the unique C-terminus of CK2α  
 Since the only major difference between the two catalytic isoforms of CK2 is the 
presence of the extended C-terminal tail on CK2α, which includes the mitotic 
phosphorylation sites (18), we next examined whether interchanging the C-termini of the 
two isoforms would affect their mitotic localization. Plasmids expressing HA-tagged 
CK2α and CK2α’, as well as chimeric versions with the C-termini interchanged (HA-
CK2α/α’, HA-CK2α’/α) (28) were transfected into U2OS cells (Figure 3.3A, and 
immunoblot analysis showed uniform expression (Figure 3.3B). Immunoblotting lysates 
from mitotic cells expressing these plasmids for phospho-CK2α showed that the HA-
CK2α’/α protein is phosphorylated at levels similar to HA-CK2α, while neither HA-
CK2α’ or HA-CK2α/α’ were phosphorylated (Figure 3.3C). HA-CK2α co-purified with 
mitotic spindles, while very little HA-CK2α’ was detected (Figure 3.3D). It seems that 
spindle localization requires the CK2α C-terminus, as when the CK2α C-terminus was 
replaced with the CK2α’ C-terminus (HA-CK2α/α’), the chimeric protein copurified with  
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Figure 3.2 
 
Figure 3.2 CK2α phosphospecific antibody peptide competition assay. CK2α 
phosphospecific antibodies were preincubated with a ten-fold molar excess of 
phosphorylated or non-phosphorylated versions of the peptide antigens used in antibody 
generation. Cells in mitosis were subjected to immunostaining with β-Tubulin and the 
pre-incubated phospho-CK2α antibodies, followed by confocal microscopy. Scale bars, 5 
μm.  
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Figure 3.3 
 
 Figure 3.3 Mitotic spindle localization is unique to the CK2α catalytic subunit. (A) 
Schematic representation of HA-tagged CK2 catalytic subunits and subunit chimeras. (B) 
Lysates from cells expressing CK2 catalytic subunit variants were immunoblotted to 
detect the HA epitope. (C) Mitotic lysates from cells expressing CK2 catalytic subunit 
variants were immunoblotted with antibodies against phospho-CK2α and HA. (D) 
Purified mitotic spindles from cells transfected with CK2 catalytic subunits were 
immunoblotted for HA and β-Tubulin. S, spindles; NC, nocodazole control samples.  
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mitotic spindles at a level similar to CK2α. These results indicate that mitotic spindle 
localization of CK2 requires the unique C-terminus of CK2α. 
 To investigate if the CK2α C-terminus alone was sufficient for localization, the 
last 91 amino acids of CK2α (amino acids 300-391) were fused to DsRed (termed DsRed-
C91). To investigate whether CK2α localization is phosphorylation-dependent, 
phosphorylation mutants of DsRed-C91 were generated; DsRed-C91-4D to mimic the 
phosphorylated state, and DsRed-C91-4A as a non-phosphorylatable form of DsRed-C91 
(Figure 3.4A).  The DsRed-C91 fusion protein was phosphorylated in mitotic cells 
(Figure 3.4B), and co-purified with isolated mitotic spindles, while DsRed alone did not 
(Figure 3.4C), indicating that the C-terminus of CK2α is capable of spindle localization 
in the absence of the remainder of the protein. Notably, this also indicates that CK2 
kinase activity is not required for its localization to the mitotic spindle. Additionally, 
neither DsRed-C91-4D or DsRed-C91-4A showed any appreciable spindle co-
purification. These results confirm that spindle localization of CK2α is dependent on its 
C-terminal phosphorylation state.  
CK2α spindle localization requires the peptidyl-prolyl isomerase Pin1 
 Next, we investigated the molecular events responsible for phospho-CK2α 
localization. Pin1 is a peptidyl-prolyl isomerase that, due to its specificity for proline 
residues preceded by phosphoserine or phosphothreonine, has been extensively 
investigated as a mitotic regulatory enzyme (20, 40). Pin1 interacts with a variety of 
important mitotic signalling proteins (19), and it is thought that cis/trans conversion of 
adjacent prolyl bonds adds an additional level of regulation to phosphorylation sites (42).  
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Figure 3.4 
 
  
108 
 
Figure 3.4 The unique C-terminus of CK2α is responsible for mitotic spindle 
localization. (A) Schematic representation of DsRed-C91 and DsRed-C91 with the 
phosphorylation sites mutated to aspartic acid (4D) or alanine (4A). Lysates from 
transfected cells were immunoblotted for DsRed and CK2α. Band marked by * is 
endogenous CK2α. (B) Lysates from cells arrested in S phase with thymidine (Thy) or 
mitosis with nocodazole (Noc) were immunoblotted for phosphorylated CK2α, 
nonphosphorylated CK2α, total CK2α, and DsRed. Mitotic lysates were also 
dephosphorylated with λ Phosphatase before immunoblotting. (C) Purified mitotic 
spindles from cells expressing DsRed, DsRed-C91, DsRed-C91-4D or DsRed-C91-4A 
were immunoblotted with DsRed and β-Tubulin antibodies. S, spindles; NC, nocodazole 
control samples.  
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As Pin1 has previously been shown to interact with the CK2α C-terminus in a 
phosphospecific manner (25), we postulated that Pin1 may have a role in localization of 
phosphorylated CK2α.  To investigate this, we employed stable cell lines expressing short 
hairpin RNA (shRNA) constructs against the 3’ untranslated region of Pin1. A control 
cell line was also generated, expressing shRNA against Luciferase. The Pin1 shRNA cell 
lines displayed a marked decrease in the amount of Pin1 expressed in the cells (Figure 
3.5A). Mitotic lysates from each cell line, immunoblotted for phospho-CK2α and 
harvested in the presence of phosphatase inhibitors, showed that CK2α phosphorylation 
was not prevented by knockdown of Pin1 (Figure 3.5B). Knockdown of Pin1 with either 
shRNA resulted in the loss of colocalization between phospho-CK2α and the mitotic 
spindle (Figure 3.5C). This loss of localization was confirmed with isolated spindles from 
each cell line, as phospho-CK2α did not co-purify with spindles from cells lacking Pin1 
(Figure 3.5D). The spindle isolations also showed association of Pin1 with the mitotic 
spindle, and this was confirmed by immunostaining (Figure 3.5E). Cells expressing Pin1 
shRNA were immunostained to control for antibody specificity. These results indicate 
that Pin1 localizes to the mitotic spindle, and is required for localization of phospho-
CK2α to the mitotic spindle. 
 We next performed rescue experiments in which wild type or mutated versions of 
Pin1 were transfected into the Pin1 shRNA A cell line (Figure 3.6A). Pin1 is composed 
of two domains: a WW domain that binds to phosphorylated residues and a peptidyl-
prolyl isomerase (PPIase) domain that isomerizes cis-trans conversion of prolyl bonds 
adjacent to phosphorylated serine or threonine (42). To determine if the WW domain is 
required, we used a Y23A mutant of Pin1, which disrupts Pin1 WW domain binding (21). 
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Figure 3.5 
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Figure 3.5 Pin1 recruits phosphorylated CK2α to the mitotic spindle. (A)  Lysates from 
stable cell lines expressing short hairpin RNA (shRNA) plasmids targeting Luciferase 
(Luc), or the Pin1 3’ untranslated region (Pin1 A, Pin1 B) were immunoblotted for Pin1 
and β-Actin. (B) Luciferase and Pin1 knockdown cells were arrested in mitosis with 
nocodazole and lysates were immunoblotted for phosphorylated CK2α, total CK2α, and 
β-Tubulin. (C) Mitotic cells with stable expression of shRNA targeting Luciferase or 
Pin1 were immunostained for phosphorylated CK2α and β-Tubulin before confocal 
microscopy. The EGFP signal represents expression of the shRNA. (D) Purified mitotic 
spindles from cells with stable expression of shRNA against Luciferase or Pin1 were 
immunoblotted for phosphorylated CK2α, total CK2α, β-Tubulin and Pin1. S, spindles; 
NC, nocodazole control samples. (E) Mitotic Luciferase or Pin1-shRNA expressing cells 
were immunostained for Pin1 and β-Tubulin and subjected to confocal microscopy. Scale 
bars, 5 μm.  
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Figure 3.6 
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Figure 3.6 Proper localization of CK2 to the mitotic spindle requires Pin1 catalytic 
activity and WW domain binding. (A) Expression of Flag-Pin1 constructs in cells with 
stable knockdown of endogenous Pin1, and table of mutational effects on Pin1 function. 
Lysates were immunoblotted with antibodies against Flag and Pin1. Luc shRNA, lysate 
from control cells expressing a Luciferase shRNA; NT, not transfected. (B) Pin1 
knockdown cells transfected with Flag-Pin1 variants were fixed in mitosis and 
immunostained for Flag and β-Tubulin. The EGFP signal represents expression of the 
shRNA. Scale bars, 5 μm. (C) Purified mitotic spindles from Luciferase knockdown cells, 
Pin1 knockdown cells, and Pin1 knockdown cells transfected with Flag-Pin1 variants 
were immunoblotted for phosphorylated CK2α, β-Tubulin, Pin1 and Flag.. S, spindles; 
NC, nocodazole control samples.  
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To investigate the effects of loss of PPIase activity, we used two different mutations in 
the Pin1 PPIase domain: C113S, (4) and R68/69A, (42), both of which are catalytically 
inactive towards phosphorylated substrates. We first assessed the ability of each Pin1 
mutant to localize to the mitotic spindle. Like wild type Pin1, the Y23A mutant localized 
to the mitotic spindle, but both the C113S and R68/69A mutants were unable to similarly 
localize (Figure 3.6B). This suggests that spindle localization of Pin1 occurs 
independently of the WW domain, but requires PPIase activity.  Following mitotic 
spindle isolation, the exogenous Pin1 mutants were then assessed for the ability to rescue 
the localization of phospho-CK2α to the spindle (Figure 3.6C). Expression of exogenous 
wild type Pin1 rescued the loss of spindle-associated phospho-CK2α observed with Pin1 
knockdown, confirming that Pin1 is indeed required for spindle localization of 
phosphorylated CK2α. Neither PPIase mutant had the ability to localize phospho-CK2α 
to the mitotic spindle. Although Pin1-Y23A was found on the mitotic spindle at similar 
levels to wild type Pin1, it was also unable to localize phospho-CK2α to the spindle. 
Taken together, these results indicate that the presence of Pin1 is indeed required for 
localization of phospho-CK2α, and that proper localization requires both the WW and 
PPIase domains of Pin1. 
Pin1 protects CK2 from dephosphorylation in vivo 
 We next sought to determine if Pin1 can isomerize the CK2α phosphorylation 
sites. While there is no direct assay to measure Pin1 activity in cells, other substrates of 
Pin1 have been identified through assessing dephosphorylation at these sites (36). As 
PP2A can only dephosphorylate residues in the trans configuration, residues isomerized 
to the cis configuration will be resistant to dephosphorylation (36). To disrupt the balance 
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between Cdk1 phosphorylation and PP2A dephosphorylation, cells expressing Pin1 
shRNA were arrested in mitosis and then treated with 20 μM roscovitine, a Cdk1 
inhibitor (24). Roscovitine treatment did not affect CK2α phosphorylation levels in cells 
expressing Luciferase shRNA, but cells expressing Pin1 shRNA showed a marked 
decrease in CK2α phosphorylation after roscovitine treatment, suggesting that the 
presence of Pin1 can protect CK2α from dephosphorylation (Figure 3.7A,B), However, 
this protection may be due to isomerization, or simply due to Pin1 physically blocking 
access of the phosphatase to the sites. To test this, we performed an in vitro assay with 
substoichiometric amounts of Pin1. Phospho-CK2α was immunoprecipitated from Pin1 
shRNA expressing cells, and incubated with 1 nM, 10 nM, or 100 nM GST-Pin1 to allow 
isomerization to occur. GST and GST-Pin1-R68/69A were used as negative controls. 
Since the amount of CK2α in the assay greatly outnumbers the amount of Pin1 in this 
assay, Pin1 would not be able to protect CK2 simply from binding to the phosphorylation 
sites and blocking access of the phosphatase. However, if Pin1 can isomerize these sites, 
the low amounts of Pin1 in the assay should be able to protect CK2 from 
dephosphorylation. After addition of PP2A, Pin1 was unable to protect CK2α from 
dephosphorylation (Figure 3.7C)., indicating that protection from dephosphorylation is 
due to physical interaction, not isomerization. Regardless of the mechanism of action, 
what is clear is that interaction with Pin1 is crucial for proper localization of 
phosphorylated CK2α during mitosis. 
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Figure 3.7 
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Figure 3.7 Pin1 protects CK2α from dephosphorylation in vivo. A. Lysates from mitotic 
luciferase and Pin1 knockdown cells treated with 20 μM roscovitine were immunoblotted 
for phosphorylated CK2α, β-Tubulin, and Pin1. B. Graph of relative phospho-CK2α 
intensity, normalized to β-Tubulin. Results are an average of three independent 
experiments. Error bars indicate one standard deviation from the mean. C. 
Phosphorylated endogenous CK2α, immunoprecipitated from mitotic cell lysates, was 
incubated with GST, GST-Pin1, or GST-Pin1-R68/69A before dephosphorylation with 
PP2A. Dephosphorylation was assessed by immunoblotting for phosphorylated and 
nonphosphorylated CK2α. OA, Okadaic Acid; HC, IgG heavy chain.  
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3.4 Discussion 
 In this study, we focused on the regulatory effect of four mitotic phosphorylation 
sites on the unique C-terminus of the CK2 catalytic isoform CK2α. While previous 
studies have observed CK2 localized at the mitotic spindle (10, 43), the mechanism for 
localization was not determined. In this report, we show for the first time that 
phosphorylation of CK2α can regulate its subcellular localization. This research also 
highlights a rare example of functional divergence between the two catalytic isoforms of 
CK2. While CK2α and CK2α’ share remarkable sequence and structural similarity 
throughout most of the proteins (18), they have completely divergent C-termini, meaning 
that CK2α’ does not contain the four mitotic phosphorylation sites in CK2α. Previous 
work on CK2 localization has produced mixed results as to whether CK2α alone, or both 
catalytic subunits can localize to the mitotic spindle (10, 43). Here we show that CK2 
localization to the mitotic spindle is mediated through CK2α. Since both the CK2α C-
terminus and the four phosphorylation sites it contains are required for localization, 
CK2α’ is incapable of mediating its own spindle localization. Our results did show a 
small amount of CK2α’ in isolated spindle preparations, probably due to the formation of 
mixed tetramers between CK2α’ and phosphorylated CK2α. This may also explain the 
disparity between previous reports. It is intriguing that in CK2α’ knockout mice, the 
presence of CK2α largely compensates for the loss (41), while CK2α’ cannot compensate 
for loss of CK2α, which is embryonic lethal (16). This suggests that the specialized 
functions of the CK2α C-terminus may be the cause of this lethality. Additionally, the 
importance of these sites is highlighted by their sequence conservation in birds and 
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mammals (18, 23). Clearly, the C-terminus of CK2α has an important mitotic role in the 
cells of higher order animals.  
 Pin1 is a peptidyl-prolyl isomerase that, due to its specificity for proline residues 
preceded by phosphoserine or phosphothreonine, has been extensively investigated as a 
mitotic regulatory enzyme (20, 40). Pin1 interacts with and isomerizes a variety of 
important mitotic signalling proteins (19), and it is postulated that cis/trans conversion of 
prolyl bonds adjacent to phosphorylated residues adds an additional level of regulation to 
these phosphorylation sites (42).  As Pin1 binds specifically to phosphorylated CK2α, we 
investigated whether loss of Pin1 would affect CK2α spindle localization. Indeed, upon 
knockdown of Pin1, phosphorylated CK2α loses the ability to localize to the mitotic 
spindle. Furthermore, we observed colocalization of Pin1 itself to the mitotic spindle. The 
requirement of Pin1 for phospho-CK2α localization to the mitotic spindle explains why 
the phosphomimetic version of the CK2α C-terminus did not localize to the mitotic 
spindle. While phosphomimetic mutations can effectively mimic phosphorylation sites 
for some interacting proteins, Pin1 cannot bind to phosphomimetic CK2α (25). Pin1 
requires an acidic residue for binding, and shows much higher affinity for phosphoserine 
or phosphothreonine than aspartic acid (42). Previous work has demonstrated that the 
interaction between the C-terminus of CK2α and Pin1 requires the WW domain (25). The 
Y23A mutation, which disrupts the binding ability of the Pin1 WW domain, localized to 
the mitotic spindle yet failed to recruit CK2α.  Interestingly, localization of Pin1 itself to 
the mitotic spindle seems to require mainly the PPIase domain, as neither PPIase domain 
mutant was able to rescue Pin1 spindle localization. It appears that both Pin1 isomerase 
activity and WW domain binding are required for Pin1-phosphorylated CK2α complexes 
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to localize to the mitotic spindle – isomerase activity is required to localize Pin1, while 
WW domain binding is required for CK2α to be brought along. Pin1 has many 
interactors/substrates on the mitotic spindle, and the overlap with known CK2 
interactors/substrates is striking, including Plk1 (17, 31), Wee1 (31, 39), and Cdc25C (30, 
36). It is intriguing to imagine that Pin1 may target phosphorylated CK2α to the spindle 
by binding to its spindle substrates, and that CK2 may catalyze additional 
phosphorylation events along these Pin1 substrates. Identification of these substrates and 
investigation of this hypothesis is an area of great interest in our future work. What is 
clear, however, is that Pin1 localizes CK2α to the mitotic spindle in a phosphorylation-
dependent manner, and in doing so may focus the activity of a phenomenally pleiotropic 
kinase towards important mitotic targets. Not only does this work contribute to the 
growing evidence for important mitotic roles for both CK2 and Pin1, but it is the first 
evidence for regulation of CK2 localization by phosphorylation, and the first report of 
Pin1 acting to localize a phosphorylated protein to the mitotic spindle. It is certainly a 
possibility that Pin1 may have a role in localization of other important mitotic regulatory 
proteins. Further investigation of this possibility may offer new insight on the regulation 
of mitotic cell division. 
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Chapter 4:  Hierarchical phosphorylation between Cdk1 and CK2 may 
contribute to the regulation of mitosis 
4.1 Introduction -  Protein phosphorylation is catalyzed by protein kinases, which are 
exquisitely regulated in the cell to ensure proper phosphorylation in response to a given 
stimulus. Kinase activity can be controlled by activating and/or inhibitory 
phosphorylation events on the kinase itself, through protein-protein interactions with 
regulatory subunits and other proteins, and through changes in subcellular localization. 
Several well-studied kinases respond to chemical second messengers such as cyclic AMP 
(cAMP). Additional modes of regulation include modulation of protein expression at the 
transcript level, and turnover of the protein product by targeted degradation. These 
mechanisms ensure that each kinase is active and able to phosphorylate its substrates only 
at the correct time and location. While all mammalian protein kinases phosphorylate 
proteins at tyrosine and/or serine/threonine residues, different kinase families have 
evolved to require specific sequence determinants in order to target a particular kinase to 
its substrates (31). For example, the large family of Cyclin-dependent kinases (Cdks), 
which are vital for cell cycle progression, phosphorylate substrates at serine/threonine 
residues that are immediately followed by a proline residue. To distinguish between these 
sites, Cdks have each evolved additional individual sequence determinants. For example, 
the optimal consensus sequence for phosphorylation by Cdk1, the master regulatory 
kinase controlling the process of mitosis, is S/T-P-V-K/R (31). Through identification of 
the optimal consensus sequence, it is possible to predict possible substrates for a 
particular kinase.  
 Several decades of work have resulted in a huge body of knowledge regarding 
kinase-substrate reactions and their individual functional effects on the cell, and large 
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scale phosphoproteomic screens have contributed large datasets of potential 
phosphorylation sites. It is estimated that one third of intracellular proteins are 
phosphorylated, many on several distinct sites (19). While it is apparent that the actions 
of protein kinases are intricately involved in every fundamental cellular process (17), our 
understanding of the interplay between distinct protein kinases has lagged considerably. 
Hierarchical protein phosphorylation is a phenomenon in which a kinase phosphorylates a 
substrate based on its unique sequence determinants, and the addition of phosphate 
creates adequate sequence determinants for nearby phosphorylation events to occur. 
These events can involve two or more distinct kinases, or can result in processive 
phosphorylation events catalyzed by only one kinase. A few protein kinases, namely 
GSK3 and CK1, catalyze primed phosphorylation events almost exclusively, as 
phosphorylation by these kinases usually requires prior phosphorylation of a nearby 
residue (12, 13). A few other kinases, including protein kinase CK2, can also utilize 
phosphorylated determinants for phosphorylation. 
 CK2 is a ubiquitously expressed serine/threonine kinase that has a multitude of 
cellular substrates, and due to this, it participates in a variety of cellular processes, 
including proliferation, apoptosis, transcription, and translation (44). Unlike many protein 
kinases, CK2 is not regulated by either second messengers or activating or inhibitory 
phosphorylation events, and is largely regarded as constitutively active. However, some 
CK2 substrates show evidence of regulated phosphorylation (14, 20). Additionally, the 
requirement for CK2 activity in a number of highly regulated cellular processes, in 
particular the regulation of cell division, indicates that CK2 must be regulated in some 
way, at least for certain substrates. Indeed, previous work in our laboratory has 
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demonstrated that during mitosis, CK2 is regulated through phosphorylation (2, 24), 
protein-protein interactions (30), and subcellular localization (see Chapter 3).  
 CK2 is an acidophilic kinase, requiring one or more acidic residues on the C-
terminal side of the phosphoacceptor site in order to recognize and phosphorylate its 
substrates. Accordingly, the minimal consensus sequence for CK2 phosphorylation is 
S/T-X-X-Acidic. X can be any amino acid, however proline, lysine, or arginine at the +1 
position are unfavourable (26, 28). The acidic determinant can also be in the +1 position 
instead of the +3 position, but is only rarely found at the +2 position. The acidic 
determinants seem to have an additive effect, and due to this, many known CK2 sites 
consist of a serine/threonine residue followed by a string of acidic residues (29). 
Interestingly, phosphoserine and phosphotyrosine (but not phosphothreonine) can 
substitute for the acidic determinant at the +3 position, enabling CK2 to participate in 
hierarchal signalling events (23, 27).  These events have not been systematically studied, 
but anecdotal evidence suggests that hierarchal phosphorylation involving CK2 can 
contribute to the regulation of cellular processes. For example, in an elegant study of the 
mitotic regulatory kinase Wee1A, Watanabe et al. demonstrated that phosphorylation of 
Wee1A by Cdk1 at serine 123 primes subsequent phosphorylation by CK2 at serine 121 
(48). Wee1A regulates Cdk1 activity through inhibitory phosphorylation, controlling the 
onset of mitosis (35). Phosphorylation by Cdk1 and CK2, as well as upstream 
phosphorylation by Plk1, promotes degradation of Wee1A, resulting in the onset of 
mitosis (48). The requirement for Cdk1 phosphorylation for subsequent CK2 
phosphorylation puts CK2, a constitutively active kinase, under the same regulatory 
controls as Cdk1, which is exquisitely controlled through a variety of mechanisms. 
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We hypothesize that hierarchical phosphorylation between Cdk1 and CK2 may modulate 
CK2 substrate recognition during mitosis, allowing phosphorylation of mitotic substrates. 
To examine the role of hierarchical phosphorylation between Cdk1 and CK2 in the 
regulation of mitosis, we have systematically determined optimal consensus sequences 
for both primed phosphorylation by CK2 in general, and for Cdk/CK2 hierarchical 
phosphorylation. Using the consensus sequence for Cdk/CK2 hierarchical 
phosphorylation, we then probed the human genome for potential substrates. The results 
indicate that hierarchical phosphorylation between Cdk1 and CK2 could contribute to the 
phosphorylation of several mitotic proteins, and therefore may contribute substantially to 
the regulation of mitosis.  
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4.2 Materials and Methods 
Purification of Active CK2 Holoenzyme – CK2 holoenzyme, consisting of GST-CK2α 
and His-CK2β, was purified from bacterial culture as described in Turowec et al. (46). 
Briefly, BL21 E. coli cells containing the plasmid pDB1 (encoding GST-CK2α) were 
grown at 37°C in 2XYT media containing 0.1 mg/mL ampicillin to an OD600 of 0.8, at 
which point 0.5 mM IPTG was added to induce protein expression for 3 hours at 37°C. 
BL21 cells containing the plasmid pAB46 (encoding His-CK2β) were grown at 37°C in 
LB media containing 50 μg/mL kanamycin to an OD600 of 0.8, then induced by addition 
of 0.5 mM IPTG for 24 hours at 15°C. Bacterial cultures were then collected by 
centrifugation, resuspended in lysis buffer (PBS with 30 μg/mL aprotinin, 20 μg/mL 
leupeptin, and 1 mM PMSF), and combined. The bacteria were lysed by two passes 
through a French press, tumbled for 15 minute at 4°C in PBS supplemented with 1% 
Triton X-100, and finally cleared by centrifugation. The supernatant was then incubated 
with glutathione-agarose beads (Sigma) for 1 hour at 4°C with constant rotation. The 
beads were washed with 20 column volumes of lysis buffer, and the enzyme was eluted 
from the beads in 1 mL fractions with first 10 mM glutathione and then 30 mM 
glutathione (both in 50 mM Tris-HCl pH 8.0 with 1 mM DTT). Fractions containing 
CK2, identified by SDS-PAGE and Coomassie blue staining, were dialyzed overnight 
into CK2 storage buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 50% Glycerol) and stored at -20°C. Enzyme concentration was determined by 
absorbance at 595 nm, measured on a Victor3 V 1420 multilabel counter (Perkin Elmer) 
using BSA standards. To maintain linear activity, the enzyme was diluted 1:5000 in CK2 
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Dilution Buffer (5 mM MOPS pH 7.0, 200 mM NaCl, 1 mg/mL BSA) immediately 
before use in kinase assays. 
Biotinylated peptide kinase assays – Biotinylated peptides were synthesized using 
standard Fmoc (9-fluorenylmethyloxycarbonyl) chemistry at a 2 μmol scale on an Intavis 
Multipep Synthesizer.  The sequences of all peptides used in this study can be found in 
Table 4.1. Biotin was added to the N-terminus of each peptide. Peptides were cleaved 
from the resin using trifluoroacetic acid, and peptide identities were confirmed by mass 
spectrometry. Peptides were resuspended in DMSO and concentrations were determined 
by absorbance at 280 nm, using an N-terminal tryptophan residue. Peptide concentration 
was adjusted to 50 mM, and aqueous 2.5 mM stock solutions were made in 20 mM 
HEPES pH 7.4. Kinase assays were performed for 10 minutes at 30°C in a final reaction 
volume of 10 μl containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl2, 1 
mM DTT, 0.1 mM ATP, and 1 μCi  [γ32P]-ATP  (specific activity 3000 Ci/mol, Perkin-
Elmer). Substrate peptides were used at 0.5 mM. Reactions were initiated by the addition 
of CK2, and stopped by the addition of 2 μL of 0.5 M EDTA (pH 8.0). 4 μL aliquots of 
each reaction were spotted onto a SAM2 streptavidin membrane (Promega). The 
membrane was washed twice in 0.1% SDS in TBS, twice in 2M NaCl, twice in 2M NaCl 
and 1% H3PO4, and twice in distilled water, and then dried under a heat lamp. Following 
24 hours of exposure to a phosphor storage screen, CK2 phosphorylation was visualized 
using a Storm Phosphorimager (Molecular Dynamics) and [γ32P] incorporation for each 
peptide was determined using ImageQuant TL software (Amersham Biosciences). All 
phosphorylation assays were performed in triplicate. For kinetic studies, each peptide was 
assayed for phosphorylation at a minimum of six different concentrations, and five 
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replicates of each concentration were used in the analysis. Km and Vmax values for each 
peptide were determined by nonlinear regression analysis fit to a Michaelis-Menten 
model for enzyme kinetics using GraphPad Prism version 5.03 for Windows (GraphPad 
Software, San Diego California USA, www.graphpad.com). Each data set was subjected 
to a replicates test for lack of fit, and the Michaelis-Menten model was deemed adequate 
for all peptides studied.  
Bioinformatics - A peptide match program was designed to search the SwissProt and 
NCBI databases for human proteins containing potential Cdk/CK2 hierarchical 
phosphorylation events. The program was engineered to search for peptides matching the 
sequence S-X-X-X-X-S-P, and score the results at positions 2-5 based on the presence of 
CK2 consensus determinants. Following a proteome-wide search for matching peptides, 
the program returned the GI number, SwissProt protein ID, peptide sequence, position 
within the protein, and CK2 site score for each hit. Results were then sorted by their CK2 
score, and results with no or negative CK2 determinants were excluded from the study.  
The resultant peptide sequences were sorted by Gene Ontology using the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) (8, 16).  
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TABLE 4.1 Sequences of peptides used in this study. 
 
Peptide Sequencea Purpose in Study 
WDDDSDDDDDAAA Canonical Positive D 
WDDDADDDDDAAA Canonical Negative D 
WEEESEEEEEAAA Canonical Positive E 
WEEEAEEEEEAAA Canonical Negative E 
WDDDSpSpSpSpSpSAAA Primed Positive 
WDDDApSpSpSpSpSAAA Primed Negative 
WDDDSSSSSSAAA Primed Negative 
WDDDSApTpTpTpTAAA STY Comparison 
WDDDSApYpYpYpYAAA STY Comparison 
WDDDSAAAAAAAA Primed Negative 
WDDDSApSpSpSpSAAA 1b/ STY Comparison 
WDDDSpSApSpSpSAAA 2 
WDDDSpSpSApSpSAAA 3 
WDDDSpSpSpSApSAAA 4, Kinetic measurements 
WDDDSpSpSpSpSAAAA 5 
WDDDSAApSpSpSAAA 12 
WDDDSApSApSpSAAA 13 
WDDDSApSpSApSAAA 14 
WDDDSApSpSpSAAAA 15 
WDDDSpSAApSpSAAA 23, Kinetic measurements 
WDDDSpSApSApSAAA 24 
WDDDSpSApSpSAAAA 25, Kinetic measurements 
WDDDSpSpSAApSAAA 34 
WDDDSpSpSApSAAAA 35 
WDDDSpSpSpSAAAAA 45, A/P Comparison 
WDDDSAAApSpSAAA 123 
WDDDSAApSApSAAA 124 
WDDDSAApSpSAAAA 125 
WDDDSApSAApSAAA 134 
WDDDSApSApSAAAA 135 
WDDDSApSpSAAAAA 145 
WDDDSpSAAApSAAA 234 
WDDDSpSAApSAAAA 235 
WDDDSpSApSAAAAA 245, Kinetic measurements, A/P Comparison 
WDDDSpSpSAAAAAA 345 
WDDDSpSAAAAAAA 2345 
WDDDSApSAAAAAA 1345 
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Peptide Sequencea Purpose in Study 
WDDDSAApSAAAAA 1245, Primed Positive, Kinetic measurements, A/P  
comparison 
WDDDSAAApSAAAA 1235 
WDDDSAAAApSAAA 1234 
WDDDSAASAAAAA Primed Negative 
WDDDSpSpSpSPVKAA A/P Comparison 
WDDDSAApSPVKAA A/P Comparison 
WDDDTApSpSpSpSAAA S/T Comparison 
WFVPSDApSPPKTK TopoII #1 Experimental 
WFVPSDASPPKTK TopoII #1 S control 
WFVPSDADPPKTK TopoII #1 D control 
WFVPADApSPPKTK TopoII #1 A control 
WPPKTKTpSPKLAN TopoII #2 Experimental 
WPPKTKTSPKLAN TopoII #2 S control 
WPPKTKTDPKLAN TopoII #2 D control 
WPPKAKTpSPKLAN TopoII #2 A control 
WDEKTDDEDFVPA TopoII Canonical Experimental 
WDEKADDEDFVPA TopoII Canonical A control 
WGFGSSpSPVKAPA Wee1 Experimental 
WGFGSSSPVKAPA Wee1 S control 
WGFGSSDPVKAPA Wee1 D control 
WGFGASpSPVKAPA Wee1 A control 
WAPSTNSpSPVLKT Separase Experimental 
WAPSTNSSPVLKT Separase S control 
WAPSTNSDPVLKT Separase D control 
WAPAANApSPVLKT Separase A control 
WLSPTISpSPPNALP Cdc27 Experimental 
WLSPTISSPPNALP Cdc27 S control 
WLSPTISDPPNALP Cdc27 D control 
WLSPAISpSPPNALP Cdc27 A control 
WDSPSQGpSPALYRN Repo-Man (CDCA2) Experimental 
WDSPSQGSPALYRN Repo-Man S control 
WDSPSQGDPALYRN Repo-Man D control 
WDSPAQGpSPALYRN Repo-Man A control 
WDDDSDApSPVKAA P +1 Acidic 
WDDDSDASPVKAA P +1 Acidic S Control 
WDDDSRApSPVKAA P +1 Basic 
WDDDSFApSPVKAA P +1 Bulky Hydrophobic 
WDDDSMApSPVKAA P +1 Methionine 
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Peptide Sequencea Purpose in Study 
WDDDSQApSPVKAA P +1 Uncharged Polar 
WDDDSHApSPVKAA P +1 Charged Polar 
WDDDSpSApSPVKAA P +1 Phosphate, A/P Comparison 
WDDDSPApSPVKAA P +1 Proline 
WDDDSADpSPVKAA P +2 Acidic 
WDDDSADSPVKAA P +2 Acidic S Control 
WDDDSARpSPVKAA P +2 Basic 
WDDDSAFpSPVKAA P +2 Bulky Hydrophobic 
WDDDSAMpSPVKAA P +2 Methionine 
WDDDSAQpSPVKAA P +2 Uncharged Polar 
WDDDSAHpSPVKAA P +2 Charged Polar 
WDDDSApSpSPVKAA P +2 Phosphate 
WDDDSAPpSPVKAA P +2 Proline 
WDDDSpSAAApSPVK P at +6, +1 pS 
WDDDSEAAApSPVK P at +6, +1 E 
WDDDSEAAASPVK P at +6, +5 S Control 
WDDDSpSAApSPVKA P at +5, +1 pS 
WDDDSEAApSPVKA P at +5, +1 E 
WDDDSEAASPVKA P at +5, +4 S Control 
WDDDSpSApSPVKAA P at +4, +1 pS 
WDDDSEApSPVKAA P at +4, +1 E 
WDDDSEASPVKAA P at +4, +3 S Control 
WDDDSAApSApSPVK P at +6, +3 pS 
WDDDSAAEApSPVK P at +6, +3 E 
WDDDSAAEASPVK P at +6, +5 S Control 
WDDDSAApSpSPVKA P at +5, +3 pS 
WDDDSAAEpSPVKA P at +5, +3 E 
WDDDSAAESPVKA P at +5, +4 S Control 
aAll peptides contain an N-terminal biotin. The phosphoacceptor site is indicated in red. 
bNumbered peptides are modelled on the peptide WDDDSpSpSpSpSpSAAA. Numbers 
indicate the positions at which phosphoserine has been replaced with alanine. 
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4.3 Results 
Potential substrates for Cdk1/CK2 hierarchical phosphorylation 
 Protein kinase CK2 is an acidophilic kinase that preferentially phosphorylates 
substrates at serine or threonine residues with aspartic acid and glutamic acid residues C-
terminal to the phosphoacceptor site. For substrates that conform to the canonical acidic 
consensus, phosphorylation is particularly favoured if an acidic determinant is present at 
the +3 position (S/T-X-X-D/E), but the positioning can vary (the +1 position is also 
highly favoured), and in many cases CK2 substrate sequences feature multiple acidic 
residues C-terminal to the phosphorylation site (29). All of these factors contribute to a 
large amount of flexibility in what constitutes a functional site for CK2 phosphorylation. 
Interestingly, CK2 may also use phosphoserine as an acidic determinant (23, 48), but the 
consensus requirements for these phosphorylation events have never been systematically 
determined. In this study, we chose to examine whether hierarchical phosphorylation 
between Cdk1 and CK2 contributes to the mitotic regulation of CK2, allowing it to 
specifically phosphorylate mitotic substrates. To begin, we first searched the PhosphoSite 
(15) database of known in vivo phosphorylation sites for mitotic proteins containing 
potential sites for Cdk1/CK2 hierarchical phosphorylation. While primed phosphorylation 
by CK2 was shown with a peptide containing phosphoserine at the +3 position (23), in 
the only known example of this phenomenon, the mitotic kinase Wee1A is 
phosphorylated by Cdk1 at the +2 position compared to the CK2 phosphoacceptor site 
(pS-S-pS-P-V-K) (48). As mentioned above, this spacing is unusual for CK2, which does 
not typically favour phosphodeterminants at the +2 position. For these reasons, we 
elected to search for proteins containing the sequence S/T-X-X-S-P. We then sorted the 
138 
 
results to include only proteins with previously reported phosphorylation events at either 
site, specifically during mitosis. A list of selected proteins previously shown to be 
phosphorylated during mitosis at sites matching the pattern S/T-X-X-S-P is shown in 
Table 4.2. The complete list is included in the supplemental material in Appendix A. As 
evident from Table 4.2, several important mitotic proteins are potentially regulated in this 
manner. To validate these results, biotinylated peptides of target sequences from selected 
candidates were incubated with CK2 and [γ32P]-ATP. For each peptide, we included two 
negative controls; one with an unphosphorylated Cdk1 site, and one with the CK2 site 
mutated to alanine as a negative control. To examine whether a normal acidic 
determinant can effectively replace the Cdk1-phosphorylated residue, we included a 
peptide with the Cdk1 site mutated to aspartic acid. Topoisomerase IIα, a known mitotic 
substrate of CK2, was chosen for further study, as PhosphoSite indicated that two sites, 
immediately downstream from a known mitotic CK2 site at T1343 (7), both fit the 
potential consensus sequence (Figure 4.1A). Furthermore, in both these sites the proline-
directed serine can be phosphorylated by Cdk1 (49).  However, upon incubation with 
CK2, the only Topoisomerase IIα peptide phosphorylated was the peptide containing the 
known canonical site at T1343 (sequence: T-D-D-E-D) (Figure 4.1B). Additionally, 
peptides with promising sequences from the mitotic regulatory proteins Separase, Repo-
Man, and Cdc27 proved to be poor substrates for CK2 primed phosphorylation, with only 
Repo-Man displaying any detectable phosphorylation (Figure 4.1C, D, E). Interestingly, 
even the known Wee1A phosphorylation site was not phosphorylated in phosphopeptide 
form (Figure 4.1F). Collectively, these results suggest that Cdk1/CK2 hierarchical  
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TABLE 4.2 Potential mitotic substrates for Cdk1/CK2 hierarchical 
phosphorylationa. 
Protein Sequence Function Reference 
CDCA2 (Repo-
Man) 
129-pSQGpSPAL Mitosis (9) 
Cdc27 366-pTISpSPPN Anaphase promoting complex 
component 
(9, 45) 
CDK7 161-pSFGpSPNR S/T Kinase (6, 9) 
CENPC1 535-pSEEpSPVY Kinetochore assembly (33) 
CENPE 2651-pSLPpSPHP Microtubule motor protein (33) 
CENPF 2993-pSRGpSPLL Kinetochore assembly (9, 33) 
CEP350 1253-pTPpTpSPLpSP Microtubule-centrosome 
attachment 
(9) 
CHED (Cdc2L5) 436-pSpSIpSPpSpT S/T Kinase (6, 9) 
CLASP1 1088-pSVGpSPpS Microtubule/Kinetochore binding 
protein 
(9) 
DSN1 77-pSpSLpSPVE Kinetochore assembly (6) 
Dynamin 2 761-pSpSHpSPpTP Microtubule binding protein (9) 
GAS2L1 489-pSpSPpSPEL Cell cycle arrest (9) 
GAS2L3 567-SpSVpSPVK Cell cycle arrest (9) 
Kinesin 13B 1379-pSIpSpSPNV Microtubule binding, kinesin-like (9) 
KIF18A 681-pTLKpSPPS Kinesin (9) 
KIF20A 864-pTDCpSPpYA Microtubule binding protein (9) 
MAP1B 1912-pTpTKpSPpSD Microtubule binding protein (9) 
MAP4 822-pSpSRpSPpSpT Microtubule binding protein (9) 
NEK1 661-pTGGpSPSK S/T Kinase (6) 
 834-pSEIpSPEG  (6) 
Sgo1 
(Shugoshin) 
433-pTQQpSPHL Chromosome cohesion in mitosis (9) 
TOP2A 1351-pSDApSPPK DNA Topoisomerase (9, 33) 
 1358-pTKTpSPKL  (9) 
Wee1 136-pSpSFpSPVR S/T Kinase (6) 
a Selected results from PhosphoSite (15), www.phosphosite.org, Search: S/T-X-X-S-P. 
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Figure 4.1 
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Figure 4.1 Candidate peptides from a PhosphoSite search for S-X-X-S-P are not ideal 
substrates for primed CK2 phosphorylation A. Sequence of amino acids 1343-1364 of 
Topoisomerase IIα. A known canonical CK2 site at T1343 is shown in green, as are two 
putative hierarchical sites at S1351 and T1358. Known Cdk1 sites at S1354 and S1361 
are shown in red. B. Biotinylated peptides corresponding to each CK2 phosphorylation 
site were incubated with CK2 and [γ-32P]-ATP, bound to a streptavidin membrane, and 
visualized by autoradiography. Phosphoacceptor residues or corresponding mutations are 
in red. C-F. Biotinylated peptides corresponding to potential Cdk1/CK2 hierarchical 
phosphorylation sites in the mitotic proteins Separase (C, amino acids 1120-1131), Repo-
Man (D, amino acids 126-139), Cdc27 (E, amino acids 363-375), and Wee1A (F, amino 
acids 118-129) were incubated with CK2 and [γ-32P]-ATP and visualized as in B.  
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phosphorylation may be unfavourable when the Cdk1 site is located at the CK2 +3 
position. 
Presence of a Cdk1 site at the +3 position drastically reduces primed CK2 
phosphorylation 
 Initial studies with sequences derived from a phosphorylation database search 
failed to produce any appreciable Cdk1/CK2 hierarchical phosphorylation. Therefore, to 
gain further insight into the consensus requirements for Cdk1/CK2 hierarchical 
phosphorylation, we next examined whether the intervening residues at positions +1 and 
+2 had any effect on CK2 primed phosphorylation. To do this, we based our assay on the 
peptide WDDDSAApSPVKAA, and changed either the +1 or +2 amino acid to arginine, 
phenylalanine, methionine, glutamine, histidine, phosphoserine, proline, or aspartic acid. 
Since aspartic acid itself is a consensus determinant for canonical CK2 phosphorylation, 
an additional peptide was included that contained the aspartic acid substitution in the 
presence of an unphosphorylated proline-directed serine. By comparing these two 
peptides, the impact of canonical phosphorylation can be separated from that of primed 
phosphorylation. Upon incubation with CK2 and [γ32P]-ATP, however, even the alanine 
containing control peptide showed minimal phosphorylation by CK2 (Figure 4.2A,B). 
This was striking, as the only previously described peptide for primed CK2 
phosphorylation, RRREEESAApSAA, contained the same determinants, yet lacked the 
CDK1 consensus site contained in the peptides in this study (23). Indeed, the only 
peptides that display increased primed CK2 phosphorylation in this assay were those with 
phosphoserine at either the +1 or +2 position, indicating that, like in the canonical 
consensus, multiple phosphorylated residues may be required for appreciable CK2  
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Figure 4.2 
 
Figure 4.2 Influence of intervening residues on Cdk1/CK2 hierarchical consensus 
sequence. A. Starting from the parent peptide Bi-WDDDSAApSPVKAA (the 
phosphoacceptor residue is shown in red), the amino acid residues present at the +1 and 
+2 positions were individually changed to R, F, M, Q, H, pS, P, or D. To control for the 
ability of aspartic acid to act as a consensus determinant for CK2, an additional peptide 
with an unphosphorylated serine at the priming site was also included (denoted D-pS). 
Peptides were incubated with CK2 and [γ-32P]-ATP, bound to streptavidin membrane, 
and [γ-32P] incorporation was visualized. B. Average [γ-32P] incorporation for each 
peptide after incubation with CK2. Values are an average of three independent 
experiments. Error bars indicate one standard deviation from the mean.  
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phosphorylation. Aspartic acid at the +1 position increased phosphorylation substantially; 
however this seems to be solely due to the formation of a canonical CK2 site, as the 
unphosphorylated control peptide showed similar levels of [γ32P] incorporation. In 
accordance with the known canonical requirements, aspartic acid at the +2 position did  
not increase CK2 phosphorylation. Interestingly, glutamine, an uncharged hydrophilic 
amino acid, slightly but reproducibly increased phosphorylation when present at the +1 
position. The utility of glutamine in a CK2 consensus sequence has never been reported 
before, but it may explain why the only candidate substrate tested above to display any 
evidence of CK2 primed phosphorylation was Repo-Man (Sequence: S-Q-G-pS-P-A-L) 
(See Figure 4.1D).  
 While this work does supply some clues on the consensus sequence for CK2 
primed phosphorylation, the lack of kinase activity towards the peptides in this study 
indicates that the +3 position, while optimal for canonical CK2 phosphorylation, may not 
be optimal for Cdk1/CK2 hierarchical phosphorylation, as it seems that the presence of a 
Cdk1 consensus site inhibits CK2 phosphorylation. To confirm this, we compared the 
phosphorylation of peptides containing identical consensus determinants with either a 
string of alanines (AAAAA) or a Cdk1 consensus site (PVKAA) following the consensus 
phosphoserines. These peptides clearly show that the Cdk1 consensus determinants 
severely impairs the ability of CK2 to phosphorylate primed sequences when present at 
the +4 to +6 positions relative to the CK2 site (Figure 4.3A,B).  
Impact of multiple phosphoserines and their order on CK2 primed phosphorylation 
 These results indicate that consensus determinants for primed phosphorylation by 
CK2 may differ from the consensus determinants for canonical phosphorylation.  
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Figure 4.3 
 
Figure 4.3 The presence of a Cdk1 consensus sequence at the +3 position dramatically 
decreases primed CK2 phosphorylation.  Biotinylated peptides with either a Cdk1 
consensus sequence or a string of alanines following a +3 phosphoserine were incubated 
with CK2 and [γ-32P]-ATP, spotted on a streptavidin membrane and visualized by 
autoradiography. [γ-32P] incorporation was visualized on a storm phosphorimager. The 
phosphoacceptor residue in these sequences is shown in red. Bi-, Biotin.  B. Average [γ-
32P] incorporation into each peptide shown in A. Each value is an average of three 
independent experiments. Error bars indicate one standard deviation from the mean. 
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Therefore, before revisiting the prospect of hierarchical signalling, we elected to 
systematically examine the consensus determinants for primed phosphorylation. To 
determine the optimal spacing required between the CK2 phosphoacceptor residue and 
the priming phosphoserine, we devised an experiment based on the parent peptide 
WDDDSpSpSpSpSpSAAA, and systematically changed phosphoserine residues to 
alanine residues in all possible combinations. This experiment also gave us the 
opportunity to examine the effects of multiple phosphorylated residues on primed CK2 
phosphorylation. As mentioned above, many canonical CK2 substrates contain several 
acidic residues C-terminal to the phosphorylation site (29). It was expected that this 
would hold true for primed substrates as well, with each additional phosphoserine adding 
to the acidity of the substrate. However, this was not the case. As shown in Figure 4.4, 
the level of CK2 phosphorylation among these substrates varied widely, even among 
peptides with the same total amount of phosphoserine. In fact, phosphorylation of the 
parent peptide (SpSpSpSpSpS) was barely detectable, and removal of almost any 
phosphoserine improved CK2 phosphorylation. The lack of phosphorylation of highly 
phosphorylated peptides suggests that there may be a threshold level of negativity 
required for CK2 phosphorylation, above which phosphorylation is actually discouraged. 
Indeed, changing additional phosphoserines to alanine increased phosphorylation by CK2 
considerably, but only in certain cases. In peptides with 2-3 phosphoserine residues, the 
ability of CK2 to phosphorylate different combinations varied wildly, indicating that, like 
in the canonical consensus sequence, the precise positioning of phosphoserine is 
important for effective phosphorylation of a primed CK2 consensus sequence.  It appears 
that, in general, the optimal number of phosphoserines for primed phosphorylation is 2-3,  
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Figure 4.4 
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Figure 4.4 Influence of quantity and spacing of phosphoserine residues on CK2 primed 
phosphorylation. A. Biotinylated peptides based on the sequence Bi-
WDDDSpSpSpSpSpSAAA were incubated with CK2 and [γ-32P]-ATP, spotted on a 
streptavidin membrane and visualized by autoradiography. A map of each peptide and the 
specific positions where phosphoserine was changed to alanine is also shown. B. Average 
[γ-32P] incorporation into each peptide shown in A. Each value is an average of three 
independent experiments. Error bars indicate one standard deviation from the mean. C. 
Peptide phosphodeterminant sequences, grouped by relative phosphorylation of each 
peptide by CK2. Sequences are colour-coded by amount of phosphoserine as in the map 
in panel A.  
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as the only peptide containing just one phosphoserine to be detectably phosphorylated 
was the previously published primed sequence, SAApSAA. 
 When the peptides are sorted into groups based on their phosphorylation levels, 
distinct patterns start to emerge (Figure 4.4C). Three peptides in the study displayed 
strong phosphorylation by CK2: SpSApSpSA, SpSApSApS, and SpSApSAA. From this, 
we conclude that the optimal consensus sequence for primed CK2 phosphorylation will 
have phosphoserines at +1, +3, and possibly an additional phosphoserine at either +4 or 
+5.   As is the case for canonical phosphorylation, primed phosphorylation by CK2 seems 
to be almost completely dependent on phosphodeterminants at the +1 and +3 positions. In 
fact, all detectably phosphorylated peptides in this study had at least one phosphoserine at 
either the +1 or +3 position, and of the 11 peptides that remained unphosphorylated after 
incubation with CK2, only 4 peptides contained a phosphoserine at either the +1 or +3 
positions. In addition to the +1 and +3 positions, additional acidity at the +4 or +5 
positions typically increased CK2 phosphorylation, provided that the apparent threshold 
of negativity was not passed. In contrast, presence of a phosphoserine residue at the +2 
position had at best a negligible effect on CK2 phosphorylation, and in many cases was 
actually inhibitory. For example, the SpSpSpSAA peptide displays only weak 
phosphorylation by CK2, but with an alanine instead of the +2 phosphoserine, the 
SpSApSAA peptide was one of the strongest peptides in the study. Acidic determinants at 
the +2 position are typically negligible for canonical signalling as well, but the inhibitory 
effects seem to be unique to primed phosphorylation. The obvious exception to this trend 
was the SpSApSpSpS peptide, which was curiously not detectably phosphorylated, even 
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though the rest of the peptides with four phosphoserines showed increased 
phosphorylation over the parent peptide.  
Enzymatic comparison of canonical and primed CK2 consensus sequences 
 
 To examine the relative likelihood of canonical and primed phosphorylation by 
CK2, we next performed kinetic studies to compare the enzymatic efficiency of CK2 on a 
selection of peptide substrates. We selected several primed peptides, including both 
strongly and weakly phosphorylated substrates, and compared them to both optimized 
canonical CK2 substrates (WDDDSDDDDDAAA and WEEESEEEEEAAA) as well as a 
known canonical mitotic substrate for CK2 phosphorylation, T1343 of Topoisomerase IIα  
As shown in Figure 4.5, when an equal amount of each peptide (0.5 mM) is incubated 
with CK2 and [γ-32P]-ATP, the strongest of the primed substrate peptides are 
phosphorylated by CK2 at comparable levels to the optimal canonical sequence 
(SDDDDD) and the known mitotic substrate (TopoII T1343), and at much higher levels 
than the previously published primed peptide (SAApSAA) (23). This suggests that 
primed substrates of CK2 may be as efficiently phosphorylated by CK2 as canonical 
substrates.  To examine this further, we performed a kinetic analysis for each detectably 
phosphorylated peptide in Figure 4.5. The SAAAAA peptide was also included in the 
analysis, but kinetic measurement was not possible due to absence of phosphorylation. 
The results of this analysis are shown in Table 4.3. Km values of all three peptides 
modelled after previously published peptides (SDDDDD, SEEEEE, and SAApSAA) are 
similar to but lower than previously published Km values (0.06 mM, 0.18 mM, and 0.57 
mM respectively) (22, 23).  The optimized canonical substrate (SDDDDD) was by far the 
best peptide in the study, with a Vmax/Km ratio (a measure of phosphorylation  
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Figure 4.5 
 
 
Figure 4.5 Relative comparison of canonical and primed phosphorylation by CK2. A. N-
terminally biotinylated synthetic peptides conforming to both canonical (acidic) and 
primed (previously phosphorylated) CK2 consensus sequences were incubated with CK2 
and [γ-32P]-ATP before spotting onto streptavidin-coated membrane. The 
phosphoacceptor residue in these sequences is shown in red. [γ-32P] incorporation was 
visualized on a Storm phosphorimager. Bi-, Biotin.  B. Relative phosphorylation of 
synthetic peptides shown in A. Values are an average of three independent experiments. 
Error bars indicate one standard deviation from the mean.  
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TABLE 4-3. Kinetic constants for phosphorylation of CK2 canonical and primed 
consensus peptides 
Peptide Vmax 
(μmol/min/mg) 
Km  
(mM) 
Vmax/Km SEVmax SEKm 
WDDDSDDDDDAAA 0.609 
 
0.017 
 
36.37 
 
0.022 
 
0.003 
 
WEEESEEEEEAAA 0.293 
 
0.046 
 
6.38 
 
0.022 
 
0.013 
 
WDEKTDDEDFVPA 0.142 
 
0.060 
 
2.36 
 
0.024 
 
0.045 
 
WDDDSAApSAAAAA 0.069 
 
0.275 
 
0.25 
 
0.006 
 
0.069 
 
WDDDSpSApSpSAAAA 0.276 
 
0.116 
 
2.38 
 
0.019 
 
0.029 
 
WDDDSpSApSAAAAA 0.183 
 
0.091 
 
2.01 
 
0.017 
 
0.031 
 
WDDDSpSpSpSApSAAA 0.130 
 
0.231 
 
0.56 
 
0.011 
 
0.050 
 
WDDDSpSAApSpSAAA 0.096 
 
0.076 
 
1.26 
 
0.006 
 
0.01 
 
Kinetic constants were determined as described in section 4.2. pS, phosphoserine; SE, 
standard error. 
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efficiency) of 36.37, compared to 6.38 for the SEEEEE peptide (demonstrating the 
difference in efficiency between aspartic acid and glutamic acid as determinants for 
phosphorylation), and 2.38 for the highest efficiency primed peptide (SpSApSpSA). 
However, the peptide representing a known canonical mitotic substrate of CK2, T1343 of 
Topoisomerase IIα, despite having a lower Km value than any of the primed substrates, 
provided a Vmax/Km value of 2.36, equal to that of the SpSApSpSA peptide.  Since 
T1343 of Topoisomerase IIα is quite effectively phosphorylated by CK2 during mitosis 
(7), this suggests that given the correct primed sequence, CK2 may be just as likely to 
phosphorylate a primed substrate as a canonical substrate.  
  Among the primed substrate peptides, it appears that both too many and too few 
phosphoserines are detrimental to CK2 phosphorylation efficiency, as the peptides with 
one phosphoserine (SAApSAA) and four phosphoserines (SpSpSpSApS) have higher 
Km values than the peptides with two or three phosphoserines. This correlates well with  
the results in Figure 4.4, where in general the highest CK2 activity was with 
diphosphopeptides and triphosphopeptides.  The Km values of the most efficient primed 
substrates (SpSApSpSA, SpSApSAA, and SpSAApSpS) were similar (0.116 mM, 0.091 
mM and 0.076 mM respectively), and the relative efficiency of phosphorylation between 
these samples seemed to depend more on their Vmax values. Due to this, the primed 
substrate with the lowest Km value (SpSAApSpS; 0.076 mM) was the least efficient 
substrate of the three, as the Vmax value for this peptide was two- to threefold lower than 
the others. These results indicate that it may be crucial to have the optimal number of 
phosphoserines in the correct spacing in order for a primed substrate to have reaction 
kinetics as favourable as a canonical substrate. 
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CK2 primed phosphorylation requires serine as both phosphodeterminant and 
phosphoacceptor  
 In previous work on primed phosphorylation by CK2, is was shown that while 
CK2 can use phosphoserine as an acidic determinant, it cannot use phosphothreonine in 
this manner (23). However, this study was done with peptides containing only one 
phosphodeterminant (RRREEESAApSA, RRREEESAApTA), which in our results show 
only weak phosphorylation.  Given the difference in phosphorylation level between our 
low efficiency (SAApSAA) and high efficiency (SpSApSpSA) primed substrates, we 
chose to revisit the question of which phosphoamino acids can act as determinants for 
CK2 phosphorylation. Phosphotyrosine has also been demonstrated to act as a 
phosphodeterminant in CK2 hierarchical signalling (27), so it was included in our study 
as well. To compare phosphorylation of peptides containing each type of 
phosphodeterminant, we generated peptides corresponding to one of the most highly 
phosphorylated primed peptides (SpSApSpSA) with phosphoserine substituted with 
either phosphotyrosine or phosphothreonine. After incubation with CK2 and [γ-32P]-ATP 
only phosphoserine proved useful as a phosphodeterminant, however, with no detectable 
phosphorylation with phosphothreonine and very little with phosphotyrosine (Figure 
4.6A). Addtionally, we examined whether there was a difference in phosphorylation if the 
serine in the CK2 phosphoacceptor site is replaced with threonine. As shown in Figure 
4.6B, substitution of serine with threonine drastically decreased phosphorylation by CK2, 
consistent with previous work on canonical phosphorylation (22). These results show that 
optimal CK2 primed phosphorylation requires serine as both the phosphoacceptor and 
phosphodeterminant residues. 
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Figure 4.6 
 
 
 
Figure 4.6 Primed CK2 phosphorylation favours serine as the phosphodeterminant and 
phosphoacceptor. A. Primed peptides with phosphoserine, phosphothreonine, or 
phosphotyrosine as the phosphodeterminants were incubated with CK2 and [γ-32P]-ATP 
before spotting onto streptavidin-coated membrane. The phosphoacceptor residue in these 
sequences is shown in red. [γ-32P] incorporation was visualized on a Storm 
phosphorimager. Bi-, Biotin.  Values are an average of three independent experiments. 
Error bars indicate one standard deviation from the mean. B. Primed phosphopeptides 
with either serine or threonine in the phosphoacceptor site were incubated with CK2 and 
[γ-32P]-ATP and processed as in panel A. 
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Cdk1 phosphorylation can synergize with canonical determinants to form a novel CK2 
phosphorylation site 
 Collectively, these results outline the various factors controlling primed 
phosphorylation by CK2, and will be useful in identifying potential substrates within the 
genome. However, while hyperphosphorylated regions like those required for primed 
CK2 phosphorylation are widely distributed in the genome (41), with respect to 
hierarchical phosphorylation between Cdk1 and CK2, presumably only one serine residue 
will be phosphorylated at any given potential site (excluding the possible effects of 
additional kinases). While in most cases one phosphoserine residue is not sufficient to 
enable primed phosphorylation by CK2 (Figure 4.4), we wondered if Cdk1 
phosphorylation could synergize with existing canonical determinants, providing enough 
additional acidity to the region to form a novel CK2 site. Alternatively, Cdk1 
phosphorylation downstream of an existing weak CK2 site could strengthen the affinity 
of CK2 for that site, leading to increased phosphorylation. The results in Figure 4.3 
indicate that Cdk1 consensus determinants following a phosphoserine at the +3 position 
drastically decreases the ability of CK2 to phosphorylate primed sites. In fact, the only 
highly phosphorylated peptide containing this sequence contained an aspartic acid at the 
+1 position (Figure 4.2). However, this was due to canonical phosphorylation, as a non-
primed control peptide was also effectively phosphorylated by CK2. Since aspartic acid is 
a much stronger determinant for CK2 phosphorylation than glutamic acid (22) (also 
compare SDDDDD and SEEEEE peptides in Figure 4.5 and Table  4.3), we used 
glutamic acid to investigate the effects of addition of a Cdk1-catalyzed phosphoserine to 
a weak canonical CK2 site. To do this, we generated biotinylated peptides with a Cdk1 
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site phosphoserine at +3, +4, or +5, and glutamic acid at either the +1 or +3 position, and 
tested the phosphorylation of these peptides by CK2. By comparing peptides with 
phosphorylated and unphosphorylated Cdk1 sites, we could compare the baseline 
efficiency of the canonical determinants with any added effect from the Cdk1 
phosphorylation event. As shown in Figure 4.7, the peptides containing one glutamic acid 
and an unphosphorylated Cdk1 site were barely phosphorylated, indicating that these 
sequences represent very weak CK2 sites. With glutamic acid at the +1 position, 
phosphorylation of the Cdk1 site at any position had little to no effect on CK2 
phosphorylation of the sequence (Figure 4.7, panels A-C). However, when glutamic acid 
was included as an acidic determinant at the +3 position, phosphorylation of a Cdk1 site 
at either the +4 or +5 position resulted in a significant increase in CK2 phosphorylation 
compared to the unphosphorylated peptide (Figure 4.7, panels D and E).  A Cdk1 site 
situated at the +5 position was particularly favourable. In this study, we also compared 
primed versions of each peptide with either alanine residues or a Cdk1 consensus 
sequence following the ultimate phosphoserine, and interestingly, while all other primed 
peptide pairs tested in this study demonstrated a sharp decrease in phosphorylation upon 
addition of the Cdk1 determinants (Figure 4.3), peptides with the Cdk1 site at the +5 
position actually displayed increased phosphorylation compared to a corresponding 
peptide with alanine residues in place of the Cdk1 site (Figure 4.7, panels A and D). This 
suggests that, while unfavourable when directly adjacent to the CK2 site, the prolyl, 
hydrophobic, and basic determinants comprising a Cdk1 consensus sequence may 
actually become favourable determinants for CK2 phosphorylation when situated farther  
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Figure 4.7  
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Figure 4.7 Continued 
 
Figure 4.7 Cdk1 phosphorylation can form a novel site for CK2 phosphorylation. 
Biotinylated peptides corresponding to various spacing options for Cdk1/CK2 
hierarchical phosphorylation were incubated with CK2 and [γ-32P]-ATP before spotting 
onto streptavidin-coated membrane. [γ-32P] incorporation was visualized on a Storm 
phosphorimager. The phosphoacceptor residue in these sequences is shown in red. Bi-, 
Biotin. Graphs represent [γ-32P] incorporation into each peptide. Values are an average of 
three independent experiments. Error bars indicate one standard deviation from the mean.  
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away from the CK2 phosphoacceptor residue. Based on these results, we conclude that 
hierarchical phosphorylation between Cdk1 and CK2 requires both canonical and primed 
consensus determinants, and occurs optimally at sequences with a weak canonical 
determinant at the +3 position followed by a Cdk1 phosphorylation site at the +5 position 
(S-X-X-E-X-pS-P-V-K). 
Genome-wide search for potential substrates of Cdk/CK2 hierarchical phosphorylation 
 Knowing the optimal spacing for Cdk1/CK2 hierarchical phosphorylation, we 
next wanted to search the human genome for protein sequences matching this spacing. 
However, while in the above experiment a glutamic acid at the +3 position was sufficient 
for hierarchical phosphorylation, given the flexibility of the CK2 consensus determinants 
it was necessary to include other options for CK2 consensus determinants. To do this, we 
searched for proteins in the human genome containing the sequences S-X-X-X-X-S-P, 
producing a dataset independent of both CK2 consensus determinants and particular Cdk 
consensus motifs. Due to this, the resultant dataset theoretically included all possible sites 
for hierarchical phosphorylation between any proline-directed kinase and any primed 
kinase. This allows additional filtering of the dataset based on the particular primed 
kinase and proline-directed kinase of interest. The total dataset is included as a table in 
Appendix A. To sort the results based on the positive and negative CK2 determinants 
found at positions 2-5 in the sequence, we implemented a scoring system as follows: The 
presence of serine at position 1 of the sequence scores 3.8, which acts as a baseline score. 
Since acidic residues are positive determinants for CK2 phosphorylation, especially at the 
+1 and +3 positions (29), presence of aspartic acid or glutamic acid were considered 
extremely favourable (+1.5) at any position. Previous work has demonstrated that proline, 
161 
 
lysine, and arginine are all negative determinants of CK2 phosphorylation when present 
at the +1 position (26, 28), so the presence of these residues at position 2 of the above 
sequence was considered extremely unfavourable (-1.5). Since our results suggest that 
non-charged hydrophilic residues like glutamine may aid in CK2 primed 
phosphorylation, we considered glutamine, asparagine, serine or threonine at positions 2-
5 to be somewhat favourable as well (+1). All other residues at these positions were 
scored as neutral. The results were sorted by score into several groups: Sequences with 
strong, intermediate, and weak canonical determinants, and sequences with either no 
canonical determinants or negative determinants. While completely arbitrary numerically, 
the scoring system worked surprisingly well, with strong candidates for CK2 
phosphorylation consistently scoring the highest score, 5.8. In general, intermediate and 
weak candidates for phosphorylation tended to score 5.3 and 4.8, respectively. Poor 
candidates for CK2 phosphorylation, with scores ranging from -0.5 to 4.8, were excluded 
from further study.  Of the 7376 results returned by the peptide match program, 1262 of 
them contained weak, intermediate, or strong canonical determinants. All potential CK2 
substrates in the dataset are included in a table in Appendix A. 
 To examine the types of genes potentially affected by hierarchical 
phosphorylation between CK2 and proline-directed kinases, we next used Gene Ontology 
(GO) analysis to determine the molecular functions of the peptide match results and the 
biological processes in which they participate. GO analysis compares the composition of 
our peptide match dataset against the human genome to identify associated biological 
processes and molecular functions that are statistically enriched in our dataset compared 
to the genome (16). A list of all genes included in GO analysis is included as a table in 
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Appendix A. Generally, the dataset was highly enriched for the molecular function 
“phosphoprotein” (58% of peptide matches; P = 5.6E10-45), though perhaps not 
surprisingly, as each peptide match contains at least two serine residues. Clustering of the 
genes in the dataset into functionally related classifications using high stringency 
parameters produced 16 separate gene clusters that were significantly enhanced in 
proteins containing a potential hierarchical phosphorylation motif, including centrosomal 
proteins, microtubule motor proteins, several GTPase regulatory proteins, and several 
classes of transcription factors (Table 4.4), indicating that several distinct groups of 
proteins are enriched in the peptide match results.  When the genes were functionally 
annotated into groups based on biological process and molecular function GO terms, 
proteins containing hierarchical phosphorylation consensus determinants tended to cluster 
into distinct groups. Using the highest stringency settings, the most significantly enriched 
biological process amongst the genes in our dataset was “negative regulation of 
microtubule depolymerization’, with an enrichment score (the mean of all P values for 
enrichment for all genes in the cluster) of 4.87 (E > 1.3 is considered significant), and a P 
value of 1.2E10-5 (Table 4.5A). With such strict stringency settings, only eight significant 
clusters were formed from the dataset, indicating that proteins containing possible 
proline-directed/CK2 hierarchical phosphorylation sites are concentrated into specific 
pathways, including those controlling microtubule dynamics, induction of apoptosis, and 
development of specific body tissues. This trend was accentuated further when annotation 
stringency was lowered to the high setting, thereby including a larger proportion of the 
dataset. Significant clustering results show that proteins containing potential proline-
directed/CK2 hierarchical phosphorylation sites are enriched in pathways controlling 
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transcription, chromatin regulation, cell death, specific developmental and differentiation 
pathways, and, with respect to mitosis, the regulation of mitotic spindle dynamics.  
Potential candidates for Cdk/CK2 hierarchical phosphorylation on the mitotic spindle 
 As our original goal was to investigate whether Cdk1 and CK2 could work 
together to phosphorylate mitotic proteins, thereby contributing to the regulation of 
mitosis, we next mined both the peptide match dataset and the resultant GO terms for 
proteins with known roles in mitosis. All proteins in the dataset listed under the GO terms 
“Microtubule cytoskeleton”, “Cell division and chromosome partitioning”, and 
“Regulation of mitotic cell cycle” were included. The resultant list contains 74 potential 
phosphorylation sites in 71 proteins (the microtubule-associated proteins MAP1B and 
MAP4 each contain two potential sites, as does the nucleolar protein Nucleophosmin) 
(Table 4.6). As the most enriched group of genes in the dataset was those involved in 
microtubule dynamics, the vast majority of mitotic candidates for hierarchical 
phosphorylation are components of the mitotic spindle. Validation of these candidates as 
potential substrates for Cdk1/CK2 hierarchical phosphorylation will undoubtedly increase 
our understanding of mitotic regulation, and determine the extent to which hierarchical 
phosphorylation contributes.  
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TABLE 4.4 Enriched gene function classifications in SXXXXSP peptide match 
results.  
Cluster Gene Function Number of 
Genes 
Enrichment 
scorea 
Fold 
Enrichment 
P valueb 
1 Nucleolar Proteins 7 10.80 16 2.60E-08 
2 Centrosomal 
Proteins 
9 7.10 44 3.60E-12 
3 Transcription 
factors (Zinc-
finger) 
67 6.91 5.3 5.90E-26 
4 Transcription 
factors (Basic 
leucine zipper) 
6 6.73 260 2.70E-13 
5 Negative 
regulators of 
transcription 
12 6.00 27 6.10E-17 
6 Positive regulators 
of transcription 
6 5.78 24 5.30E-08 
7 Regulation of Rab 
GTPase activation 
5 5.67 230 1.30E-10 
8 Positive regulators 
of transcription 
7 5.14 17 7.20E-07 
9 WD40 Repeat 
proteins 
12 4.50 57 1.40E-20 
10 Microtubule motor 
proteins 
12 4.28 98 6.30E-14 
11 3'5'-cyclic 
nucleotide 
phosphodiesterases 
6 4.16 660 1.90E-15 
12c Small GTPase 
regulation 
8 4.04 230 7.80E-18 
12c Positive regulators 
of apoptosis 
8 4.04 37 3.90E-12 
13 Helicases 7 3.54 79 1.40E-12 
14 Ubiquitin 
Peptidases 
11 3.39 250 2.00E-25 
15 Transcription 
Factors 
(Homeobox) 
5 3.24 80 9.50E-09 
16 Protein Kinases 30 2.19 27 2.10E-29 
a The enrichment score represents the geometric mean of all the enrichment P values from 
all genes in the cluster. E > 1.3 is considered significant. 
b The P value represents the significance of gene-term enrichment in this study. A P value 
of < 0.05 indicates significant enrichment in this dataset compared to the human genome. 
c Genes in Cluster 12 had two functional classifications. 
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TABLE 4.5 Functional annotation analysis of SXXXXSP peptide match results. 
A. Highest Stringency 
Cluster Representative GO Term # of Genes E
a Fold Enrichment P value
b 
1 Negative regulation of 
microtubule 
depolymerization 
7 4.87 12.23 1.19E-05 
2 Regulation of 
microtubule 
depolymerization/ 
repolymerization 
8 3.34 7.21 8.85E-05 
3 3'5'-cyclic nucleotide 
phosphodiesterase 
activity 
7 2.77 7.79 2.01E-04 
4 Histone 
methyltransferase 
activity 
7 2.33 4.79 3.03E-03 
5 Embryonic limb 
morphogenesis 
9 1.67 2.89 1.24E-02 
6 Positive regulation of 
apoptosis 
25 1.65 1.63 2.10E-02 
7 Digestive tract 
morphogenesis 
4 1.35 5.32 3.73E-02 
8 Regulation of apoptosis 39 1.28 1.36 4.80E-02 
B. High Stringency 
Cluster Representative GO Term # of Genes E
a Fold Enrichment P value
b 
1 Regulation of gene 
expression 
159 8.28 1.56 1.30E-09 
2 GTPase regulator 
activity 
44 7.17 2.91 6.06E-10 
3 Biological regulation 310 4.88 1.20 8.11E-05 
4 Chromatin modification 27 4.42 2.75 5.77E-06 
5 Negative regulation of 
microtubule 
depolymerization 
7 4.10 12.22 1.19E-05 
6 Negative regulation of 
cytoskeleton 
organization 
11 4.07 5.59 2.12E-05 
7 Transcription 124 4.02 1.65 7.36E-09 
8 Transcription from RNA 
Polymerase II promoter 
20 3.33 2.39 7.52E-04 
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TABLE 4.5 continued 
Cluster Representative GO Term # of Genes E 
Fold 
Enrichment P value 
9 Negative regulation of 
gene expression 
36 3.10 2.00 1.36E-04 
10 Positive regulation of 
transcription 
38 3.06 1.88 2.69E-04 
11 3'5'-cyclic nucleotide 
phosphodiesterase 
activity 
7 2.77 7.79 2.01E-04 
12 Negative regulation of 
transcription 
32 2.62 1.95 5.20E-04 
13 Immune system 
development 
21 2.40 1.94 2.21E-03 
14 GTPase binding 13 2.38 3.18 7.63E-04 
15 Apoptosis 35 2.09 1.63 5.60E-03 
16 Stem cell differentiation 6 2.04 5.24 5.10E-03 
17 Microtubule motor 
activity 
10 1.90 3.46 2.20E-03 
18 Histone 
methyltransferase 
activity 
7 1.89 4.79 3.00E-03 
19 Embryonic limb 
morphogenesis 
9 1.67 2.89 1.20E-02 
20 Positive regulation of 
apoptosis 
25 1.65 1.63 2.10E-02 
21 Regulation of neuron 
differentiation 
14 1.60 2.52 8.10E-03 
22 Metal ion binding 178 1.39 1.13 3.74E-02 
23 Digestive tract 
morphogenesis 
4 1.34 6.58 2.10E-02 
a The enrichment score represents the geometric mean of all the enrichment P values from 
all genes in the cluster. E > 1.3 is considered significant. 
b The P value represents the significance of gene-term enrichment in this study. A P value 
of < 0.05 indicates significant enrichment in this dataset compared to the human genome. 
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TABLE 4.6 Potential mitotic spindle substrates for Cdk/CK2 hierarchical 
phosphorylation. 
Gene Name Position Sequence CK2 Score 
5-azacytidine induced 1 8 traigSVPERSPagv 4.8 
Actin filament associated protein 1-
like 2 
207 llcykSSKDHSPqld 5.3 
Amyloid beta (A4) precursor protein-
binding, family B, member 2 
265 swttlSQDSASPssp 4.8 
B-cell CLL/lymphoma 6 460 gsprsSSESHSPlym 4.8 
Brain-enriched guanylate kinase-
associated homolog 
547 dslepSSMEASPemh 5.3 
Budding uninhibited by 
benzimidazoles 1 homolog beta (yeast) 
568 sesitSNEDVSPdvc 5.3 
CAP-GLY domain containing linker 
protein 2 
36 aavaaSSKEGSPlhk 5.3 
Caspase recruitment domain family, 
member 11 
477 eaddsSTSEESPeds 5.3 
CDK5 regulatory subunit associated 
protein 2 
47 llpnvSEETVSPtra 5.3 
Centromere protein J 725 rergiSSREDSPqvc 5.3 
Centrosomal protein 164kDa 1232 slsseSSESFSPphr 4.8 
Centrosomal protein 350kDa 1647 ghhddSDEEASPekt 5.8 
Centrosomal protein kizuna 617 seasfSSSEGSPlsr 5.3 
Checkpoint with forkhead and ring 
finger domains 
190 ptasaSSTEPSPagr 5.3 
CHK1 checkpoint homolog 295 skhiqSNLDFSPvns 5.3 
Ciliary rootlet coiled-coil, rootletin 1477 glnspSTLECSPgsq 5.3 
Cortactin binding protein 2 1579 lrmpvSQKEVSPlss 5.3 
CP110 protein 164 dlardSEGFNSPkqc 4.8 
Cyclin B3 43 tkispSSLQESPssl 4.8 
Cytoplasmic linker associated protein 
1 
759 dtsreSSRDTSParg 5.3 
Cytoplasmic linker associated protein 
2 
768 easreSSRDTSPvrs 5.3 
DAB2 interacting protein 28 rslpgSLSEKSPsme 4.8 
Dedicator of cytokinesis protein 5 1507 evkqiSTEEISPlen 5.3 
Dedicator of cytokinesis protein 6 1660 eesaiSDDILSPdee 4.8 
Dedicator of cytokinesis protein 7 1720 eesavSDDVVSPdee 4.8 
Dedicator of cytokinesis protein 8 1705 eesvvSEDTLSPded 5.3 
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TABLE 4.6 Continued. 
Gene Name Position Sequence CK2 Score 
Dynein heavy chain domain 1 1628 ktiasSEPSLSPaac 5.3 
Dynein, axonemal, heavy chain 5 2400 vfmssSILDWSPile 4.8 
Dynein, axonemal, heavy chain 8 538 yffknSDILSSPdgk 4.8 
Dynein, cytoplasmic 2, heavy chain 1 407 lknyiSEIQDSPqql 5.3 
Farnesyltransferase, CAAX box, alpha 367 lqskhSTENDSPtnv 4.8 
FYVE and coiled-coil domain 
containing 1 
1244 sgsgtSQGEPSPals 5.3 
Growth arrest-specific 2 like 1 600 qalssSSDEGSPcpg 5.3 
Hepatocyte nuclear factor 4, alpha 13 gapveSSYDTSPseg 5.3 
Intraflagellar transport 20 homolog 93 cklclSDSSDSPtsp 5.3 
Kinesin family member 18B 458 megnsSDQEQSPede 5.8 
Kinesin family member 1B 862 lpligSQEQKSPgsh 4.8 
Kinesin family member 20A 861 tptcqSSTDCSPyar 5.3 
Kinesin family member 21A 1265 sdsgtSEASLSPpss 5.3 
Kinesin heavy chain member 2A 134 aqqngSVSDISPvqa 4.8 
Kinesin light chain 3 496 rtlsaSTQDLSPh 5.3 
Kinesin light chain 3 161 dppaeSQQSESPprr 4.8 
Lysosomal trafficking regulator 1384 lkiieSDTTMSPsqy 5.3 
MAP/microtubule affinity-regulating 
kinase 1 
469 tvgskSEMTASPlvg 5.3 
Microtubule-associated protein 1A 1197 dtqslSLSEESPske 4.8 
Microtubule-associated protein 1B 1723 elisvSQVEASPsts 5.3 
Microtubule-associated protein 1B 1959 ysydiSEKTTSPpev 5.3 
Microtubule-associated protein 4 93 hgvegSDTTGSPtef 5.3 
Microtubule-associated protein 4 199 lnsphSESFVSPeav 4.8 
Microtubule-associated protein tau 226 rdvdeSSPQDSPpsk 4.8 
M-Phase phosphoprotein 237 tfislSSTDVSPnqs 5.3 
Myosin XVIIIB 108 ilgkeSEGSRSPdpe 5.3 
NEDD8 activating enzyme E1 subunit 
1 
102 sdvsgSFVEESPenl 4.8 
Neuron navigator 1 1259 klqhgSTETASPsik 4.8 
Ninein-like 179 lqtwdSEDFGSPqks 4.8 
Nucleophosmin/nucleoplasmin, 2 153 edadiSLEEQSPvkq 4.8 
Nucleophosmin/nucleoplasmin, 2 190 eeiraSVRDKSPvkk 4.8 
Pericentrin 48 savdaSVQEESPvtk 4.8 
Phosphodiesterase 4D, cAMP-specific  196 lyrsdSDYDLSPksm 5.8 
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TABLE 4.6 Continued. 
Gene Name Position Sequence CK2 Score 
Protein kinase, membrane associated 
tyrosine/threonine 1 
88 frgeaSETLQSPgyd 4.8 
PTPRF interacting protein, binding 
protein 1 (liprin beta 1) 
354 daqgfSDLEKSPspt 5.8 
RAB11 family interacting protein 3 
(class II) 
396 dygegSEAELSPetl 5.8 
Rho/Rac guanine nucleotide exchange 
factor (GEF) 2 
642 rglfrSESLESPrge 4.8 
SMAD family member 6 316 apgefSDASMSPdat 5.3 
Spectrin repeat containing, nuclear 
envelope 1 
159 vdsivSSETPSPpsk 4.8 
Sperm associated antigen 17 464 dlvppSLREPSPrad 4.8 
Sperm associated antigen 4 100 vrggaSEPTGSPvvs 5.3 
Synaptojanin 2 570 sgatdSQDDSSPadi 5.3 
Syntrophin, beta 2 227 psfsgSEDSGSPkhq 5.3 
Transformation/transcription domain-
associated protein 
2334 qailtSLIEKSPdak 4.8 
TRIO and F-actin binding protein 131 nedpgSDPTSSPdsa 5.3 
V-myc myelocytomatosis viral 
oncogene homolog 
239 sdsllSSTESSPqgs 5.3 
Zinc finger protein 655 279 ksceaSDKSCSPssg 5.3 
Zinc finger, C3H1-type containing 122 rmpssSLSESSPrps 4.8 
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4.4 Discussion 
 In this study, we have examined the consensus requirements for phosphorylation 
of primed sequences by protein kinase CK2, in an effort to determine whether interplay 
between CK2 and the main mitotic regulatory kinase Cdk1 could contribute to mitotic 
signalling. The results of our study demonstrate that this may indeed be the case, as we 
have shown that phosphorylation of an adjacent Cdk1 consensus sequence can contribute 
to the formation of a novel site for CK2 phosphorylation. This indicates that CK2 kinase 
activity towards particular substrates can be regulated by the actions of proline-directed 
kinases. In a genome-wide search for sites matching the consensus sequence for 
hierarchical phosphorylation by proline-directed kinases and CK2, the mitotic spindle 
was particularly enriched with proteins containing putative consensus sequences. 
 This study is the first to systematically investigate CK2 primed phosphorylation, 
and the results indicate that in terms of positioning, primed consensus determinants tend 
to follow similar patterns as canonical determinants. For example, primed 
phosphorylation preferentially requires phosphodeterminants at the +1 and +3 positions. 
The similarities in spacing requirements are due to the geometry of the CK2 substrate 
binding cleft, which uses three distinct basic regions of the kinase to coordinate acidic 
determinants for phosphorylation into the active site, positioning the phosphoacceptor 
residue for catalysis (39). There are, however, several subtle differences in the optimal 
sequences for each type of phosphorylation. For example, while in canonical signalling  
the +2 position is negligible (39), in primed signalling we found that in most cases 
phosphodeterminants at the +2 position actually inhibited phosphorylation. Additionally, 
while a canonical site typically contains multiple acidic determinants (29), too many 
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phosphodeterminants actually inhibits CK2 phosphorylation of a substrate, and due to 
this there appears to be a limit on the acceptable number of phosphosites in a primed CK2 
consensus sequence, at 2-3. This may be explained by the fact that while aspartic acid and 
glutamic acid, with pKa values of 3.9 and 4.07, respectively, will each bear a maximum 
of one negative charge at physiological pH, each phosphoryl group, with a  pKa value of 
~6.7, will most likely have two negative charges at physiological pH (18). Since binding 
of CK2 to its substrates appears to be largely dependent on negative charges in the 
substrate, we propose that CK2 sites may have an upper threshold of negativity, above 
which the high number of negative charges may interfere with substrate phosphorylation. 
This idea is supported by mutational studies performed on the basic regions of the CK2 
substrate binding cleft, as mutation of certain basic residues to alanine results in 
decreased CK2 phosphorylation due to an increase in Km, meaning that CK2 cannot bind 
its substrates as effectively (39). This may also somewhat explain why 
phosphodeterminants at the +2 position actually decrease primed phosphorylation: the 
basic residues in the CK2 substrate binding pocket are optimally positioned to bind to 
acidic determinants at the +1 and +3 positions, but an additional two negative charges 
between these two binding sites may affect electrostatic interactions between the basic 
residues and proper acidic residues dramatically. When each determinant has one 
negative charge, an acidic residue at the +2 position is ineffectual; with each site 
containing two negative charges the binding pocket may be overwhelmed and bind the 
substrate incorrectly, leading to decreased phosphorylation. Due to this, it seems that the 
increased acidity of phosphoserine results in increased selectivity in the phosphorylation 
of primed substrates compared to canonical substrates. It is intriguing to speculate that 
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this enhanced emphasis on optimal positioning may act as a regulatory mechanism 
controlling these events. As sites of hyperphosphorylation are rampant in the human 
phosphoproteome (41), the strict requirements observed may ensure hierarchical 
phosphorylation by CK2 only at very specific layouts of phosphoserine residues. In 
addition, the increased acidity of phosphoserine means that residue to residue, less 
phosphoserine would be required than aspartic acid or glutamic acid to create a functional 
CK2 site. This would in fact increase the likelihood of primed phosphorylation in vivo, as 
CK2 would only require 2-3 phosphorylated residues, albeit with the correct spacing, in 
order to efficiently catalyze phosphorylation. 
 During the course of this study, we also conducted experiments to determine the 
preferences for different phosphoresidues as both phosphodeterminants and 
phosphoacceptors. As the human phosphoproteome is composed of approximately 86.4% 
phosphoserine, 11.8% phosphothreonine, and 1.8% phosphotyrosine (34), it is perhaps 
not surprising that predominantly phosphoserine residues are found in hierarchical 
phosphorylation events, but our results demonstrate that in fact only serine is favourable 
as both the phosphodeterminant for CK2 phosphorylation and as the CK2 
phosphoacceptor residue. This suggests that hierarchical phosphorylation somehow 
evolved to involve only phosphoserine. The reasons behind this preference are probably 
due to subtle structural differences between phosphodeterminant residues that impact the 
ability to the substrate to properly fit in the CK2 substrate binding domain. In the case of 
phosphothreonine, the additional methyl group may skew the angle of the phosphate in 
relation to the remainder of the substrate, which may lead to decreased affinity for the 
CK2 substrate binding pocket. The lack of primed phosphorylation with 
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phosphothreonine as a determinant may be unique to CK2, as CK1, another primed 
kinase, can use both phosphoserine and phosphothreonine as phosphodeterminants (13).  
Conversely, while CK2 can and in most cases does utilize aspartic acid and glutamic acid 
as consensus determinants, CK1 cannot (13), indicating that the loss of phosphothreonine 
as a possible determinant for CK2 phosphorylation may be due to subtle differences in 
the substrate binding pocket of CK2 give it the unique ability to participate in both 
canonical and primed phosphorylation. In the case of phosphotyrosine, the increased 
length of phosphotyrosine compared to phosphoserine may impact the ability of the 
phosphodeterminant to fit in the binding pocket, although the impact is presumably less 
than that for phosphothreonine, as phosphotyrosine in the phosphodeterminant positions 
did lead to substrate phosphorylation, albeit at much lower levels than when 
phosphoserine is used as a phosphodeterminant. At the phosphoacceptor site, it is 
important to consider that CK2 tends to prefer serine over threonine in general, as do 
most serine/threonine kinases (37), and accordingly our results show that even with 
identical phosphodeterminants to a highly phosphorylated serine-containing peptide, 
phosphorylation of threonine was only barely detectable. It should also be noted that CK2 
can in certain cases phosphorylate tyrosine residues (47), but in the context of primed 
phosphorylation, this remains to be investigated. 
 With respect to phosphorylation efficiency, the primed peptides that displayed 
maximal [γ-32P] incorporation showed similar levels of phosphorylation to both the 
optimal canonical CK2 substrate peptide (SDDDDD) and a peptide based on the 
canonical consensus sequence of a known mitotic substrate of CK2, Topoisomerase IIα 
(T1343), indicating that given the correct sequence determinants, primed phosphorylation 
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by CK2 can be just as efficient as canonical phosphorylation.  Kinetic analysis of 
canonical and primed peptides confirmed this, as the better primed substrates had quite 
respectable Km values, and exhibited a Km/Vmax ratio comparable to the Topoisomerase 
IIα mitotic phosphorylation site, suggesting that primed phosphorylation by CK2 may be 
as likely to occur in the cell as some canonical events.   
 Since CK2 prefers phosphodeterminants at the +3 position, we originally 
hypothesized that Cdk1/CK2 hierarchical phosphorylation sites would generally contain 
the Cdk1 phosphoserine at the CK2 +3 position (SXXSPVK). While a number of mitotic 
proteins contain similar motifs, our results indicate that hierarchical phosphorylation of 
these sequences is extremely unfavourable. This seems to be due to the close proximity of 
the prolyl, hydrophobic, and basic characteristics of the Cdk1 consensus sequence to the 
CK2 site, as similar peptides with alanine residues following the Cdk1 phosphoserine 
were phosphorylated quite well by CK2. This, combined with the observation that 
multiple phosphodeterminants are required for appreciable primed phosphorylation by 
CK2, makes it unlikely that these types of events would occur in a cellular context, at 
least not without the added contribution of other kinases, which indeed may be a 
possibility. The mitotic regulatory kinase Plk1 may be a likely candidate for these sorts of 
higher order phosphorylation events, as its phosphorylation determinants mirror those of 
CK2, with Plk1 requiring acidic residues N-terminal to the phosphosite (31), and Plk1 
interacts with CK2 during mitosis via the mitotic phosphorylation sites (likely catalyzed 
by Cdk1) located in the C-terminus of CK2α (25). The interaction between Cdk1 and 
CK2 during mitosis could also aid in the phosphorylation of these events, with Cdk1 
essentially targeting CK2 to these sites. Regardless, our results show that, at least in 
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peptide form, Cdk1/CK2 hierarchical phosphorylation is unfavourable when the Cdk1 
site is the only phosphodeterminant downstream and extremely unfavourable when the 
Cdk1 consensus determinants are close to the CK2 site. In fact, during investigation of 
this possibility, even Wee1A, which was previously reported to undergo Cdk1/CK2 
hierarchical phosphorylation in vivo, was not detectably phosphorylated by CK2 in our 
assay. This was initially worrisome, but further investigation revealed an additional 
known Cdk1 phosphorylation site at serine 127 of Wee1A (6), which may add enough 
additional acidity to the sequence to form an efficient CK2 site. As this site was not 
phosphorylated in our peptide (and in fact was changed to alanine to remove the possible 
effects of additional serine residues), we were unable to observe any effects it may have 
on phosphorylation of serine 121 by CK2. Even with this additional phosphoserine 
residue, however, the positioning of these sites remains unusual, as the sequence contains 
both a phosphoserine at the +2 position and a proline at the +3 position. However, there 
are instances of canonical CK2 substrates that do not match the typical consensus 
sequence (29), and it is possible that Wee1A may be the exception to the rule in terms of 
primed CK2 phosphorylation. 
 As our results suggest that purely primed hierarchical phosphorylation between 
Cdk1 and CK2 is unlikely, we next investigated the possibility of hierarchical 
phosphorylation between Cdk1 and CK2 in the context of mixed consensus determinants. 
To do this, we started with a weak canonical CK2 consensus motif (a single glutamic acid 
residue at either the +1 or +3 positions), and asked whether phosphorylation of a Cdk1 
site downstream from the CK2 site could synergize with the existing weak CK2 
consensus determinant. The results from this experiment were striking, and again 
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highlight the strict spacing requirements for efficient CK2 phosphorylation. We found 
that Cdk1 sites can indeed contribute to the formation of novel CK2 sites, as long as the 
Cdk1 site phosphoserine is located a minimum of four amino acids downstream from the 
CK2 site, and optimally five amino acids downstream. Interestingly, while the presence 
of Cdk1 consensus determinants drastically decreased CK2 phosphorylation when the 
Cdk1 phosphoserine was located at the +3 position, the presence of the same Cdk1 
consensus determinants farther downstream actually increased CK2 primed 
phosphorylation compared to similar peptides containing alanines, suggesting that these 
residues may be favourable determinants for CK2 phosphorylation, provided they are 
positioned far enough away from the active site of CK2. 
 These results demonstrate that the phosphorylation of a Cdk1 site can, with the 
correct positioning, drastically increase phosphorylation of a weak canonical CK2 site. 
Accordingly, we were interested in determining if these sites existed in the genome, as in 
the cell this effect could have a dramatic impact on CK2 signalling, and may explain how 
CK2, while constitutively active, can be targeted to particular substrates in response to a 
specific stimulus. While our main goal was to specifically investigate the possibility of 
interplay between CK2 and Cdk1, we opted to expand our search to look for genomic 
instances of the sequence SXXXXSP. It is important to note that results theoretically 
represent hierarchical phosphorylation events between any proline-directed kinase and 
any primed kinase. The Cdk1 consensus sequence was removed from the search to avoid 
the loss of possible substrates due to atypical Cdk1 consensus determinants. We reasoned 
that the precise proline-directed kinase involved could be inferred for any given match 
based on the precise determinants present in the amino acid sequence and the cellular 
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properties of the gene product involved, for example its expression throughout the cell 
cycle. Also, it is much more likely that the proline-directed kinases acting on these sites 
would be cyclin-dependent kinases and not MAPKs, as MAPKs typically require an 
additional proline at the -2 position (31), which in our sequence lies at the +3 position 
with respect to the CK2 site, a position where proline would be extremely unfavourable. 
Similarly, the sequence used in the peptide match search does not match the optimal 
spacing of consensus determinants for phosphorylation by CK1 (pS/pTXXS)(13) or 
GSK3 (SXXXpS) (12), indicating that no other known primed kinase is likely to 
appreciably phosphorylate these sites. Additionally, we sorted the resultant peptide 
matches based on the presence of CK2 canonical determinants. The search for canonical 
determinants was conducted after the more generic peptide match search because while 
the experiment conducted demonstrated that a glutamic acid at the +3 position was 
sufficient to synergize with the phosphorylated Cdk1 site, CK2 canonical determinants 
can be much more flexible, and we wished to avoid missing any possible substrates 
containing other combinations of CK2 canonical determinants. To then isolate the 
promising CK2 substrates from the rest of the results, we devised a scoring matrix based 
on known CK2 consensus requirements. The scoring system allowed us to quickly 
exclude unfavourable sequences, and organize the peptides containing CK2 determinants 
into three groups based on the strength of the putative CK2 sites in each result. It is 
expected that, when tested, genes in the different groups will vary in their initial 
phosphorylation status and may also show varied effects after addition of the Cdk 
phosphoserine. Indeed, many of the results in the group with the strongest consensus 
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determinants may be sufficient to form canonical phosphorylation sites that are 
indifferent to downstream phosphorylation. 
 GO analysis of the peptide match dataset produced several distinct and highly 
significant clusters, indicating that instances of hierarchical phosphorylation between 
CK2 and proline-directed kinases may occur specifically in certain biological pathways.  
Intriguingly, the predominant biological processes found to be enriched in our peptide 
match results overlap well with the known functions of cyclin-dependent kinases, the two 
most well studied being the regulation of cell cycle progression and the regulation of 
transcription (10).  
 As the goal of this study was to examine possible interplay between Cdk1 and 
CK2, we were encouraged by the extremely significant enrichment of specific families of 
mitotic genes in the peptide match results. In particular, the most significant biological 
function enriched in the study was ‘negative regulation of microtubule depolymerization’, 
and the genes clustered into this group included a myriad of structural components of the 
mitotic spindle, including several microtubule binding proteins (MAPs), centrosomal 
components, and kinetochore components, as well as several ATP-driven motor proteins 
(Kinesins, Dynein). Additional peptide match results included several mitotic regulatory 
proteins, including the known Spindle Assembly Checkpoint (SAC) component Bub1 
(32), CHFR, a relatively uncharacterized checkpoint protein that localizes to the mitotic 
spindle and  may act as a sensor for microtubule disruption (3), and Chk1, a well known 
component of the G1/S and G2/M DNA damage checkpoints (38) that has recently been 
implicated in SAC signalling as well (5, 36). Taken together, this suggests that 
Cdk1/CK2 hierarchical phosphorylation may play a role in the regulation of microtubule 
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dynamics, potentially as part of the SAC. Several lines of evidence suggest that CK2 
could be a vital component of SAC signalling, which acts at the metaphase to anaphase 
transition to ensure that all chromosomes are properly attached to the mitotic spindle 
before initiation of sister chromatid separation at the onset of anaphase (32). CK2 has 
been shown to localize to the mitotic spindle and centrosomes (21, 50), and proteomic 
investigations have identified CK2 as a component of both the centrosome (1) and the 
spindle midbody (42). Localization of CK2 to the mitotic spindle is dependent on the 
mitotic phosphorylation of the CK2α catalytic subunit (see Chapter 3), which is thought 
to be catalyzed by Cdk1 (2, 24, 43). These sites, while phosphorylated during normal 
mitosis, are maximally phosphorylated in response to treatment with mitotic spindle 
poisons like nocodazole (2, 24), indicating a role for CK2 in the SAC. Indeed, disruption 
of these phosphorylation sites results in multiple defects in mitosis, including 
centrosomal amplification, induction of mitotic catastrophe, and abrogation of the SAC 
(43). Additionally, attenuation of CK2 activity through chemical inhibitors or knockdown 
of CK2 subunits has also been demonstrated to neutralize the actions of the SAC (40). 
The validation of our peptide match results will hopefully shed new light on the role of 
CK2 in the SAC, particularly in the context of Cdk1/CK2 hierarchical phosphorylation. 
 While there was enrichment of several kinds of proteins involved in mitosis in our 
peptide match results, we did not see a corresponding enrichment in proteins involved in 
the G1/S transition, in which both Cdks and CK2 play active roles (10, 44). Interestingly, 
as with MAPKs, two of the main G1/S regulatory Cdks, Cdk4 and Cdk6, tend to require 
an additional proline at the -2 position (31). Additionally, although CK2 interacts directly 
with the Cdk-activating kinase (CAK) complex, which includes Cdk7, and is responsible 
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for activation of the G1/S Cdks following growth signalling, the consensus determinants 
for Cdk7 phosphorylation, which include basic residues at the -3 and -4 positions (31), 
would presumably interfere with Cdk7/CK2 hierarchical phosphorylation. It is tempting 
to speculate that this may in part explain the lack of enrichment of G1/S biological 
processes in the peptide match results.    
 Besides cell cycle related processes, the overwhelming majority of the enrichment 
in the peptide match results stemmed from genes involved in transcriptional control, 
particularly transcription from RNA polymerase II-driven promoters. The results 
indicated that our dataset contains multiple enriched clusters of different families of 
transcription factors, as well as separate clusters containing both positive and negative 
regulators of transcription. Interestingly, Cdks (mainly Cdk7, Cdk8, and Cdk9) have been 
shown to regulate transcription both directly, through the phosphorylation of both the 
RNA polymerase II C terminal domain (CTD) and various transcription factors, as well 
as indirectly through interactions with both activators and suppressors of transcription 
(11).  CK2 is also a well-known regulator of transcription. Like Cdk1, it also directly 
regulates RNA polymerase II via CTD phosphorylation, and phosphorylates a variety of 
RNA polymerase II general transcription factors, including TFIIA, TFIIE, and TFIIF, 
leading to increased transcriptional activation (4). CK2 also phosphorylates a variety of 
other transcription factors, leading to either activation or repression of transcription, 
depending on the substrate (44). As Cdks and CK2 seem to have multiple, overlapping 
roles in the regulation of transcription, interplay between the two kinase families may 
have a significant effect on cellular gene expression. 
181 
 
 In this study, we have examined the possibility of hierarchical phosphorylation 
between CK2 and Cdks, particularly Cdk1, and the results of this endeavour suggest that 
instances of interplay between the two kinases may have a significant impact on mitosis, 
and particularly the regulation of the mitotic spindle. Our future work will involve kinase 
assays with peptide arrays to assess promising substrates for hierarchical 
phosphorylation. To determine the impact of previous phosphorylation on CK2 
phosphorylation at these sites, peptide arrays will contain peptides of each sequence in 
both the unphosphorylated and phosphorylated states. This will also allow us to judge the 
optimal strength of the initial CK2 site in each peptide, as presumably at least some of the 
stronger CK2 candidates will be canonical CK2 sites, and phosphorylation at these sites 
may increase with the addition of the phosphodeterminant or may remain unchanged. By 
comparing any trends observed between peptides with strong, intermediate and weak 
initial CK2 sites, we may be able to gain insight into the consensus requirements for these 
mixed phosphorylation events. Interesting candidates will then be assayed for in vitro 
phosphorylation of the full length protein, as phosphorylation of peptide substrates does 
not eliminate the possibility of these sites being inaccessible to kinases when contained in 
a folded protein.  The use of full length proteins will require successive phosphorylation 
assays with first Cdk1 and then CK2. Lastly, it remains to be seen whether these events 
occur in cells, and if so, what impact on cellular signalling hierarchical phosphorylation 
will have. We plan to investigate this by expressing phosphorylation site mutants of 
promising candidates in human cells and assaying the effects of expression on substrate 
function and mitotic progression. Through this work, we hope to demonstrate that 
Cdk1/CK2 hierarchical phosphorylation contributes to mitotic signalling, and may in part 
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explain how a constitutively active kinase such as CK2 can play such specific roles in a 
multitude of cellular processes. 
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Chapter 5: Summary and Perspectives 
5.1 Overview 
 Mitosis is a highly regulated process that ensures the proper separation of 
chromosomes to the daughter cells, avoiding aneuploidy and genomic instability. As 
highlighted in this thesis, protein kinase CK2, and in particular the CK2α catalytic 
subunit, is crucial for proper cell division, but as CK2 is not subject to the strict, on/off 
forms of regulation often observed with other kinases, its participation in highly regulated 
processes implies that CK2 is regulated through more subtle means. Therefore, we 
hypothesized that CK2 is differentially regulated during mitosis, enabling CK2 to 
perform unique functions specific to cell division. First, we sought to examine the effects 
of mitotic phosphorylation of CK2α on mitotic progression. Although it has been long 
known that CK2α is maximally phosphorylated in cells arrested in mitosis by nocodazole 
treatment (3, 19), and that these phosphorylation sites form an interaction site for the 
peptidyl-prolyl isomerase Pin1 (27), the mechanism by which the phosphorylation of 
CK2α contributes to mitotic division has remained largely unknown. We have 
demonstrated that perturbation of these sites leads to multiple defects in cell division, 
indicating that proper phosphorylation of CK2α is crucial for normal cell division.  
Second, we have examined the subcellular localization of CK2α during mitosis, and 
showed that phosphorylation of CK2α leads to its localization to the mitotic spindle. This 
localization is dependent on the interaction between phosphorylated CK2α and Pin1, and 
could potentially target CK2 to important mitotic substrates. Lastly, to examine the 
possibility that interplay with the master mitotic regulatory kinase, Cdk1, may regulate 
CK2 activity during mitosis, we have outlined the consensus requirements for 
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hierarchical phosphorylation between the two kinases. We then used this consensus to 
predict several possible substrates, particularly among components of the mitotic spindle. 
Taken together, this thesis outlines multiple mechanisms by which CK2 may be regulated 
in order to fulfill its mitotic functions, including phosphorylation, subcellular 
localization, and interplay with other kinases. The data in this thesis and the implications 
of these findings are discussed in the following sections. 
5.2 Regulation of CK2 through phosphorylation of CK2α 
5.2.1 CK2α phosphorylation in mitosis 
 Upon entrance into mitosis, the cell undergoes a massive wave of 
phosphorylation, potentially altering the function of a myriad of enzymes (34). For the 
majority of proteins known to be phosphorylated during mitosis, the function of this 
phosphorylation remains unknown. The work in this thesis provides some vital clues 
towards determining the roles of the mitotic phosphorylation of CK2. The generation and 
characterization of phosphospecific antibodies against the CK2α C-terminal 
phosphorylation sites proved to be instrumental, allowing us to examine the temporal and 
spatial regulation of these phosphorylation events in a way that was not previously 
possible. These antibodies allowed us to demonstrate for the first time that CK2α is 
phosphorylated during the normal progression of mitotic cell division, not just in cells 
arrested in mitosis by activation of the spindle assembly checkpoint (SAC).  We 
determined that in normal mitosis, CK2α is phosphorylated during prophase and 
metaphase, and dephosphorylated during anaphase. This corresponds well with the idea 
that Cdk1 is the kinase responsible for CK2α phosphorylation (3, 19), as phosphorylation 
of CK2α temporally corresponded with the activation of Cdk1. Additionally, the 
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phosphospecific antibodies allowed us to specifically visualize phosphorylated CK2α in 
mitotic cells for the first time. This lead to the observation that phosphorylated CK2α, but 
not unphosphorylated CK2α, localizes to the mitotic spindle during mitosis. This work 
provides an explanation for the phosphorylation of CK2α during mitosis: the C-terminus 
of CK2α is phosphorylated in order to localize a subset of cellular CK2 to the mitotic 
spindle during its formation and organization. Previous work in our laboratory had 
demonstrated that the peptidyl-prolyl isomerase Pin1, another enzyme known to be 
important in mitosis (24), can interact with CK2α through a phosphodependent 
interaction with the CK2α C-terminus (27), and our work suggests that the purpose of this 
interaction is to localize phosphorylated CK2α to the mitotic spindle. Unfortunately, due 
to lack of assays for Pin1 activity, it was not possible to determine whether Pin1 
enzymatically alters the CK2α phosphorylation sites, somehow resulting in CK2 
localization (possibly through additional protein-protein interactions), or whether Pin1 
itself directly localizes CK2 to the mitotic spindle. In fact, the observation that Pin1 itself 
localizes to the mitotic spindle indicates that direct localization is certainly a possibility. 
However, a recently discovered phosphodependent interaction between the CK2α C-
terminus and the mitotic kinase Plk1 (22) indicates that Pin1 may not be the only protein 
affecting the localization of CK2, as Plk1 also localizes to the mitotic spindle (10). While 
questions remain, the work in this thesis has expanded our understanding of the mitotic 
phosphorylation of CK2α and its role during cell cycle progression. 
5.2.2 Disruption of CK2α phosphorylation in cells 
 The use of phosphospecific antibodies provided a wealth of information on 
mitotic CK2α phosphorylation, but in order to examine what possible effect these sites 
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have on mitotic progression, we also studied the effects of disrupting the CK2α 
phosphorylation sites. Accordingly, we developed stable cell lines with tetracycline-
regulated expression of a bidirectional plasmid expressing both HA-tagged CK2α and 
Myc-tagged CK2β. This system has several advantages: first, the tetracycline regulation 
allows for comparison of one cell line in the presence and absence of tetracycline, 
eliminating the risk of clonal variation between different cell lines. Second, using a 
bidirectional plasmid to co-ordinately express both CK2α and CK2β maintains the 
stoichiometry of the tetrameric holoenzyme, minimizing possible effects of large amounts 
of free catalytic subunits. To study the impact of the CK2α phosphorylation sites on 
mitotic progression, we used cell lines expressing wild type CK2α, two phosphomimetic 
forms (CK2α-4D, CK2α-4E), or a nonphosphorylatable form (CK2α-4A). These cell 
lines allowed us to examine several aspects of cellular function: growth curves indicated 
decreased proliferation upon expression of all three phosphorylation site mutants, 
particularly the phosphomimetic mutants; cell cycle analysis revealed that expression of 
phosphomimetic CK2α lead to a loss of mitotic cells, which was identified through 
viability assays and immunofluorescence staining as mitotic catastrophe, a form of cell 
death during mitosis. Cells expressing phosphomimetic forms of CK2α also displayed 
abnormal centrosomes, which lead to chromosomal missegregation and may have been 
the stimulus for induction of mitotic catastrophe in these cells.  Notably, cells expressing 
non-phosphorylatable CK2α did not show these phenotypes, but did show decreased 
ability to arrest via the SAC upon nocodazole treatment. These results indicate that 
proper regulation of CK2α phosphorylation is crucial for proper mitotic progression.  
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 While investigating the localization of phosphorylated CK2α, C-terminal 
fragments of CK2α containing the same phosphorylation site mutations were examined 
for their ability to localize to the mitotic spindle. Interestingly, we observed no spindle 
localization of any C-terminal mutant fragment, while the wild type C-terminal fragment 
localized to the spindle independently of the remainder of the protein. This result 
suggests that all the observed phenotypes may be due to lack of phosphorylation of a few 
particular substrates of CK2 on the mitotic spindle. Expression of the non-
phosphorylatable form of CK2α leads to defects in the SAC, suggesting that one or more 
of the regulatory proteins involved in the SAC may potentially be a substrate of CK2. 
Indeed, the phosphorylation of CK2α was originally observed in cells treated with the 
mitotic spindle poison nocodazole (19), and work in this thesis demonstrates that CK2α 
phosphorylation is dramatically increased in cells with an activated SAC compared to 
normal mitotic cells, also consistent with a role for CK2 in the SAC. Activation of the 
SAC inhibits the activity of the Anaphase Promoting Complex /Cyclosome (APC/C), a 
ubiquitin ligase that promotes progression from metaphase to anaphase through the 
ubiquitination and targeted degradation of several key mitotic proteins, including Cyclin 
B (29). Inhibition of Cyclin B degradation results in prolonged activation of Cdk1, which 
would in turn increase the ratio of phosphorylated CK2α to unphosphorylated CK2α in 
the mitotic cell. This may lead to increased CK2 localization to the mitotic spindle 
(Figure 5.1). The effects of this increase in phosphorylated CK2α remain unelucidated, 
but if CK2 is indeed a component of SAC signalling, this would form a positive feedback 
loop, possibly maintaining cell cycle arrest until the spindle defect has been repaired.  
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 Expression of CK2α phosphomimetic mutants caused more severe mitotic defects, 
but did not cause the SAC defect observed in cells expressing nonphosphorylatable 
CK2α. Intriguingly, this difference in phenotype occurs despite the observation that 
neither form can properly localize to the mitotic spindle. In fact, the lack of spindle 
localization, despite the presence of negative charges to mimic the phosphorylation sites, 
is easily explained by the fact that Pin1, which we found to be required for CK2α 
localization, has a much higher affinity for phosphoserine and phosphothreonine than 
aspartic acid or glutamic acid (52), and has been demonstrated to be incapable of binding 
to phosphomimetic CK2α (27). However, one would expect that lack of phosphomimetic 
CK2α on the spindle would lead to the same SAC defect, and this was not observed. It is 
possible that the more dramatic phenotypes observed upon phosphomimetic CK2α 
expression are dominant negative effects, as the centrosomal defects these cells display 
would most certainly warrant an activated SAC. It seems that the response of these cells 
is to bypass the SAC entirely and instead induce mitotic catastrophe, a form of apoptosis 
during mitosis that is believed to be induced in situations where continuing cell division 
would risk aneuploidy in the daughter cells (4). While the cellular signalling pathways 
involved in the induction and execution of mitotic catastrophe have not yet been 
delineated, it is likely that CK2 could play a role, given the mounting evidence that CK2 
is an important regulator of apoptotic signalling. Overexpression of CK2 protects cells 
from drug-induced apoptosis (7, 12), and inhibition of CK2 sensitizes cancer cells to both  
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Figure 5.1 
 
Figure 5.1 Model of the effects of spindle assembly checkpoint on the regulation of CK2. 
During metaphase, chromosomes attach to the microtubules of the mitotic spindle 
through a multiprotein complex called the kinetochore. The kinetochore also contains the 
components of the SAC, which monitors chromosome attachment. In the event of an 
unattached kinetochore, the SAC is activated, and the Mitotic Checkpoint Complex 
(MCC), composed of Mad2, BubR1, and Bub3, binds to Cdc20, a cofactor of the 
Anaphase Promoting Complex/Cyclosome (APC/C). Binding to Cdc20 inhibits activation 
of the APC/C, a ubiquitin ligase that targets Cyclin B for degradation by the 26S 
proteasome, enabling progression into anaphase. Inhibition of the APC/C by the SAC 
therefore leads to increased Cdk1 activation, which results in maximal CK2 
phosphorylation and localization to the mitotic spindle. P, phosphorylated residue; Ub, 
ubiquitin.  
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receptor-mediated apoptosis (14, 15) and intracellular apoptosis in response to DNA 
damage (53, 54). CK2 phosphorylates a number of apoptotic regulatory proteins through 
a mechanism that, like hierarchical phosphorylation, exploits the unique consensus 
determinants of CK2 in order to affect widespread regulation of a biological process. In 
this case, the similarities between the acidic consensus requirements of CK2 and caspase 
cleavage motifs, which centre on an acidic aspartic acid residue, allows CK2 to 
phosphorylate residues within or near a caspase cleavage motif (18), blocking the access 
of the caspase to its substrate and protecting the substrate from cleavage (47). CK2 also 
directly regulates several caspases through phosphorylation, including caspase 9 (26) and 
caspase 3 (8).  Furthermore, caspase 2, which is believed to be instrumental for induction 
of mitotic catastrophe (4), is also a CK2 substrate. Phosphorylation of caspase 2 by CK2 
inhibits its ability to dimerize, thereby preventing its activation through autoproteolysis 
(44).  
 As mentioned above, the mitotic catastrophe observed in cells expressing 
phosphomimetic CK2α is correlated with centrosomal defects, suggesting that CK2 may 
play a role in the maintenance of centrosomal integrity. The centrosomes, which act as 
the microtubule organizing centres of mammalian cells, are replicated during S phase 
along with the chromosomes, and undergo several maturation stages before migrating to 
opposite poles of the cell to promote the formation of a bipolar mitotic spindle (6). 
Notably, CK2 localizes to the centrosomes (16), and proteomic investigation has 
confirmed that CK2 is a indeed a component of the centrosome (1). Additionally, the 
results of our peptide match search for proteins containing proline-directed sites for CK2 
hierarchical phosphorylation were greatly enriched for centrosomal proteins, suggesting 
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that several novel centrosomal substrates of CK2 may exist. Intriguingly, both of the 
mitotic regulatory proteins known to bind specifically to phosphorylated CK2α, Plk1 and 
Pin1, have important regulatory roles in centrosome maturation and microtubule 
nucleation. Plk1 is a major regulator of centrosome maturation during prophase (6), and 
is required for proper bipolar spindle formation (48). Overexpression of Plk1 leads to 
centrosomal amplification (17), and conversely inhibition of Plk1 leads to monopolar 
spindles (10). Pin1 localizes to the centrosomes, and like Plk1 its overexpression causes 
centrosomal amplification (46). Interestingly, we observed that in cells with stable 
knockdown of Pin1, the centrosomes fail to separate; leading to monopolar spindles (see 
Figure 3.5, panel C). While this does not necessarily implicate CK2 in the effect, 
phosphorylated CK2α does not localize to the mitotic spindle in these cells, suggesting 
that the phenotype may be linked to lack of CK2 activity at the centrosomes. Not only do 
both enzymes bind the phosphorylated CK2α C-terminus, but Pin1 and Plk1 also interact 
directly in mitotic cells (43). Additionally, Plk1 participates in hierarchical 
phosphorylation with CK2 and Cdk1 (49), and Pin1 targets the proline-directed 
phosphorylation sites catalyzed by Cdk1 (52). The intricate interplay between these four 
important mitotic enzymes suggests the possibility of multienzyme complexes that could 
be targeted towards different functions. The presence of Pin1 in these complexes may 
play a role in enabling hierarchical phosphorylation between the three kinases, as prolyl 
isomerization of Cdk-phosphorylated sequences to the cis form renders the site resistant 
to dephosphorylation (45), potentially prolonging the phosphorylation at the site and 
enabling its use as a phosphodeterminant. Clearly, much more work is needed to 
delineate the roles of CK2 in mitosis, but the various phenotypes observed upon 
199 
 
disruption of mitotic phosphorylation of CK2α clearly indicate that CK2 is crucial for 
mitotic progression, and is potentially involved in multiple pathways ensuring proper cell 
division. 
 The fact that all of the phenotypes observed in cells expressing phosphorylation-
site mutants of CK2α occurred without any obvious defects in kinase activity corresponds 
well with our later discovery that phosphorylation of CK2 modulates its localization to 
the mitotic spindle. Localization would regulate CK2 through targeting it towards certain 
mitotic substrates (and possibly also away from non-mitotic substrates), not through 
direct inhibition of CK2 kinase activity. Interestingly, our work in Chapter 4 on 
hierarchical phosphorylation by CK2 yielded an extensive list of potential CK2 substrates 
associated with the mitotic spindle, adding further evidence for an important role for CK2 
at the mitotic spindle. 
5.3 Regulation of CK2 through hierarchical phosphorylation 
 In an effort to understand how CK2 can be essentially constitutively active, and 
yet participate in multiple highly regulated processes, we chose to investigate whether 
interplay with other protein kinases could contribute to CK2 regulation. Given that most 
proteins are phosphorylated at multiple sites (33), and that an estimated 20% of the 
phosphoproteome can be attributed to CK2 alone (38), the interplay between CK2 and 
other kinases could have a substantial impact on the topology of the phosphoproteome. 
This may be particularly important during mitosis, when the majority of phosphorylation 
events depend, at least indirectly, on the activation of the mitotic master regulatory 
kinase, Cdk1 (34).  Indeed, Wee1A represents a published example of hierarchical 
phosphorylation between Cdk1 and CK2 during mitosis (49). We therefore hypothesized 
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that hierarchical phosphorylation by Cdk1 and CK2 may be a widespread phenomenon 
during mitosis. An intriguing aspect of this idea is that in these cases, CK2 would 
essentially be under the same regulation of the priming kinase, in this case Cdk1, and this 
may explain how CK2 is targeted toward mitotic substrates. 
5.3.1 Structural comparison of canonical and primed phosphorylation 
by CK2 
 CK2 is one of very few protein kinases that can utilize previously phosphorylated 
residues as consensus determinants to phosphorylate adjacent serine residues. However, 
this aspect of CK2 activity has not been systematically investigated. Accordingly, we 
performed a detailed investigation of the optimal consensus sequence for primed 
phosphorylation by CK2. This work found that, for the most part, primed 
phosphorylation requires similar consensus determinants as canonical phosphorylation, as 
positive determinants at the +1 and +3 positions relative to the phosphoacceptor site were 
particularly favourable, and multiple phosphoserine residues were optimal for efficient 
phosphorylation. However, we also observed some subtle differences, such as increased 
sensitivity to determinants in the +2 position, and an apparent increased reliance of 
optimal spacing for primed phosphorylation compared to canonical phosphorylation. 
Based on our knowledge of the mechanism by which CK2 binds its substrates, it is 
conceivable that these subtle differences are due to the increased negativity of 
phosphoserine, which is dianionic at physiological pH. While to date no structure of CK2 
in complex with a peptide substrate has been solved, mutational studies have shown that 
coordination of a substrate in the CK2 catalytic cleft requires the concerted actions of 
three distinct basic regions in the sequence of the CK2 catalytic subunits (39, 40).  These 
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basic residues are responsible for the proper coordination of acidic determinants on the 
substrate in the active site, allowing optimal positioning of the phosphoacceptor site for 
CK2 phosphorylation, and provide an explanation for the acidophilic nature of CK2. 
Additionally, the three groups of basic residues are responsible for the coordination of 
distinct determinants, with R191, R195, and K198 responsible for recognition of 
determinants at the +1 position, K79, R80 and K83 coordinating the +3 determinant, and 
K74-77 coordinating determinants at the +4 and +5 positions, as well as aiding in 
coordinating the +3 determinant (40). Therefore, CK2 consensus determinants are often 
found at these specific positions, even in canonical phosphorylation. This model of 
substrate binding is supported by a recently solved crystal structure of CK2α with two 
sulphate ions coordinated in the positions of the +1 and +3 determinants (30). However, 
binding of CK2 substrates in the catalytic cleft is flexible, as mutation of substrate 
determinants at the +1 and +3 positions can increase the importance of additional 
determinants at suboptimal positions (39, 40), indicating that to some extent, CK2 
substrates can shift their positions in the binding pocket to optimally orient their 
phosphoacceptor residue, allowing suboptimal consensus sequences to be 
phosphorylated. However, while this seems to be the case for canonical substrates, the 
increased acidity of phosphoserine may restrict the flexibility of the binding cleft, and 
this may explain why optimal positioning of residues, particularly at the +1 and +3 
positions, seems to be much more crucial for primed phosphorylation compared to 
canonical phosphorylation. Additionally, the increased sensitivity towards substrates with 
phosphoserine at the +2 position may also be explained by the increased negativity of 
primed substrates. The basic residues that accommodate acidic residues at the +1 and +3 
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positions could easily accommodate the dianionic phosphoserine in primed sequences (as 
they do the sulphate ions in the aforementioned CK2α crystal structure), as multiple 
positively charged residues exist at each site. However, the presence of an additional 
dianionic phosphoserine directly in between these sites may interfere with proper 
interactions between the +1 and +3 phosphoserines and their respective binding sites, 
inhibiting CK2 phosphorylation.  It is intriguing to speculate that this would lead to 
increased specificity for primed phosphorylation compared to canonical phosphorylation, 
ensuring that primed phosphorylation by CK2 occurs only at specific sites. 
5.3.2 CK2 hierarchical phosphorylation in mitosis 
 Since this study concerned the regulatory forces acting on CK2 during mitosis, we 
were particularly interested in determining the optimal consensus sequence for potential 
hierarchical phosphorylation events involving CK2 and the master mitotic regulatory 
kinase, Cdk1. Using the hierarchical phosphorylation of Wee1 as an example, we first 
attempted to investigate the optimal consensus sequence for direct primed 
phosphorylation events between Cdk1 and CK2, with the Cdk1 site at the +3 position 
relative to the CK2 phosphoacceptor sites. However, while several mitotic proteins 
contain these motifs, our results showed that these sequences were unsuitable for 
Cdk1/CK2 hierarchical phosphorylation. One reason for this is the presence of only a 
single phosphorylated residue at these sites, and the other is that presence of a Cdk1 
consensus sequence was inhibitory when situated so close to the CK2 phosphoacceptor 
site. We next investigated whether phosphorylation of a Cdk1 site could synergize with 
weak CK2 canonical determinants to form novel sites for CK2 phosphorylation, and the 
results were striking, with a Cdk1 phosphoserine at the +5 position relative to the CK2 
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site enabling a dramatic increase in CK2 phosphorylation. This result suggests that there 
may be an entirely new list of potential substrates for CK2 among proteins with weak 
CK2 determinants adjacent to phosphorylation events catalyzed by other kinases. 
Strikingly, these sites would not be subjected to the constitutive activity displayed by 
CK2 towards the majority of its canonical substrates, but instead would be under the 
same regulatory constraints as the priming kinase. GO analysis of the results of our 
peptide match search showed that proteins containing sequences matching this pattern are 
highly enriched among centrosomal and mitotic spindle components, as well as several 
mitotic spindle regulatory proteins, including components of the SAC.  These results 
indicate that phosphorylation of these ‘conditional’ CK2 substrates has the potential to 
dramatically affect the regulation of the mitotic spindle; consistent with our model that 
CK2α phosphorylation leads to its localization to the mitotic spindle, enabling 
phosphorylation of specific mitotic spindle substrates. The possibility of hierarchical 
phosphorylation of mitotic spindle substrates suggests that even once CK2 has localized 
to the mitotic spindle, additional regulatory forces (the activation states of priming 
kinases) ensure that CK2 phosphorylates its substrates with temporal precision 
throughout mitotic progression. While we examined interplay between Cdk1 and CK2, it 
is also possible that Plk1 phosphorylation could form novel CK2 sites, or lead to 
increased phosphorylation at existing CK2 sites. This is possible because the consensus 
determinants for Plk1 phosphorylation somewhat mirror the CK2 consensus 
determinants, requiring acidic residues N-terminal to the phosphoacceptor site (28). In 
this respect, for a CK2 site and a Plk1 site with shared acidic determinants, 
phosphorylation of the Plk1 site could increase the total acidity of the sequence, 
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promoting CK2 phosphorylation (Figure 5.2A).   Plk1 is highly regulated throughout 
mitotic progression, and displays dynamic localization, localizing to the centrosomes 
during prophase, the kinetochores at the metaphase–anaphase transition, and the spindle 
midbody during cytokinesis (36). Consequently, the dynamic localization of Plk1 could 
temporally control CK2 phosphorylation at each of these sites. In fact, as some Plk1 
sequences contain a proline following the acceptor site (28), it is likely that some of our 
peptide match results could represent Plk1/CK2 hierarchical phosphorylation events. It is 
also worth noting that acidophilic serine/threonine kinases like CK2 and Plk1 are rare in 
the human kinome, as the vast majority of human S/T kinases are basophilic (28), and 
therefore not amenable to participation in hierarchical phosphorylation with CK2. For 
example, the other main kinase family acting during mitosis, the Aurora kinases, are 
unlikely to prime substrates for CK2 phosphorylation, as the consensus requirements for 
these basophilic kinases would impede CK2 phosphorylation of nearby sequences (X-R-
X-S for Aurora A; R-R-R-R-S for Auroras B and C) (28) (Figure 5.2B). This suggests 
that CK2 hierarchical phosphorylation may have evolved to allow interplay with only 
certain kinases.  
5.3.3 Hierarchical phosphorylation as a signalling module 
 Our work on hierarchical phosphorylation also highlights the fact that as much as 
we know about individual phosphorylation events and their functional effects, a full 
understanding of the impact of phosphorylation on a given protein is impossible until we 
can identify the full complement of phosphorylation sites, the temporal regulation of the 
sites, and the interplay between them. Hierarchical phosphorylation is just one example  
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Figure 5.2 
 
 
Figure 5.2 Potential for CK2 to participate in hierarchical phosphorylation with other 
major mitotic regulatory kinases. Based on the consensus determinants for 
phosphorylation by Plk1 (A) and Aurora kinases (B), Plk1 phosphorylation sites are 
favourable as sites for primed CK2 phosphorylation, as the Plk1 site could synergize with 
shared acidic determinants to either form a novel CK2 site or increase phosphorylation at 
an existing site. In contrast, Aurora kinases depend on N-terminal basic determinants to 
recognize and phosphorylate substrates, and these basic residues will inhibit CK2 
phosphorylation of nearby phosphoacceptor sites. A single phosphorylated CK2α subunit 
is shown for simplicity. P, Phosphate.  
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of this interplay, and the first systematic study of the phenomenon is contained in this 
thesis. Ongoing efforts to compile accessible databases of in vivo phosphorylation sites 
will undoubtedly lead to increased understanding of the integration of various signals and 
pathways in the cell. In fact, analysis of existing phosphoproteomic data reveals that 
multisite phosphorylation is widespread in the human proteome. For example, in a study 
of 70,000 reported in vivo phosphorylation sites, a striking 54% of phosphoserine and 
phosphothreonine residues in the human phosphoproteome were found to be no farther 
than four amino acids away from another phosphoserine or phosphothreonine (41). An 
independent study of known phosphorylation sites in both mice and humans revealed a 
similar overabundance of phosphorylation sites that not only clustered into specific 
regions of substrates, but also seemed to be activated simultaneously (51). This clustering 
of sites indicates that the impact of processive and hierarchical phosphorylation on 
cellular signalling may be extensive, and potentially adds considerably to the already long 
list of potential CK2 substrates. The extreme clustering of phosphorylation sites observed 
in the phosphoproteome had led to the notion that combinations of phosphorylation sites 
may collectively act as higher order ‘modules’ that act as one to elicit a certain biological 
response (51). Mathematically, this idea has merit. A protein phosphorylated at N sites 
will exist in 2N different phosphorylation states. For a protein with two phosphorylation 
sites, this equates to 22, or 4, different states, and it is entirely conceivable that these four 
states could all have distinct cellular functions. However, if each phosphorylation site on 
a protein elicited an independent functional response, a protein with 10 phosphorylation 
sites would exist in 210, or 1024 different phosphorylation states. It is highly unlikely that 
each of these states would be relevant biologically (37). Given the clustering of 
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phosphorylation sites and the apparent widespread use of hierarchical phosphorylation in 
the phosphoproteome, it is likely that a protein with 10 phosphorylation sites would in 
actuality have considerably less than 1024 different phosphorylation states. In this light, 
individual phosphorylation sites can be thought of as essentially building blocks, which 
together form various modules that can elicit different cellular responses. The functional 
effects of these modules may depend on the extent of phosphorylation within the region, 
as well as the pattern of the phosphorylation sites (37).   Adding additional complexity, 
the interplay between phosphorylation sites and sites of other post-translational 
modifications, such as acetylation or SUMOylation, has not yet been systematically 
identified. Also important to delineate are the protein-protein interactions resulting from 
the modification of specific sites, including those involving the modular phospho-binding 
domains found in a multitude of signalling proteins. For example, in the Wee1 study that 
prompted our investigation, Cdk1 phosphorylation of serine 123 not only allows CK2 
phosphorylation of serine 121, it also forms a docking site for the PBD of Plk1, resulting 
in phosphorylation of serine 53 by Plk1 (49). Clearly, the cataloguing of all 
posttranslational modifications and their interrelated effects on protein function 
represents a phenomenal amount of work, but only with a fully integrated knowledge of 
all the forces acting on a given protein following a given stimulus can we begin to fully 
understand the cellular functions of that protein. Our work outlining how CK2 uses 
phosphoserine as a determinant for phosphorylation will be vital to understanding how 
CK2 contributes to hierarchical phosphorylation in the cell.   
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5.4 Mechanisms for regulating CK2 activity in mitosis 
 The purpose of the work contained in this thesis was to gain a better 
understanding of the subtle regulatory forces acting on CK2 during mitosis. The presence 
of four mitotic phosphorylation sites on CK2α were our first indication that CK2, while 
constitutively active and involved in a myriad of cellular processes, may be differentially 
regulated during mitosis, enabling it to perform specific roles unique to mitosis. Indeed, 
these phosphorylation sites are merely the first step in the process of subverting a subset 
of cellular CK2 in order to enable cell division. Results in this thesis demonstrate that, 
once activated at the G2/M transition, Cdk1 phosphorylates a small fraction of the total 
CK2α in the cell. Phosphorylation leads to the formation of a phosphodependent binding 
site for Pin1, a peptidyl-prolyl isomerase, and this interaction is required for localization 
of CK2 to the mitotic spindle. The role of this localization is presumably to position CK2 
in the vicinity of specific mitotic substrates associated with the spindle. Along with 
possible canonical CK2 substrates associated with the mitotic spindle, this also places 
CK2 in the proximity of numerous Cdk1 substrates, and the phosphorylation status of 
these Cdk1 sites may influence the ability of CK2 to phosphorylate upstream sites 
(Figure 5.3). The subtle, multifaceted regulation of a small fraction of cellular CK2α 
appears to be sufficient for mitotic progression, but in the event of a spindle insult, 
activation of the SAC leads to an increase in CK2 phosphorylation, recruiting additional 
CK2 molecules to the mitotic spindle. Collectively, these mechanisms act in concert to 
allow CK2 to fulfill its mitotic functions. 
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Figure 5.3 
 
Figure 5.3 Mechanisms of regulating CK2 in mitotic cell division. As Cdk1 is activated 
at the G2/M transition, it phosphorylates a portion of the cellular CK2, on both the CK2α 
and CK2β subunits. The CK2α’ subunit is not phosphorylated by Cdk1. Phosphorylation 
of CK2α forms binding sites for both Pin1 and Plk1. The role of the Plk1 interaction is 
unknown, but the interaction with Pin1 results in the localization of phosphorylated CK2 
to the mitotic spindle, where it is presumably targeted towards canonical mitotic spindle 
substrates. Additionally, it is possible that hierarchical phosphorylation involving Cdk1 
and CK2 can contribute to the regulation of CK2 activity for certain mitotic spindle 
substrates, particularly at the centrosomes and kinetochores.  
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5.5 Future Directions 
5.5.1 CK2 mitotic pathway determination  
 The work in this thesis has outlined the subtle regulatory forces acting on CK2 
during mitosis, but the precise roles CK2 plays in mitotic signalling pathways have yet to 
be determined. As the results in Chapter 4 indicate that several mitotic proteins are 
potential substrates for Cdk1/CK2 hierarchical phosphorylation, testing and validation of 
these substrates may provide a wealth of new insights into the role of CK2 in mitosis. 
The first step in the validation of these potential substrates would be to generate a peptide 
array containing the putative consensus sequences from potential mitotic Cdk1/CK2 
substrates. As these sequences contain canonical CK2 determinants as well, to compare 
the relative contributions of the acidic and phosphorylated determinants two peptides 
could be generated for each sequence, one with serine at the proline-directed site, and 
another with phosphoserine. The peptide array would be incubated with CK2 and [γ-32P]-
ATP to measure the relative phosphorylation of each peptide. The unphosphorylated 
peptides could also be incubated with Cdk1 and [γ-32P]-ATP to test the specificity of the 
proline-directed phosphorylation site. Additionally, the unphosphorylated peptides would 
allow sequential phosphorylation assays, first with Cdk1 and cold ATP, and then with 
CK2 and [γ-32P]-ATP. By comparing this array to the array incubated with CK2 alone, 
we could determine the ability of Cdk1 and CK2 to sequentially phosphorylate each 
peptide. The results of the peptide array experiments would provide an indication of how 
widespread the effects of hierarchical phosphorylation may be, and more importantly, 
which substrates may be promising candidates for further study. Promising candidates 
would next be tested for hierarchical phosphorylation in vitro using full length 
211 
 
recombinant proteins, using the same general method as for the peptide arrays. These in 
vitro assays will provide further evidence that these sites represent potential physiological 
substrates, as a positive result with a peptide substrate, while encouraging, does not 
reflect the natural environment of the amino acid sequence, which could be buried within 
a folded protein and therefore inaccessible for phosphorylation. To test the cell cycle 
specificity of phosphorylation, recombinant substrates could also be incubated with 
lysates from interphase and mitotic cells and assayed for phosphorylation. Candidate 
substrates that are phosphorylated in vitro could then be investigated in human cells. To 
test the sites for mitotic phosphorylation, affinity-tagged exogenous proteins would be 
transfected into cells, and cells would be arrested in mitosis. Upon lysis, the exogenous 
protein could be immunoprecipitated using the affinity tag, and in vivo phosphorylation 
sites could be identified by mass spectrometry. Phosphorylation-site mutants of candidate 
substrates could also be expressed in cells to assess the effects of disruption of the sites 
on mitosis. Mutant forms would include a nonphosphorylatable mutant with alanine 
residues replacing both sites, a phosphomimetic mutant with aspartic acid residues at both 
sites, as well as single mutations to both alanine and aspartic acid, which would 
effectively uncouple the two phosphorylation sites. In particular, a mutant protein with a 
serine at the CK2 site and an aspartic acid at the Cdk1 site could illuminate the 
consequences of loss of regulation at these sites, as CK2 could presumably phosphorylate 
the mutant protein regardless of Cdk1 activation. Since the mitotic peptide match results 
in Chapter 4 were highly enriched for mitotic spindle components, cells expressing 
phosphorylation-site mutants of candidate substrates would be assayed for mitotic spindle 
defects through immunofluorescence and fluorescent microscopy, and for SAC defects 
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through cell cycle analysis using flow cytometry, as in our study of CK2α 
phosphorylation-site mutants presented in Chapter 2.  These studies would be 
complemented with rescue experiments, in which the endogenous candidate protein 
would be depleted using RNA interference (RNAi), and the phosphorylation-site mutants 
would be assayed for the ability to maintain normal protein function in cells.  
 In addition to possible mitotic substrates for Cdk1/CK2 hierarchical 
phosphorylation, identification of canonical mitotic substrates of CK2 would be useful in 
identifying the precise roles of CK2 during mitosis. To identify these substrates, one 
approach could be the utilization of CK2 gatekeeper mutants. Chemical genetics studies 
have demonstrated that when a single hydrophobic residue in the ATP binding pocket of 
a kinase, termed the ‘gatekeeper’ residue, is mutated to a smaller amino acid (glycine or 
alanine), a hydrophobic pocket into the ATP binding site forms (20, 42). Bulky ATP-
derivatives that normally cannot fit in the ATP binding pocket are accommodated by the 
hydrophobic pocket, allowing specific detection of phosphorylation by the kinase of 
interest in the absence of contaminating signals. Gatekeeper mutants have been generated 
for several protein kinases, leading to the identification of both known and novel 
substrates (9). Generation and characterization of CK2 gatekeeper mutants is an area of 
ongoing investigation in our laboratory, and if a suitable CK2 gatekeeper mutant and 
ATP derivative are identified, they could be used to identify novel mitotic substrates of 
CK2, though the incubation of mitotic lysates with the CK2 gatekeeper mutant and ATP-
derivative. To isolate and identify phosphorylated peptides, an ATP derivative with a γ-
thiophosphate would be used, to facilitate purification of phosphopeptides using 
iodoacetamide beads as in Figure 5.4. This ‘Capture and Release’ approach has been used  
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Figure 5.4 
 
 
Figure 5.4 A ‘capture and release’ strategy to identify mitotic spindle substrates of CK2. 
Mitotic spindles can be isolated from Taxol-stabilized metaphase cells. If desired, the 
spindles could then be dephosphorylated with lambda phosphatase (λ-PPase) to strip 
them of in vivo phosphorylation sites. The isolated spindles would then be incubated with 
a CK2 gatekeeper mutant (GK-CK2) and an ATP derivative containing a terminal 
thiophosphate. After digestion to peptides, thiophoshorylated peptides would bind 
covalently to iodoacetamide beads, and non-thiophosphorylated peptides would be 
washed away. Phosphopeptides would then be eluted from the iodoacetamide by 
hydrolysis, and identified by mass spectrometry.  
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successfully to identify both previously known and novel mitotic substrates of Cdk1 (3). 
To specifically identify CK2 substrates on the mitotic spindle, this approach could be 
combined with the mitotic spindle isolation used in Chapter 3. 
 CK2 gatekeeper mutants would also allow assessment of the impact of 
hierarchical signalling using both Cdk1 and CK2 at the same time, which would better 
mimic the in vivo conditions. By incubating the candidate protein with wild-type Cdk1 
and [γ-32P]-ATP along with a gatekeeper mutant of CK2 and a [γ-35S]-ATP derivative, 
we would be able to assess the phosphorylation of a potential substrate for hierarchical 
phosphorylation and be able to distinguish Cdk1 phosphorylation from CK2 
phosphorylation.  
 Equally important to identifying mitotic substrates of CK2 will be identification 
of mitotic protein complexes including CK2, particularly those mediated via the CK2α C-
terminal phosphorylation sites. Thus far, only two direct interactors of the CK2α have 
been identified, and identification of higher order complexes could supply great insight  
on both the roles of CK2 in mitosis as well as additional regulatory forces influencing 
CK2 activity. A proteomic approach coupling large-scale isolation of complexes with 
identification of components through high throughput mass spectrometry could be useful 
in the identification of complexes involving phosphorylated CK2α. To identify direct 
interactors of the CK2α C-terminus, an in vitro GST pulldown approach could be 
utilized. Indeed, both the known interactions with the CK2α C-terminus, namely Pin1 and 
the PBD of Plk1, were identified through GST pulldowns (22, 27). To specifically 
identify proteins interacting with the CK2α C-terminus, truncated C-terminal fragments 
like those used in Chapter 3 could be used in these studies. To identify phosphospecific 
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interactions with the CK2α C-terminus, it would be necessary to first phosphorylate 
CK2α, and this can be readily accomplished through incubation of CK2 with purified 
active Cdk1 (19, 27). Phosphodependency of interactions could be tested by comparing 
the interaction profiles of CK2α in the presence or absence of Cdk1. 
 To potentially identify larger protein complexes that may be associated with CK2 
in a mitotic context, affinity purification of CK2 from mitotic cells could be coupled to 
mass spectrometric analysis. Our laboratory has developed several stable cell lines 
expressing CK2 with various epitope tags (HA, Myc, TAP) that could be used in this 
regard. After expressing the exogenous version in cells, the cells would be arrested in 
mitosis using nocodazole, and CK2 would be purified from the mitotic lysates using 
antibodies against the attached affinity tag. After digestion to peptides and 
chromatographic separation, all interacting proteins copurifying with CK2 could be 
identified. By comparing the composition of the CK2 interactome under different 
conditions, for example through synchronizing cells at different stages of the cell cycle, 
the specific complexes important to the various stages of the cell cycle could be identified 
and studied in detail. To specifically investigate possible protein complexes involving its 
C-terminal phosphorylation sites, phosphorylation-site mutants of CK2α could be 
included in the study, and phosphodependent interactions identified by comparing the 
interaction profiles of the phosphorylation mutants to those of unphosphorylated and 
phosphorylated CK2α.  Comprehensive knowledge of the various complexes involving 
CK2 will provide insight into the roles of CK2, as well as how it may be regulated in 
various cellular processes.  
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5.5.2 CK2β phosphorylation in mitosis 
 One aspect of CK2 signalling during mitosis was not examined during the course 
of these studies, namely the mitotic phosphorylation of the regulatory subunit, CK2β. 
Interestingly, CK2β is also phosphorylated by Cdk1, and therefore its phosphorylation 
would presumably be temporally regulated similarly to CK2α. However, the function of 
this phosphorylation event remains unknown. It is possible that the phosphorylated CK2β 
may act in concert with phosphorylated CK2α to aid in the mitotic localization of CK2 to 
the mitotic spindle. Additionally, the CK2β phosphorylation site may serve as a binding 
site for additional mitotic interactions with CK2.  
 Interestingly, while CK2β is best known as a component of the CK2 holoenzyme, 
it can associate with other kinases independently of the CK2 catalytic subunits, including 
c-Mos (5), A-Raf (13), Chk1 (11), and Wee1 (31, 32). It is intriguing to speculate that the 
mitotic phosphorylation of CK2β may somehow mediate its interactions with these 
kinases. Indeed, binding to c-Mos, A-Raf, and Chk1 is mediated through the CK2β C-
terminus (2), in an area close to its Cdk1 phosphorylation site. Interestingly, interaction 
of Chk1 with CK2β results in increased Chk1-catalyzed phosphorylation of Cdc25C, an 
important mitotic phosphatase that is responsible for activation of Cdk1(11). Conversely, 
the Wee1-CK2β interaction results in inhibition of Wee1 phosphorylation of Cdk1 (31). 
While CK2β interactions increase Chk1 activity and decrease Wee1 activity, the end 
result is the same: increased activation of Cdk1, leading to mitotic entry (55). If Cdk1 
phosphorylation of CK2β does impact CK2β binding to Wee1 and Chk1, this would 
represent an additional positive feedback loop, maximizing Cdk1 activation to ensure 
entry into mitosis. 
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5.5.3 CK2α/α’ chimeric mice 
 An interesting aspect of this work is that the differential regulation of CK2α and 
CK2α’ during mitosis is one of very few examples of functional divergence between the 
two catalytic isoforms of CK2. In fact, of the hundreds of known CK2 substrates, very 
few show a preference for either catalytic subunit, and very few interacting proteins 
discriminate between the two forms (18). In yeast, deletion of either catalytic isoform 
does not affect survival, with deletion of both Cka1 and Cka2 required for loss of 
viability (35). However, while CK2α’ knockout mice are viable, albeit with defects in 
spermatogenesis (50), CK2α knockout mice undergo embryonic lethality at day 10.5, 
displaying a host of developmental defects, including severe defects in both neural tube 
and cardiac development (21). This indicates that in mammalian cells, CK2α has at least 
one additional and crucial function that cannot be performed by CK2α’. The fact that 
CK2α and CK2α’ share over 90% similarity over most of their sequences, yet have 
completely divergent C-termini (23), suggests that the difference in viability seen in these 
mice may be due to the presence of the unique CK2α C-terminal domain. While 
completely different from the shorter C-terminal domain of CK2α’, the CK2α C-terminal 
domain is highly conserved among birds and mammals, including retention of the four 
mitotic phosphorylation sites (23, 25). In the course of studying the mitotic localization 
of phosphorylated CK2α, we found that the C-terminus of CK2α when phosphorylated 
can localize to the mitotic spindle even in the absence of the remainder of the protein. 
Additionally, while CK2α’ showed only minimal spindle localization, a chimeric protein 
with the CK2α C-terminal domain fused to the conserved portion of CK2α’ showed 
similar levels of spindle localization as CK2α. To determine if the C-terminal domain of 
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CK2α is the crucial element required for viability, transgenic mice expressing chimeric 
versions of CK2 (CK2α/α’, CK2α’/α) could be generated. By comparing these mice to 
the CK2α and CK2α’ knockout mice, the true impact of the CK2α C-terminus on 
mammalian life could be elucidated. 
5.5.4 CK2 hierarchical phosphorylation in signal transduction 
 While we set out to determine if Cdk1/CK2 hierarchical phosphorylation can 
contribute to mitotic signalling, the results of our peptide match search and GO analysis 
indicate that hierarchical phosphorylation between CK2 and proline-directed kinases can 
also potentially occur in other pathways, and provide several new avenues for study. In 
particular, the enrichment of both positive and negative regulators of transcription 
suggests that hierarchical phosphorylation may significantly affect gene expression.  To 
investigate the effects of hierarchical phosphorylation between CK2 and the various Cdks 
involved in transcriptional regulation, the approach outlined in section 5.5.1 could be 
easily adapted.  
 Additionally, our results on the optimal spacing and number of multiple 
phosphoserines as phosphodeterminants will be valuable in recognizing possible 
substrates for non-proline directed hierarchical signalling events involving CK2. Judging 
by the results of our study, potential substrates for primed phosphorylation would not 
only require multiple phosphodeterminants, but also the correct spacing of the 
phosphorylated residues. To search the genome for these types of events, a peptide match 
search for serine-rich regions could be coupled to searches of various phosphorylation 
site databases, to identify sequences with known phosphorylation sites in the correct 
quantity and positioning. Validation of potential substrates could then be carried out as in 
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section 5.5.1. Given the widespread existence of hyperphosphorylated regions in the 
human phosphoproteome (37, 51), identification of new substrates regulated in this 
manner would certainly provide insight into the various roles of CK2 in cellular life.  
5.6 Perspectives  
 Protein phosphorylation regulates every aspect of cellular signalling, yet in many 
cases the regulatory forces controlling phosphorylation events remain poorly understood. 
In this thesis, we examined the subtle regulatory mechanisms that enable protein kinase 
CK2, a constitutively active kinase, to perform regulated functions specific to cell 
division.  
 Our study initially focused on four mitotic phosphorylation sites on the unique C-
terminus of CK2α. These phosphorylation sites had only been shown in cells arrested in 
mitosis with the mitotic spindle poison nocodazole, and the generation of 
phosphospecific antibodies allowed us to examine CK2α phosphorylation in normally 
progressing mitotic cells for the first time. Our results show that CK2α is phosphorylated 
in mitosis during prophase and metaphase, consistent with the notion that Cdk1 is the 
kinase responsible. Expression of CK2α phosphorylation-site mutants in human cells lead 
to multiple defects in mitosis, including centrosomal amplification, induction of mitotic 
catastrophe, and abrogation of the SAC. These severe defects demonstrate that CK2 has 
important roles in mitotic progression, and that proper phosphorylation of CK2α is 
crucial for the proper execution of these roles. 
 Since the CK2α phosphorylation sites proved vital for mitotic progression, we 
hypothesized that phosphorylation of these sites may serve to regulate CK2 activity, and 
set out to determine the mechanism of this regulation. Since phosphorylation of the CK2α 
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C-terminal domain does not directly affect CK2 kinase activity, we used the 
phosphospecific antibodies to examine whether phosphorylation had any effect on CK2 
localization. Strikingly, we found that phosphorylated, but not unphosphorylated, CK2α 
localizes to the mitotic spindle. In addition, we found that localization of phosphorylated 
CK2α to the mitotic spindle requires the presence of a known phosphodependent 
interactor of the CK2α C-terminus, the peptidyl prolyl isomerase Pin1. This is the first 
example of Pin1 acting to localize an interaction partner to the mitotic spindle, and while 
we were unable to determine if Pin1 actually isomerizes the CK2α phosphorylation sites, 
we also demonstrated that Pin1 itself localizes to the mitotic spindle, suggesting that Pin1 
and CK2α may localize to the mitotic spindle as a complex.  
 Localization of phosphorylated CK2α to the mitotic spindle may act to target a 
portion of cellular CK2 towards substrates associated with the mitotic spindle. In order to 
further examine the regulatory mechanisms acting on CK2 during mitosis, we next chose 
to examine the possibility that hierarchical phosphorylation between CK2 and Cdk1 may 
contribute to the regulation of CK2 activity towards certain mitotic substrates. This 
possibility was intriguing because at these sites, CK2 activity would depend on the 
activation state of Cdk1, essentially putting CK2 under the same strict regulatory forces. 
However, our results show that hierarchical phosphorylation between Cdk1 and CK2 is 
unlikely to occur using strictly primed determinants. Due to this, we next asked whether a 
downstream Cdk1 site could synergize with weak canonical determinants to form a novel 
CK2 site. This was indeed the case, and we conducted a genome-wide peptide match 
search to identify possible candidate substrates. Strikingly, GO analysis revealed that the 
most highly enriched group of proteins in the peptide match results are components of the 
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mitotic spindle. This indicates that Cdk1/CK2 hierarchical phosphorylation may have a 
significant impact on the phosphorylation status of the mitotic spindle. Validation and 
characterization of these substrates will provide a wealth of information on the roles of 
CK2 in mitotic regulation.   
 Collectively, the results in this thesis show that CK2 activity is regulated through 
phosphorylation, protein-protein interactions, subcellular localization, and hierarchical 
phosphorylation to ensure proper mitotic progression. This demonstrates that although 
CK2 is constitutively active, it is indeed subjected to various subtle regulatory 
mechanisms that allow it to participate in a multitude of cellular signalling pathways. 
Further work on the regulation and roles of CK2 in various cellular processes, 
particularly through the use of chemical genetics, proteomics and bioinformatics, will not 
only expand our understanding of how CK2 acts in these pathways, but also our 
understanding of the complex integration of cellular signalling. 
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